InPlay from Briefing.com

5:42 pm Approach Resources beats by $0.05, misses on revs (AREX) : Reports Q1 (Mar) earnings of $0.06 per share, $0.05 better than the Capital IQ Consensus Estimate of $0.01; revenues rose 18.5% year/year to $36.27 mln vs the $36.98 mln consensus.

• Production for first quarter 2013 totaled 754 MBoe (8.4 MBoe/d), compared to production of 654 MBoe (7.2 MBoe/d) in first quarter 2012, a 15% increase
• Oil production for first quarter 2013 increased 63% to 310 MBbls, compared to 191 MBbls produced in first quarter 2012.
• Production for first quarter 2013 was 41% oil, 28% NGLs and 31% natural gas, compared to 29% oil, 33% NGLs and 38% natural gas in first quarter 2012.
• Costs incurred during first quarter 2013 totaled $69.5 million, consisting of $61.8 million for drilling and completion activities, $6.7 million for pipeline, infrastructure projects and other equipment and $1 million for acreage acquisitions and extensions and 3-D seismic data acquisition.

5:35 pm Outdoor Channel agrees to increased price in transaction with Kroenke Sports & Entertainment; merger consideration increased to $9.35 (OUTD) : Co announced that it entered into an amendment to its merger agreement dated March 13, 2013 with Kroenke Sports & Entertainment, LLC ("KSE"). Under the terms of the amended merger agreement, the merger consideration has been increased to $9.35 per share (compared to the previously agreed consideration of $8.75 per share), which increased consideration represents a premium of 23.8% to Outdoor Channel's closing stock price on March 1, 2013, which was the last trading day prior to the public disclosure of KSE's proposal to acquire Outdoor Channel. Outdoor Channel's board of directors approved the amendment to the merger agreement and recommends that Outdoor Channel's stockholders vote to approve the adoption of the amended merger agreement at the special meeting of Outdoor Channel stockholders to be held on May 8, 2013.

5:28 pm DaVita: U.S. District Court dismisses case against DaVita (DVA) : Co announced that a U.S. District Court has dismissed a civil complaint filed in 2011 against DaVita? in the U.S. District Court for the Eastern District of Michigan. The company previously reported in its 2013 annual report Form 10-K that it was served with the civil complaint in January of this year by a former patient, Laura Turner-Hooks. At the time the company was served with the complaint, it learned that the U.S. Department of Justice had investigated the matter and declined to intervene or pursue the allegations in the case.

5:27 pm MGM Resorts announces launch of exchange offer for 6.750% senior notes due 2020 (MGM) : Co announced that it has commenced an offer to exchange any and all of its outstanding $1.0 billion aggregate principal amount of 6.750% Senior Notes due 2020 for new 6.750% Senior Notes due 2020 that have been registered under the Securities Act of 1933, as amended.

5:24 pm Southwestern Energy beats by $0.04, misses on revs (SWN) : Reports Q1 (Mar) earnings of $0.42 per share, excluding non-recurring items, $0.04 better than the Capital IQ Consensus Estimate of $0.38; revenues rose 9.2% year/year to $504.5 mln vs the $529.44 mln consensus.

"This results from our production which grew by 11% and our constant focus on keeping our costs low. Our gross operated production in the Marcellus Shale was slower than planned early in the quarter but reached 400 MMcf of gas per day in mid-April and, as a result, we have raised our production guidance in the latter half of the year. When you add on top of this the sizeable acreage acquisition in the Marcellus we announced earlier this week and our continued optimism about our New Ventures projects, we are looking forward to delivering even more value during 2013."

5:18 pm Canadian Natrl Res misses by $0.05, beats on revs (CNQ) : Reports Q1 (Mar) earnings of CC$0.37 per share, excluding non-recurring items, CC$0.05 worse than the Capital IQ Consensus Estimate of CC$0.42; revenues rose 3.3% year/year to CC$4.1 bln vs the CC$3.38 bln consensus.

Outlook:
The co forecasts 2013 production levels before royalties to average between 1,085 and 1,145 MMcf/d of natural gas and between 482,000 and 513,000 bbl/d of crude oil and NGLs. Q2/13 production guidance before royalties is forecast to average between 1,090 and 1,110 MMcf/d of natural gas and between 435,000 and 461,000 bbl/d of crude oil and NGLs

5:08 pm CubeSmart reports FFO in-line, beats on revs; guides Q2 FFO in-line; guides FY13 FFO in-line (CUBE) : Reports Q1 (Mar) funds from operations of $0.20 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.20; revenues rose 22.5% year/year to $78.5 mln vs the $77.15 mln consensus.

Guidance: Co issues in-line guidance for Q2, sees FFO of $0.21-$0.22 vs. $0.21 Capital IQ Consensus Estimate. Co issues in-line guidance for FY13, sees FFO of $0.81-$0.86 vs. $0.85 Capital IQ Consensus Estimate. Co sees FY13 same-store net operating income growth of 5.75% to 6.75% over 2012 (previously 5.0% to 6.0%), driven by revenue growth of 5.5% to 6.0% (previously 4.75% to 5.25%) and expense growth of 4.0% to 5.0% (previously 3.5% to 4.5%).

5:08 pm Rent-A-Center announces accelerated stock buyback (RCII) : Co announced that it has entered into an agreement with Goldman, Sachs & Co. to repurchase $200 million of the Company's common stock under an accelerated stock buyback program (the "ASB transaction"). The Company is purchasing these shares as part of its previously authorized $1.25 billion common stock repurchase plan. Proceeds from the Company's recently completed debt offering will be used to fund the ASB transaction. Under the agreement, the Company is scheduled to pay $200 million to Goldman Sachs on May 7, 2013 and to receive approximately 4.6 million shares, currently estimated to represent approximately 80% of the shares expected to be purchased in the ASB transaction.

5:07 pm Hillenbrand misses by $0.04, misses on revs; guides FY13 EPS in-line, revs in-line (HI) : Reports Q2 (Mar) earnings of $0.49 per share, $0.04 worse than the Capital IQ Consensus Estimate of $0.53; revenues rose 53.4% year/year to $398.5 mln vs the $437.85 mln consensus.

Co issues in-line guidance for FY13, sees EPS of $1.82-1.92, excluding non-recurring items, vs. $1.89 Capital IQ Consensus Estimate; sees FY13 revs of $1.6 bln vs. $1.6 bln Capital IQ Consensus Estimate.

5:02 pm Pilgrim's Pride beats by $0.01, reports revs in-line (PPC) : Reports Q1 (Mar) earnings of $0.21 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.20; revenues rose 7.8% year/year to $2.04 bln vs the $2.03 bln consensus.

Co reported EBITDA of $116.9 million and net income of $54.6 million, resulting in earnings per share of $0.21 for the quarter.

"Every quarter we see that our strategy and execution is working effectively. We delivered better results year over year despite $141 million of increased feed ingredient costs. By focusing on creating value with our key customers, we have diversified our product mix, honed our execution and are seeing our portfolio of business become a more profitable model,"

5:01 pm Medtronic announces FDA classification of deep brain stimulation lead cap communication (MDT) : Co issued an Urgent Medical Device Correction notification in February 2013 to provide physicians with information concerning the potential for deep brain stimulation (DBS) lead damage associated with the use of the lead cap provided in Medtronic DBS lead kits and dystonia therapy kits. Medtronic has received reports of DBS leads being damaged due to twisting of the connector within the lead cap during the surgical procedure. Depending on the extent of lead damage due to twisting of the connector during the placement and removal of the lead cap, lead replacement may be required or optimal therapy may not be achieved. A manufacturing change intended to address the issue is currently under FDA review, and in the meantime Medtronic has issued modified instructions to physicians who may use DBS lead caps.

5:01 pm Marketaxess announces total monthly trading volume for April 2013 of $56.6 bln, consisting of $36.1 bln in U.S. high-grade volume, $15.1 bln other credit volume, and $5.4 bln in liquid products volume (MKTX) :  

5:00 pm Addus HomeCare beats by $0.06, beats on revs (ADUS) : Reports Q1 (Mar) earnings of $0.20 per share, excluding non-recurring items, $0.06 better than the Capital IQ Consensus Estimate of $0.14; revenues rose 7.0% year/year to $63 mln vs the $62.14 mln consensus.

Subsequent Events
"The State of Illinois passed legislation in April 2013 to increase funding for the Illinois Department on Aging ("IDoA") for the fiscal year ending June 30, 2013. This legislation is pending the governor's signature. As part of the legislation, IDoA was required to submit a plan to improve the cost effectiveness of the program. As a result, IDoA initiated technical changes to the method for reimbursing providers effective May 1, 2013. We estimate that Q1 net service revenues would have been reduced by ~$0.6 million with no corresponding reduction in the cost of service revenues, if such changes had been in effect beginning January 1, 2013. Given the recent increase in Addus' share price, it is likely Addus will be required to audit our compliance with Section 404 of the Sarbanes-Oxley Act. If required, the Company will have to invest in additional staff and establish processes necessary to meet the documentation requirements and incur increased external audit fees to include an audit of our internal controls."

4:58 pm Parametric Sound reports EPS of ($0.30) vs. ($0.22) in prior year; revs rose to $155K from $60K in prior year (PAMT) : The Company also reported progress in each of its business sectors: commercial, consumer and health applications. Discussions with companies interested in pursuing strategic options beyond licensing are progressing... As previously announced, the Company has been approached by several industry leaders in key target verticals to discuss strategic alternatives for its HyperSound (:HSS) technology. It has engaged the investment bank Houlihan Lokey to help assess the opportunities. The Company has received a term sheet from a leader in one of its target verticals and is now undergoing due diligence. The Company has also received and is evaluating strategic inquiries from additional parties.

4:56 pm Globus Medical beats by $0.01, beats on revs (GMED) : Reports Q1 (Mar) earnings of $0.21 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.20; revenues rose 10.9% year/year to $105 mln vs the $103.14 mln consensus. Non-GAAP Adjusted EBITDA was 33.8% of sales.

"I am very pleased with this quarter's results, especially measured against our strong first quarter last year. Once again, our ability to deliver innovative products, attract top sales force talent and maintain financial discipline has enabled us to consistently deliver superior growth and profitability. We launched two products this quarter, and are on track to reach our annual target of 5-10 new products annually."

4:54 pm Allergan: FDA Advisory Committee unanimously recommends JUVEDERM VOLUMA XC as a safe and effective treatment option for cheek augmentation to correct age-related volume deficit in the mid-face (AGN) : Co announced that the FDA General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee has voted unanimously that the benefits of JUVEDERM VOLUMA XC, an injectable hyaluronic acid dermal filler for cheek augmentation to correct age-related volume deficit in the mid-face, outweigh the risks. If approved, JUVEDERM VOLUMA XC would be the first and only dermal filler in the United States with this indication. The Advisory Committee's recommendation, although not binding, will be considered by the FDA when making the final approval decision for JUVEDERM VOLUMA XC. If approved by the FDA, Allergan anticipates launching JUVEDERM VOLUMA XC in late 2013.

4:53 pm AMN Healthcare Services beats by $0.04, beats on revs; guides Q2 revs in-line (AHS) : Reports Q1 (Mar) earnings of $0.16 per share, $0.04 better than the Capital IQ Consensus Estimate of $0.12; revenues rose 11.4% year/year to $252.1 mln vs the $247.88 mln consensus.

• Co issues in-line guidance for Q2, sees Q2 revs of $251 to $255 mln vs. $254.24 mln Capital IQ Consensus Estimate. Gross margin is expected to be approximately 28.5%. SG&A expenses as a percentage of revenue are expected to be approximately 21.0% to 21.5%. Adjusted EBITDA margin is expected to be approximately 7.5% to 8.0%.

4:52 pm MBIA announces settlement with Flagstar Bank (FBC) of $110 mln in cash and other consideration (MBI) : Co announced that its wholly-owned subsidiary, MBIA Insurance Corporation has entered into an agreement to settle the lawsuit filed by MBIA Corp. on January 11, 2013 against Flagstar Bank and certain affiliated entities. The lawsuit related to approximately ".1 bln of securitization transactions backed by second-lien mortgages which were insured by co in 2006 and 2007. Under the terms of the Settlement Agreement, co will terminate its pending lawsuit against Flagstar and in exchange will receive "10.0 mln in cash and other consideration. Co will use the cash received to repay a portion of its secured loan from National Public Finance Guarantee Corp. in accordance with its terms.

4:52 pm Kite Realty beats by $0.03, beats on revs; guides FY13 FFO in-line (KRG) : Reports Q1 (Mar) funds from operations of $0.14 per share, $0.03 better than the Capital IQ Consensus Estimate of $0.11; revenues rose 29.4% year/year to $32.1 mln vs the $28.37 mln consensus.

Co raises in-line guidance for FY13, sees FFO of $0.44-0.48 vs. $0.45 Capital IQ Consensus Estimate, from $0.43-0.47.

4:51 pm MasTec beats by $0.03, beats on revs; guides Q2 EPS below consensus, revs below consensus; guides FY13, revs in-line (MTZ) : Reports Q1 (Mar) earnings of $0.27 per share, ex-items, $0.03 better than the Capital IQ Consensus Estimate of $0.24; revenues rose 24.4% year/year to $918.6 mln vs the $854.87 mln consensus.

Guidance: Co issues downside guidance for Q2, sees EPS of $0.42 vs. $0.48 Capital IQ Consensus Estimate; sees Q2 revs of $950 mln vs. $1.02 bln Capital IQ Consensus Estimate. Second quarter 2013 continuing operations EBITDA is estimated to be $103 million and continuing operations EBITDA margin is currently estimated to be 10.8%.

Co issues guidance for FY13, sees adjusted EPS of $1.80, inclusive of $0.04-$0.05 of additional interest costs related to the recent upsized senior note offering. Current consensus is for EPS of $1.84. Co sees FY13 revs at the high end of its prior range at $4.0 bln vs. $4.01 bln Capital IQ Consensus Estimate.

4:49 pm Black Hills Corp beats by $0.13 (BKH) : Reports Q1 (Mar) earnings of $0.87 per share, $0.13 better than the Capital IQ Consensus Estimate of $0.74. 

• "Adjusted earnings per share increased 34 percent resulting from higher earnings at our electric and gas utilities and lower interest expense. The utilities benefited from customer rate adjustments, the Wyoming construction financing rider and increased demand across most customer classes. A return to more normal weather provided approximately $0.10 per share positive earnings impact compared to the same quarter last year, mostly in the gas utilities. Interest expense was down due to lower outstanding debt."

4:49 pm National Fuel Gas beats by $0.04, misses on revs; guides FY13 EPS above consensus (NFG) : Reports Q2 (Mar) earnings of $1.02 per share, $0.04 better than the Capital IQ Consensus Estimate of $0.98; revenues rose 8.2% year/year to $597.8 mln vs the $616.8 mln consensus. Co issues upside guidance for FY13, sees EPS of $2.95-3.10, up from prior guidance of $2.75-3.00, and vs. $2.94 Capital IQ Consensus Estimate.

4:48 pm Chemtura misses by $0.03, misses on revs (CHMT) : Reports Q1 (Mar) earnings of $0.15 per share, $0.03 worse than the Capital IQ Consensus Estimate of $0.18; revenues fell 1.9% year/year to $606 mln vs the $640.85 mln consensus.

"We anticipate that Industrial Performance Products, Consumer Products and Chemtura AgroSolutions will continue their positive performance trends in Q2 of 2013," observed Mr. Rogerson. While we expect that demand from insulation foam and electronics applications will improve during 2013, current customer indications suggest a marked improvement is unlikely in Q2, leading us to project only modest improvement from Industrial Engineered Products for Q2. In the interim, we are focused on establishing appropriate pricing levels for bromine based products and implementing cost reduction actions." "For Chemtura, the second quarter will show significant sequential improvement with the benefit of our seasonal businesses. However, unless we see a more marked improvement from Industrial Engineered Products, it will be a significant challenge to equal the performance levels of Q2 of 2012."

4:46 pm Select Medical misses by $0.02, misses on revs; guides FY13 EPS below consensus, revs in-line (SEM) : Reports Q1 (Mar) earnings of $0.25 per share, excluding non-recurring items, $0.02 worse than the Capital IQ Consensus Estimate of $0.27; revenues rose 0.8% year/year to $749.95 mln vs the $760.59 mln consensus.

• Co issues mixed guidance for FY13, sees EPS of $0.87 to $0.94, excluding non-recurring items, vs. $1.01 Capital IQ Consensus Estimate; sees FY13 revs of $2.925 to $3.025 bln vs. $3 bln Capital IQ Consensus Estimate.

4:46 pm Entravision reports EPS in-line, revs in-line (EVC) : Reports Q1 (Mar) loss of $0.01 per share, in-line with the Capital IQ Consensus Estimate consensus of ($0.01); revenues rose 5.6% year/year to $49.1 mln vs the $48.82 mln consensus.

4:45 pm Expeditors Intl increases semi-annual dividend to $0.30 from $0.28 per share (EXPD) :  

4:44 pm Home Properties beats by $0.01, reports revs in-line; guides Q2 FFO in-line; raises low end of FY13 FFO (HME) : Reports Q1 (Mar) funds from operations of $1.05 per share, $0.01 better than the Capital IQ Consensus Estimate of $1.04; revenues rose 9.1% year/year to $167.1 mln vs the $166.65 mln consensus.

Co issues in-line guidance for Q2, sees FFO of $1.07-1.11 vs. $1.08 Capital IQ Consensus Estimate.

Co issues in-line guidance for FY13, raises FFO to $4.32-4.44 from $4.28-4.44 vs. $4.38 Capital IQ Consensus Estimate.

4:43 pm Dick's Sporting Goods announces Andre Hawaux will join the co in June, 2013 as Executive Vice President-Finance, Administration and Chief Financial Officer (DKS) : Mr. Hawaux joins co with over 30 years of experience, most recently as President, Consumer Foods at ConAgra Foods.

4:42 pm Hain Celestial reports EPS in-line, misses on revs; guides FY13 EPS in-line, revs below consensus (HAIN) : Reports Q3 (Mar) earnings of $0.72 per share, excluding non-recurring items, in-line with the Capital IQ Consensus Estimate consensus of $0.72; revenues rose 21.4% year/year to $456.09 mln vs the $480.26 mln consensus.

• Co issues mixed guidance for FY13, sees EPS of $2.43 to $2.47 vs. $2.46 Capital IQ Consensus Estimate; sees FY13 revs of $1.727 to $1.734 bln vs. $1.74 bln Capital IQ Consensus Estimate.

4:42 pm Emulex beats by $0.01, beats on revs; guides Q4 EPS below consensus, revs above consensus (ELX) : Reports Q3 (Mar) earnings of $0.14 per share, excluding non-recurring items, $0.01 better than the Capital IQ Consensus Estimate of $0.13; revenues fell 7.1% year/year to $116.8 mln vs the $112.56 mln consensus.

Co issues downside EPS guidance for Q4, sees EPS of $0.11-0.13 vs. $0.16 Capital IQ Consensus Estimate; sees Q4 revs of $118-122 mln vs. $116.90 mln Capital IQ Consensus Estimate.

4:42 pm Camden Property beats by $0.01, reports revs in-line; guides Q2 FFO in-line; guides FY13 FFO in-line (CPT) : Reports Q1 (Mar) funds from operations of $0.96 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.95; revenues rose 15.6% year/year to $196.2 mln vs the $195.7 mln consensus.

Co issues in-line guidance for Q2, sees FFO of $0.96-1.00, excluding non-recurring items, vs. $0.98 Capital IQ Consensus Estimate.

Co issues in-line guidance for FY13, raises FFO to $3.89-4.05, excluding non-recurring items, from $3.85-4.05 vs. $3.97 Capital IQ Consensus Estimate.

4:42 pm Microchip beats by $0.02, reports revs in-line; guides Q1 EPS above consensus, revs in-line (MCHP) : Reports Q4 (Mar) earnings of $0.49 per share, $0.02 better than the Capital IQ Consensus Estimate of $0.47; revenues rose 26.9% year/year to $430.1 mln vs the $426.96 mln consensus.

• Co issues guidance for Q1, sees EPS of $0.50-0.54 vs. $0.49 Capital IQ Consensus Estimate; sees Q1 revs of $438.7-456.0 mln vs. $447.37 mln Capital IQ Consensus Estimate.

4:41 pm Fortune Brands Home & Security beats by $0.08, beats on revs; raises FY13 EPS above consensus, revs in-line (FBHS) : Reports Q1 (Mar) earnings of $0.24 per share, before charges/gains, $0.08 better than the Capital IQ Consensus Estimate of $0.16; revenues rose 11.4% year/year to $890 mln vs the $862.95 mln consensus.

Co issues guidance for FY13, raises EPS of $1.23-1.33 from prior guidance of $1.13-1.23 vs. $1.22 Capital IQ Consensus Estimate; sees FY13 revs of +9-11% calc to ~$3.914-3.986 bln vs. $3.92 bln Capital IQ Consensus Estimate. (prior guidance called for revenue to increase at 'high single digit rate').

"Sales in our home products segments grew a combined 16 percent vs. last year, once again outperforming the market, with our cabinets, plumbing and entry doors performing especially well. Importantly, this was very profitable growth, with total company operating income before charges/gains tripling. New housing construction continued at a strong pace, and spending for home repairs and remodeling began to improve despite cooler weather in many parts of the country that held back exterior projects like windows,"

Dividend: On April 30, 2013, the Company announced its Board of Directors approved a quarterly cash dividend payment of $0.10 per share of common stock. The Company is initiating this dividend approximately 19 months after becoming an independent company.

4:41 pm Active Network misses by $0.07, beats on revs; guides Q2 revs below consensus (ACTV) : Reports Q1 (Mar) loss of $0.25 per share, $0.07 worse than the Capital IQ Consensus Estimate of ($0.18); revenues rose 12.3% year/year to $106 mln vs the $104.89 mln consensus. Gross margin increased 230 bps to 52.6%.

Gudiance: Co issues downside guidance for Q2, sees Q2 revs of $128-$133 mln vs. $136.39 mln Capital IQ Consensus Estimate. Registrations are expected to grow approximately 3% to 8% and revenue per registration is expected to grow approximately 3% to 5% compared to the same period in the prior year. The company expects a net loss of $10 million to $3 million and Adjusted EBITDA in the range of $18 million to $21 million.

For FY13, co states that "Due to the recent management changes, ACTV is prioritizing and accelerating its strategic and financial goals for the remainder of the year. Accordingly, the Company will not be providing full year 2013 guidance at this time, but expects to do so once it has had an opportunity to align its financial projections with its go-forward strategy."

4:40 pm Avon Products: Co has received a judgement for ~$28.4 mln in dispute with Cessna Aircraft (AVP) : Co reports that it has received a Memorandum and Order of the United States District Court for the District of Kansas which heard the motion by Cessna Aircraft Company, as filed by Cessna on November 26, 2012, to vacate the arbitration award made on November 16, 2012 in favour of the co in the amount of $27.4 mln.  Cessna's motion to vacate was denied and the Court affirmed the award to the Company.  In addition, the Court awarded post-award prejudgement interest at a rate of 10% per annum from December 16, 2012 to the date of judgement.  This prejudgement interest award totals approximately $1 mln.  The Court is expected to enter final judgement against Cessna in the amount of approximately $28.4 mln on or about May 8, 2013.  Cessna could appeal the judgement to the United States Court of Appeals for the Tenth Circuit by filing a notice within thirty days of entry of judgement.

4:40 pm Bill Barrett misses by $0.25, misses on revs (BBG) : Reports Q1 (Mar) loss of $0.25 per share, excluding non-recurring items, $0.25 worse than the Capital IQ Consensus Estimate of ($0.00); revenues fell 22.8% year/year to $138.3 mln vs the $142.87 mln consensus.

FY13 guidance: Capital expenditures of $475 to $525 million, unchanged. Oil and natural gas production of 86 to 90 Bcfe, on a three-stream basis, unchanged. The Company is targeting 50%-plus growth in oil production in 2013 over 2012 and expects approximately 6% to 8% of production will be NGLs (assuming ethane rejection for the year), unchanged. Lease operating costs of $62 to $67 million, unchanged. Gathering, transportation and processing costs of $65 to $68 million, reduced from $72 to $75 million. The reduction is a result of a change in accounting methodology effective January 1, 2013 in which certain crude oil trucking charges are classified as a reduction in revenue rather than as a transportation expense. General and administrative expenses before non-cash stock-based compensation cost of $50-54 million, unchanged.

4:39 pm Sierra Wireless beats by $0.03, beats on revs; guides Q2 EPS in-line, revs above consensus (SWIR) : Reports Q1 (Mar) loss of $0.02 per share, excluding non-recurring items, $0.03 better than the Capital IQ Consensus Estimate of ($0.05); revenues rose 9.9% year/year to $101.4 mln vs the $100.07 mln consensus.

Co issues in-line guidance for Q2, sees EPS of $0.01-0.04, excluding non-recurring items, vs. $0.04 Capital IQ Consensus Estimate; upside Q2 revs of $107-111 vs. $106.10 mln Capital IQ Consensus Estimate.

4:38 pm Apt Inv & Mgt beats by $0.02, beats on revs; guides Q2 FFO below consensus; raises FY13 FFO slightly, in-line (AIV) : Reports Q1 (Mar) funds from operations of $0.48 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus Estimate of $0.46; revenues rose 1.3% year/year to $255.5 mln vs the $246.73 mln consensus.

Co issues downside guidance for Q2, sees FFO of $0.45-0.49, excluding non-recurring items, vs. $0.50 Capital IQ Consensus Estimate.

Co issues in-line guidance for FY13, raises FFO $0.02 to $1.94-2.10, excluding non-recurring items, vs. $2.01 Capital IQ Consensus Estimate.  

"Aimco had a solid first quarter and we are on track for a good year. First quarter property operating results were on target and portfolio management activities were executed as planned. In the first quarter we began lease-up at two of our redevelopment properties, Lincoln Place and Elm Creek. As expected, total leverage continues to decline with predictable income growth and scheduled property debt amortization paid from retained earnings. We are off to a good start in 2013."

4:38 pm OpenTable beats by $0.02, reports revs in-line; guides Q2 EPS in-line, revs in-line; guides FY13 EPS in-line, revs in-line (OPEN) : Reports Q1 (Mar) earnings of $0.45 per share, $0.02 better than the Capital IQ Consensus Estimate of $0.43; revenues rose 15.5% year/year to $45.5 mln vs the $45.57 mln consensus.

• Installed restaurant base as of March 31, 2013, totaled 20,128, a 13% increase over March 31, 2012.
• Seated diners totaled 34.3 million, a 24% increase over Q1 2012.
• Guidance:
• Co issues in-line guidance for Q2, sees EPS of $0.45-0.49 vs. $0.47 Capital IQ Consensus Estimate; sees Q2 revs of $44.9-46.2 mln vs. $46.66 mln Capital IQ Consensus Estimate.
• Co issues in-line guidance for FY13, sees EPS of $1.88-2.02 vs. $1.90 Capital IQ Consensus Estimate; sees FY13 revs of $185.3-190.9 mln vs. $189.43 mln Capital IQ Consensus Estimate.

"We're pleased with seated diner growth during the first quarter in both our North America and International business segments," said Matt Roberts, President and CEO of OpenTable. "More than one third of the 34 million diners we seated in North America during the quarter were attributable to mobile, and we're continuing to optimize our mobile products around the globe to further capitalize on the opportunity."

4:38 pm Dun & Bradstreet misses by $0.02, misses on revs; reaffirmed FY13 guidance (DNB) : Reports Q1 (Mar) earnings of $1.36 per share, excluding non-recurring items, $0.02 worse than the Capital IQ Consensus Estimate of $1.38; revenues fell 5.4% year/year to $381 mln vs the $386.94 mln consensus.

•  Co reaffirmed its financial guidance for the full year 2013:
• Core revenue growth of 0% to 3%, before the effect of foreign exchange
• Operating income decline of 6% to 3%, before non-core gains and charges, including $25 million to $30 million in costs related to the deployment of our new data supply chain
• Diluted EPS growth of 8% to 11%, before non-core gains and charges
• Free cash flow of $270 million to $300 million, which excludes the impact of legacy tax matters and any potential regulatory fines associated with our China operations

4:35 pm CEC Entertainment beats by $0.09, beats on revs; guides FY13 EPS above consensus (CEC) : Reports Q1 (Mar) earnings of $1.90 per share, $0.09 better than the Capital IQ Consensus Estimate of $1.81; revenues rose 3.5% year/year to $255.3 mln vs the $246.9 mln consensus. Co issues upside guidance for FY13, sees EPS of $2.80-2.95 vs. $2.69 Capital IQ Consensus Estimate.

4:34 pm Hercules Tech beats by $0.02, beats on revs (HTGC) : Reports Q1 (Mar) earnings of $0.27 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus Estimate of $0.25; total investment income rose 38.4% year/year to $31 mln vs the $29.35 mln consensus. Q1 2013 NII of ~$15.0 million, or $0.27 per share, up 31.6% from Q1 2012 Q1 DNOI of $16.2 million, or $0.30 per share, up 32.8% from Q1 2012

4:34 pm American Vanguard beats by $0.13, beats on revs (AVD) : Reports Q1 (Mar) earnings of $0.59 per share, $0.13 better than the Capital IQ Consensus Estimate of $0.46; revenues rose 39.2% year/year to $121.5 mln vs the $113.55 mln consensus.

Commentary: "Our net sales increase of 39% was driven largely by the strong demand for both our granular soil insecticides and our Impact herbicide in the U.S. corn market. Gross profit margins rose to 44% on a profitable product mix, improved pricing and continued progress on factory utilization. Operating expenses as a percentage of net sales declined to 23%, despite higher selling and administrative expenses associated with our dynamic growth. Stronger sales, improved gross margins and operating expense management enabled us to improve our net income by 94%...to a very strong 14% of net sales."

4:34 pm Cumberland Pharma reports EPS in-line, beats on revs (CPIX) : Reports Q1 (Mar) earnings of $0.05 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.05; revenues were unchanged from the year-ago period at $10.3 mln.

4:33 pm Loews Corp Prices $1.0 bln offering of senior notes; $500 mln of 2.625% senior notes due 2023 and $500 mln of 4.125% senior notes due 2043 (L) : Co intends to use the net proceeds from the offering for general corporate purposes. Barclays, J.P. Morgan, BofA Merrill Lynch, Citigroup, and Wells Fargo Securities are acting as joint book-running managers for the offering.

4:33 pm Pool increases quarterly dividend by 19% to $0.19 per share from $0.16 per share (POOL) :  

4:32 pm Center Bancorp, Inc. announces resignation of CFO Vincent Tozzi (CNBC) : Co announced that Vincent Tozzi has informed the Corporation that he is resigning from the positions of Vice President, Treasurer & Chief Financial Officer of Center and as Senior Vice President and Chief Financial Officer of UCNB, effective May 31, 2013, to pursue other business opportunities. The Bank announced that Francis "Rich" Patryn, Senior Vice President & Comptroller, will be assuming the role of interim Chief Financial Officer. Rich currently serves as UCNB's Comptroller, a role he assumed in 1997. Rich holds a BS from St. Peters College and is a Graduate of the Stonier Graduate School of Banking.

4:31 pm AtriCure misses by $0.01, beats on revs; guides FY13 revs in-line (ATRC) : Reports Q1 (Mar) loss of $0.10 per share, $0.01 worse than the Capital IQ Consensus Estimate of ($0.09); revenues rose 11.2% year/year to $19.4 mln vs the $18.6 mln consensus. Co issues in-line guidance for FY13, sees FY13 revs of $76.5-78.0 mln vs. $77.5 mln Capital IQ Consensus Estimate.

4:31 pm QLogic beats by $0.01, beats on revs (QLGC) : Reports Q4 (Mar) earnings of $0.17 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.16; revenues fell 13.5% year/year to $116.9 mln vs the $115.35 mln consensus.

4:31 pm Zimmer Hldgs acquires Knee Creations' Business; financial terms not disclosed (ZMH) :  

4:31 pm Weight Watchers beats by $0.27, reports revs in-line; narrows FY13 EPS guidance range, above consensus (WTW) : Reports Q1 (Mar) earnings of $0.87 per share, $0.27 better than the Capital IQ Consensus Estimate of $0.60; revenues fell 3.3% year/year to $486.9 mln vs the $484.27 mln consensus.

Co issues upside guidance for FY13, narrows EPS to $3.60-3.90 from prior guidance of $3.50-4.00 versus the $3.59 Capital IQ Consensus Estimate.

"As we previously indicated, the winter diet season proved to be challenging for recruitment across our businesses given a weak consumer backdrop and an intensely competitive environment. In response, we have made several adjustments to improve our position in the market with consumers, including new advertising campaigns. Further, we are gaining early traction with our cost savings program while continuing to work to innovate our core product offerings to better enable us to increasingly address the ever growing obesity epidemic,"

Guidance Details: The Company has narrowed its full year 2013 earnings guidance to a range of between $3.60 and $3.90 per fully diluted share, which includes the impact of approximately $0.15 related to higher interest expense from the Company's recent debt refinancing. This earnings guidance range excludes an expected one-time charge to be taken in the second quarter related to the write-off of fees associated with the debt refinancing. The new earnings guidance range compares with the Company's previously provided earnings guidance range of between $3.50 and $4.00 per fully diluted share.

4:31 pm Procera Networks misses by $0.10, beats on revs; raises FY13 revs above consensus (PKT) : Reports Q1 (Mar) loss of $0.16 per share, $0.10 worse than the Capital IQ Consensus Estimate of ($0.06); revenues rose 14.9% year/year to $14.17 mln vs the $13.59 mln consensus.

Co issues upside guidance for FY13, sees FY13 revs of at least 30% growth year over year (calcs to ~$77.52 mln) vs. $74.87 mln Capital IQ Consensus Estimate. This is raised from prior guidance of +25-30% growth.

4:30 pm Burger King Franchisee Yi-Ko Holding GmbH acquires company-owned BURGER KING Restaurants in Germany (BKW) : Co announced the sale of its wholly-owned subsidiary Burger King GmbH and its 91 company-owned BURGER KING restaurants in Germany to Yi-Ko Holding GmbH, owned and operated by Mr. Ergun Yildiz and Mr. Alexander Kolobov. As part of the transaction, Yi-Ko Holding GmbH has agreed to develop new BURGER KING restaurants during the next five years and remodel an additional 57 BURGER KING restaurants during the next 18 months.

4:30 pm Kodiak Oil & Gas misses by $0.07, reports revs in-line (KOG) : Reports Q1 (Mar) earnings of $0.07 per share, $0.07 worse than the Capital IQ Consensus Estimate of $0.14; revenues rose 106.6% year/year to $165.1 mln vs the $166.09 mln consensus. Net income for the first quarter 2013 includes an unrealized loss of $17.2 million related to the mark-to-market of derivative instruments used for commodity hedging. The net effect, after-tax, of the non-cash hedging activities decreased Kodiak's reported net income for the first quarter 2013 by $0.04 per basic and diluted share.

4:30 pm Callidus Software announces Bob Corey as new CFO (CALD) : Prior to joining the Company, Mr. Corey served as the chief financial officer of FrontRange Solutions USA Inc., an enterprise software company, since May 2012. Mr. Corey is replacing Ronald J. Fior, who has served as the Company's Senior Vice President, Finance & Operations and Chief Financial Officer for the past ten years. Mr. Fior will remain in his present role through the filing of the Company's Form 10-Q for the first quarter of 2013, and will continue with the Company through July 31, 2013 to help ensure a smooth transition.

4:30 pm Masimo reports EPS in-line, beats on revs (MASI) : Reports Q1 (Mar) earnings of $0.28 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.28; revenues rose 14.0% year/year to $135.9 mln vs the $134.46 mln consensus. First quarter 2013 earnings per share were reduced by approximately $0.03 due to non-operating expenses primarily related to realized and unrealized net losses on foreign currency denominated transactions due to the strengthening of the U.S. dollar against the Japanese yen.

4:29 pm Move beats by $0.01, reports revs in-line; guides Q2 revs above consensus; guides FY13 revs in-line, announces $20 mln stock repurchase program (MOVE) : Reports Q1 (Mar) earnings of $0.09 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.08; revenues rose 13.6% year/year to $54.2 mln vs the $53.81 mln consensus.

Other Metrics: Average monthly unique users of Move's web and mobile sites grew 10% year-over-year to more than 28 million in the first quarter. Mobile app page views grew significantly, up over 100% year-over-year in Q1, while page views on the web also rose by 3% year-over-year. Cash provided by operating activities was $3.5 million and $4.1 million for the quarters ended March 31, 2013 and 2012, respectively.

Share Buyback: Move also announced that its Board of Directors has authorized a two year, $20 million stock repurchase program.

Guidance: Co issues upside guidance for Q2, sees Q2 revs of $56-$56.5 mln vs. $55.46 mln Capital IQ Consensus Estimate. Co issues in-line guidance for FY13, sees FY13 revs of $224-$226 mln vs. $224.53 mln Capital IQ Consensus Estimate. Expects to report Adjusted EBITDA margin of approximately 14%.

4:28 pm Omnicell beats by $0.02, reports revs in-line (OMCL) : Reports Q1 (Mar) earnings of $0.21 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus Estimate of $0.19; revenues rose 35.8% year/year to $87.1 mln vs the $87.2 mln consensus.

4:27 pm inContact beats by $0.01, reports revs in-line (SAAS) : Reports Q1 (Mar) loss of $0.02 per share, $0.01 better than the Capital IQ Consensus Estimate of ($0.03); revenues rose 23.4% year/year to $31.6 mln vs the $31.51 mln consensus.  Software segment revenue totaled $16.2 million for the quarter ended March 31, 2013, an increase of $3.9 million or 31% from $12.3 million in Q1 2012. Telecom segment revenue for Q1 2013 was $15.5 million for the quarter ended March 31, 2013, an increase of $2.2 million or 17% from $13.3 million in Q1 2012, driven by increases in software-related telecom revenue. This increase marks the tenth consecutive quarter that software and software related telecom revenue has increased.

4:27 pm Power Integrations misses by $0.03, misses on revs; guides Q2 revs in-line (POWI) : Reports Q1 (Mar) earnings of $0.47 per share, excluding non-recurring items, $0.03 worse than the Capital IQ Consensus Estimate of $0.50; revenues rose 7.3% year/year to $77.04 mln vs the $79.39 mln consensus.

• Co issues in-line guidance for Q2, sees Q2 revs of $79-85 mln vs. $83.11 mln Capital IQ Consensus Estimate.
• Q2 non-GAAP gross margin is expected to be between 52 percent and 53 percent.

4:26 pm ON Semiconductor beats by $0.03, reports revs in-line; guides Q2 revs in-line (ONNN) : Reports Q1 (Mar) earnings of $0.10 per share, excluding non-recurring items, $0.03 better than the Capital IQ Consensus Estimate of $0.07; revenues fell 11.2% year/year to $661 mln vs the $665.69 mln consensus.

Co issues in-line guidance for Q2, sees Q2 revs of $675-715 mln vs. $702.60 mln Capital IQ Consensus Estimate. "Backlog levels for the second quarter of 2013 represent ~80 to 85 percent of our anticipated second quarter 2013 revenues. We expect that average selling prices for the second quarter of 2013 will be down ~one to two percent when compared to the first quarter of 2013. The outlook for the second quarter of 2013 includes stock-based compensation expense of ~$10 to $12 million."

4:26 pm Mylan Labs reports EPS in-line, misses on revs; reaffirms FY13 EPS guidance (MYL) : Reports Q1 (Mar) earnings of $0.62 per share, excluding non-recurring items, in-line with the Capital IQ Consensus Estimate consensus of $0.62; revenues rose 3.0% year/year to $1.63 bln vs the $1.69 bln consensus.

Co reaffirms guidance for FY13, sees EPS of $2.75-2.95 vs. $2.87 Capital IQ Consensus Estimate.

Adjusted operating cash flow of $90 million for the three months ended March 31, 2013, an increase of 30%  compared to the same prior year period. Third party net revenues from North America were $732.8 million for the current quarter, compared to $767.7 million for the comparable prior year period, representing a decrease of $34.9 million, or 4.5%. Third party net revenues from Asia Pacific were $305.1 million for the current quarter, compared to $298.7 million for the comparable prior year period, an increase of $6.4 million, or 2.2%.

4:26 pm Thor Industries pre-reports AprQ revenue in-line with consensus (THO) : Co provides guidance for Q3 (Apr). Co expects to report revenue of $1.05 bln vs $1.06 bln Capital IQ consensus.

• RV sales were $929.3 mln in Q3, up 15.1% YoY. Towable RV sales were $742.1 mln, up 9.1% YoY. Motorized RV sales increased 47.8% YoY to $187.2 mln. Bus sales were flat at $119.2 mln.
• Consolidated backlog on April 30 was $849.2 mln, up 28.0% YoY.
• "Thor achieved record sales for the third quarter of fiscal 2013 based on the strength of the overall RV market and in particular, the growing recovery of the motorized RV market. We have seen improving retail traffic and increased dealer optimism as signs of a healthy market entering the seasonally important spring and summer selling period."
• Co will report full Q3 results on June 6.

4:25 pm XL Capital beats by $0.29, misses on revs (XL) : Reports Q1 (Mar) net operating earnings of $0.93 per share, $0.29 better than the Capital IQ Consensus Estimate of $0.64; net premiums written rose 4.0% year/year to $2.04 bln vs the $2.11 bln consensus.

4:24 pm Axcelis Tech misses by $0.01, misses on revs (ACLS) : Reports Q1 (Mar) loss of $0.08 per share, $0.01 worse than the Capital IQ Consensus Estimate of ($0.07); revenues fell 26.0% year/year to $40.7 mln vs the $43.56 mln consensus.

4:24 pm MRC Global beats by $0.01, misses on revs; guides FY13 EPS below consensus, revs in-line (MRC) : Reports Q1 (Mar) earnings of $0.45 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.44; revenues fell 5.6% year/year to $1.3 bln vs the $1.36 bln consensus.

Commentary: "The industry-wide slowdown we saw in the fourth quarter continued into the first two months of this year, particularly in the upstream and midstream sectors, resulting in lower revenues as compared to our strong first quarter a year ago. However, our gross profit improved over the same period a year ago as we continued to rebalance our product mix away from the OCTG business. We also realized substantial interest expense savings due to the refinancing steps we took in the fourth quarter of 2012. As a result, we generated net income growth of 23% in the quarter..." 

Guidance: Co issues mixed guidance for FY13, sees EPS of $2.10-$2.30 vs. $2.33 Capital IQ Consensus Estimate; sees FY13 revs of $5.75-$5.95 bln vs. $5.91 bln Capital IQ Consensus Estimate. Co sees Adj. EBITDA of $480-$510 mln.

4:24 pm Neurocrine Biosci reports EPS in-line, misses on revs (NBIX) : Reports Q1 (Mar) loss of $0.18 per share, in-line with the Capital IQ Consensus Estimate consensus of ($0.18); revenues fell 93.8% year/year to $0.7 mln vs the $1.07 mln consensus. The Company's balance sheet at March 31, 2013 reflected total assets of $183.9 million, including cash, cash equivalents, investments and receivables of $176.9 million compared with balances at December 31, 2012 of $196.0 million and $188.3 million, respectively.  

4:24 pm Mohawk beats by $0.03, misses on revs; guides Q2 EPS above consensus (MHK) : Reports Q1 (Mar) earnings of $0.87 per share, excluding non-recurring items, $0.03 better than the Capital IQ Consensus Estimate of $0.84; revenues rose 5.5% year/year to $1.49 bln vs the $1.53 bln consensus. Co issues upside guidance for Q2, sees EPS of $1.58-1.67, excluding non-recurring items, vs. $1.52 Capital IQ Consensus Estimate.

4:24 pm CafePress beats by $0.01, beats on revs; guides Q2 EPS below consensus, revs in-line; reaffirms FY13 EPS guidance, guides FY13 revs in-line (PRSS) : Reports Q1 (Mar) loss of $0.08 per share, $0.01 better than the Capital IQ Consensus Estimate of ($0.09); revenues rose 31.7% year/year to $52.51 mln vs the $46.8 mln consensus.

• Orders totaled 1,429,106, a 70% year-over-year increase, including the consolidation of EZ Prints, Inc. into CafePress' business.
• Average Order Size (AOS) was $35 including the consolidation of EZ Prints, a 27% decrease year-over-year, reflecting the smaller order size of the EZ Prints B2B business. AOS excluding the impact of EZ Prints was $53, a 10% increase year-over-year.

Co issues mixed guidance for Q2, sees EPS of ($0.11)-($0.04), excluding non-recurring items, vs. ($0.02) Capital IQ Consensus Estimate; sees Q2 revs of $50.5-54.5 mln vs. $53.98 mln Capital IQ Consensus Estimate. "Our second quarter guidance reflects a shift in the historical weighting of our business due to the revenue and profit seasonality of newly acquired businesses, the expected timing of partner programs and the continued investment in the consolidation of our manufacturing operations. All of these factors point toward a higher percentage of revenue and profit in the fourth quarter for CafePress."

Co issues mixed guidance for FY13, sees EPS of $0.07-0.22, excluding non-recurring items, vs. $0.17 Capital IQ Consensus Estimate; sees FY13 revs of $248-261 mln (raised from $246-259 mln) vs. $252.02 mln Capital IQ Consensus Estimate.

4:24 pm Univ Elec beats by $0.04, beats on revs; guides Q2 EPS in-line, revs above consensus (UEIC) : Reports Q1 (Mar) earnings of $0.26 per share, excluding non-recurring items, $0.04 better than the Capital IQ Consensus Estimate of $0.22; revenues rose 10.6% year/year to $114.7 mln vs the $108.09 mln consensus.

Co issues guidance for Q2, sees EPS of $0.36-0.46, excluding non-recurring items, vs. $0.41 Capital IQ Consensus Estimate; sees Q2 revs of $124-130 mln vs. $121.22 mln Capital IQ Consensus Estimate.

 "Subscription broadcasting remains a strong contributor to sales, particularly in the Americas and Europe where subscribers continue to upgrade and add new services. Our core businesses also remain strong, and we are gaining traction by embedding our technologies into new categories including smart devices such as smartphones, tablets, smart TVs, game consoles and over-the-top services. Interfaces are becoming more dynamic and complex, presenting significant opportunities for UEI as we are the recognized leader in providing comprehensive yet simple device control technologies. We are talking to all the major players in the midst of their development plans, and the future has never looked brighter."

4:23 pm Neustar beats by $0.01, reports revs in-line; guides FY13 EPS in-line, revs in-line (NSR) : Reports Q1 (Mar) earnings of $0.80 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.79; revenues rose 8.4% year/year to $216.4 mln vs the $217.38 mln consensus. Co issues in-line guidance for FY13, sees EPS of $3.28-3.43 vs. $3.34 Capital IQ Consensus Estimate; sees FY13 revs of $895-915 mln vs. $905.03 mln Capital IQ Consensus Estimate.

4:22 pm Genomic Health misses by $0.01, reports revs in-line (GHDX) : Reports Q1 (Mar) loss of $0.03 per share, $0.01 worse than the Capital IQ Consensus Estimate of ($0.02); revenues rose 7.9% year/year to $63.1 mln vs the $62.9 mln consensus.

4:21 pm Genomic Health and ECOG-ACRIN Cancer Research Group announce publication of positive DCIS validation study in the Journal of the National Cancer Institute (GHDX) : The study demonstrated that 70 percent of patients who met the eligibility criteria for participation in ECOG E5194 had a low DCIS Score and may be able to forego radiation therapy. Compared with patients whose tumor had an intermediate or high DCIS Score, patients with a low DCIS Score had a significantly lower likelihood of a local recurrence at 10 years (about 11 percent vs. 26 percent, respectively). In addition, a low DCIS Score was associated with a significantly lower risk of developing invasive breast cancer, which was approximately 4 percent in the low score group, 12 percent in the intermediate score group, and 19 percent in the high score group. The DCIS Score was predictive of local recurrence across patient subgroups regardless of lesion size, grade, surgical margins, or menopausal status.

4:20 pm Cardtronics beats by $0.02, misses on revs; reaffirms FY13 EPS guidance, revs guidance (CATM) : Reports Q1 (Mar) earnings of $0.40 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus Estimate of $0.38; revenues rose 3.5% year/year to $197.7 mln vs the $200.42 mln consensus. Co reaffirms guidance for FY13, sees EPS of $1.72-1.79 vs. $1.74 Capital IQ Consensus Estimate; sees FY13 revs of $835-850 mln vs. $843.14 mln Capital IQ Consensus Estimate.

4:20 pm Oplink Comms misses by $0.01, reports revs in-line; guides Q4 EPS in-line, revs in-line (OPLK) : Reports Q3 (Mar) earnings of $0.18 per share, $0.01 worse than the Capital IQ Consensus Estimate of $0.19; revenues rose 0.2% year/year to $44.1 mln vs the $43.87 mln consensus.

Guidance: Co issues in-line guidance for Q4, sees EPS of $0.18-$0.24 vs. $0.22 Capital IQ Consensus Estimate; sees Q4 revs of $43-$47 mln vs. $46.32 mln Capital IQ Consensus Estimate.

4:20 pm RealPage reports EPS in-line, revs in-line; guides Q2 and FY13 in-line (RP) : Reports Q1 (Mar) earnings of $0.13 per share, excluding non-recurring items, in-line with the Capital IQ Consensus Estimate consensus of $0.13; non-GAAP revenues rose 19.4% year/year to $89.0 mln vs the $88.9 mln consensus. Co issues in-line guidance for Q2, sees EPS of $0.13-0.14, excluding non-recurring items, vs. $0.14 Capital IQ Consensus Estimate; sees Q2 non-GAAP revs of $93.5-95.0 mln vs. $94.4 mln Capital IQ Consensus Estimate. Co issues in-line guidance for FY13, sees EPS of $0.57-0.60, excluding non-recurring items, vs. $0.59 Capital IQ Consensus Estimate; sees FY13 non-GAAP revs of $384-390 mln vs. $385.5 mln Capital IQ Consensus Estimate.

4:19 pm Mettler-Toledo beats by $0.04, misses on revs; guides Q2 EPS below consensus; raises FY13 EPS in-line (MTD) : Reports Q1 (Mar) earnings of $1.84 per share, $0.04 better than the Capital IQ Consensus Estimate of $1.80; revenues fell 2.1% year/year to $524.35 mln vs the $534.16 mln consensus.

Co issues downside guidance for Q2, sees EPS of $2.30-2.35, excluding non-recurring items, vs. $2.36 Capital IQ Consensus Estimate.

Co issues in-line guidance for FY13, sees EPS of $10.40-10.60, excluding non-recurring items, (raised from $10.30-10.55) vs. $10.57 Capital IQ Consensus Estimate.

"While market conditions remain challenging with significant uncertainty in the global economy, we expect conditions to improve as the year progresses.  We made adjustments to our cost structure last year in anticipation of slower market growth.  Therefore, while we will continue to monitor the environment closely, we believe we are well positioned to expand margins despite modest sales growth expectations for the year.  We remain focused on the execution of our strategic initiatives and continue to see opportunities to further gain market share, despite the environment."

4:19 pm Chefs' Warehouse reports EPS in-line, revs in-line; guides FY13 EPS in-line, revs above consensus (CHEF) : Reports Q1 (Mar) earnings of $0.14 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.14; revenues rose 42.1% year/year to $139.4 mln vs the $138.06 mln consensus.

• Co issues mixed guidance for FY13, sees EPS of $0.88-0.98 vs. $0.94 Capital IQ Consensus Estimate; sees FY13 revs of $650-690 mln vs. $619.62 mln Capital IQ Consensus Estimate.
• "We are very pleased with our first quarter results as we continued to integrate the Michael's and Queensgate acquisitions, while remaining focused on growing our core customer base," said Chris Pappas, chairman and chief executive officer of The Chefs' Warehouse, Inc. "Subsequent to the end of the quarter, we continued our growth strategy of pursing attractive acquisitions with our May 1st announcement of the acquisition of Qzina Specialty Foods. Our pipeline of acquisition candidates interested in becoming part of The Chefs' Warehouse remains very strong. In addition, we noted modest sequential improvement in our customers' businesses in the quarter. We were also pleased with the $100.0 million long-term debt financing we completed on April 17th. We believe the proceeds from this financing will help us continue to build The Chefs' Warehouse into the leading specialty foods distributor in the country."

4:18 pm DCT Industrial Trust beats by $0.01, beats on revs; raised FFO in-line (DCT) : Reports Q1 (Mar) funds from operations of $0.11 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.10; revenues rose 17.1% year/year to $73.2 mln vs the $70.14 mln consensus.

Co raised guidance for FY13, sees FFO of $0.41-0.46 vs. $0.43 Capital IQ Consensus Estimate, up from $0.40-0.45.

4:17 pm Emergent BioSolutions misses by $0.08, misses on revs; guides Q2 revs in-line; guides FY13 revs in-line (EBS) : Reports Q1 (Mar) loss of $0.22 per share, $0.08 worse than the Capital IQ Consensus Estimate of ($0.14); revenues fell 14.3% year/year to $43.1 mln vs the $46.17 mln consensus.

Co issues in-line guidance for Q2, sees Q2 revs of $70-80 mln vs. $76.43 mln Capital IQ Consensus Estimate.

Co issues reaffirms guidance for FY13, sees FY13 revs of $290-310 mln vs. $297.65 mln Capital IQ Consensus Estimate; split between product sales of $230 to $240 million and contracts and grants revenue of $60 to $70 million. The co is also reaffirming its full year 2013 net income forecast of $20 to $30 million.

4:17 pm Audience beats by $0.09, beats on revs; guides Q2 EPS above consensus, revs in-line (ADNC) : Reports Q1 (Mar) earnings of $0.27 per share, $0.09 better than the Capital IQ Consensus Estimate of $0.18; revenues rose 51.8% year/year to $47.2 mln vs the $44.57 mln consensus.

Gross margin on a GAAP basis for the first quarter of 2013 was 54.0% of revenue, compared to 56.9% of revenue for the same period in 2012.

Commentary: "Audience earSmart solutions continued to gain traction during the first quarter of 2013 with new products shipping from key customers including Samsung, Dell, Huawei and Xiaomi. We believe our diversification strategy is creating a strong foundation for long term growth as Advanced Voice leads the next wave of human interface across numerous consumer platforms."

Guidance: Co issues mixed guidance for Q2, sees EPS of $0.15-$0.19 vs. $0.13 Capital IQ Consensus Estimate; sees Q2 revs of $43-$46 mln vs. $43.54 mln Capital IQ Consensus Estimate. Second quarter non-GAAP gross margin is expected to be in the range of 56.5% to 59.5%.

4:17 pm Health Management beats by $0.02, beats on revs (HMA) : Reports Q1 (Mar) earnings of $0.13 per share, $0.02 better than the Capital IQ Consensus Estimate of $0.11; revenues rose 2.2% year/year to $1.72 bln vs the $1.71 bln consensus.

• Adjusted EBITDA was $198.9 mln

4:16 pm Carbonite reports EPS in-line, revs in-line; guides Q2 EPS in-line, revs above consensus; guides FY13 EPS in-line, revs in-line (CARB) : Reports Q1 (Mar) loss of $0.18 per share, in-line with the Capital IQ Consensus Estimate consensus of ($0.18); revenues rose 31.7% year/year to $24.5 mln vs the $24.46 mln consensus.

• Bookings for the first quarter of 2013 were $29.3 million, an increase of 20% from $24.5 million in the first quarter 2012.
• Co issues mixed guidance for Q2, sees EPS of ($0.10) to ($0.12), excluding non-recurring items, vs. ($0.11) Capital IQ Consensus Estimate; sees Q2 revs of $25.7-25.9 mln vs. $25.54 mln Capital IQ Consensus Estimate.
• Co issues in-line guidance for FY13, sees EPS of ($0.40) to ($0.44) vs. ($0.42) Capital IQ Consensus Estimate; sees FY13 revs of $104.0 to $106.0 mln vs. $105.40 mln Capital IQ Consensus Estimate.

4:16 pm Parametric Sound's directed sound product to be installed in additional Build-A-Bear Workshop (BBW) stores (PAMT) : Co announced that Build-A-Bear Workshop (BBW) will include the Company's HyperSound product in an additional 20-25 newly designed stores that it plans to open across North America this year.

4:16 pm Pros Holdings beats by $0.02, beats on revs; guides Q2 EPS below consensus, revs above consensus (PRO) : Reports Q1 (Mar) earnings of $0.15 per share, $0.02 better than the Capital IQ Consensus Estimate of $0.13; revenues rose 24.4% year/year to $33.6 mln vs the $33.02 mln consensus. Co issues mixed guidance for Q2, sees EPS of $0.09-0.11 vs. $0.12 Capital IQ Consensus Estimate; sees Q2 revs of $34.8-35.4 mln vs. $34.50 mln Capital IQ Consensus Estimate.

4:15 pm ADA-ES Awarded $30 million in contracts for activated carbon and dry sorbent injection systems from multiple utilities (ADES) : Co announced that it has recently received awards and letters of intent to award for approximately $30 million in Activated Carbon Injection (ACI) and Dry Sorbent Injection (DSI) systems from multiple utilities. Work has begun on some of the projects and deliveries of the systems are scheduled to begin in 2014. ADA believes that the MATS and other emission control regulations could generate a total market in excess of $1 billion for ACI and DSI systems. Since the MATS market commenced in 2011, ADA has won or received letters of intent to award contracts currently valued at approximately $75 million for DSI and ACI systems. They are currently working on bids or discussing potential projects for ACI and DSI systems in excess of $180 million.

4:15 pm Lee Enterprises promotes Kevin Mowbray to Chief Operating Officer (LEE) : Mr. Mowbray has been president and publisher of the Post-Dispatch since 2006.

4:15 pm Navigators Group beats by $0.02, beats on revs (NAVG) : Reports Q1 (Mar) earnings of $0.75 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus Estimate of $0.73; revenues rose 12.4% year/year to $221.37 mln vs the $217.05 mln consensus.

4:14 pm LinkedIn beats Q1 ests; guides Q2 EBITDA, revs below consensus; raises FY13 EBITDA, rev guidance (below consensus) (LNKD) : Reports Q1 (Mar) earnings of $0.45 per share, excluding non-recurring items, $0.14 better than the Capital IQ Consensus Estimate of $0.31; revenues rose 72.3% year/year to $324.7 mln vs the $318.04 mln consensus; adj. EBITDA $83.4 mln vs. $67-69 mln vs. $71 mln consensus.

Co issues downside guidance for Q2, sees Q2 revs of $342-347 mln vs. $359.89 mln Capital IQ Consensus Estimate; sees Q2 adj. EBITDA of $77-79 mln vs. the ~$85 mln consensus.

Co raises FY13 guidance below consensus, raises FY13 rev to $1.43-1.46 bln from $1.41-1.44 vs. $1.50 bln Capital IQ Consensus Estimate; raises FY13 adj. EBITDA to $330-345 mln from $315-330 mln vs. the $357 mln consensus.

Talent Solutions: Revenue from Talent Solutions products totaled $161.0 million, an increase of 90% compared to the fourth quarter of 2011. Talent Solutions revenue represented 53% of total revenue in the fourth quarter of 2012, compared to 51% in the fourth quarter of 2011.

Marketing Solutions: Revenue from Marketing Solutions products totaled $83.2 million, an increase of 68% compared to the fourth quarter of 2011. Marketing Solutions revenue represented 27% of total revenue in the fourth quarter of 2012, compared to 30% in the fourth quarter of 2011.

Premium Subscriptions: Revenue from Premium Subscriptions products totaled $59.4 million, an increase of 79% compared to the fourth quarter of 2011. Premium Subscriptions represented 20% of total revenue in the fourth quarter of 2012 and 2011. 

4:13 pm Bruker Corp. misses by $0.06, misses on revs; lowers FY13 EPS below consensus (BRKR) : Reports Q1 (Mar) earnings of $0.08 per share, excluding non-recurring items, $0.06 worse than the Capital IQ Consensus Estimate of $0.14; revenues fell 3.0% year/year to $393.4 mln vs the $416.76 mln consensus. Co issues downside guidance for FY13, sees EPS of $0.80-0.83 vs. $0.91 Capital IQ Consensus Estimate, a reduction of $0.08 from previous guidance, due primarily to the weaker

4:13 pm National Cinemedia beats by $0.01, beats on revs; guides Q2 revs in-line; reaffirms FY13 revs guidance (NCMI) : Reports Q1 (Mar) net of breakeven, $0.01 better than the Capital IQ Consensus Estimate of ($0.01); revenues rose 3.9% year/year to $82.2 mln vs the $79.94 mln consensus.

• Co issues in-line guidance for Q2, sees Q2 revs of $117-122 mln vs. $115.72 mln Capital IQ Consensus Estimate.
• Co reaffirms guidance for FY13, sees FY13 revs of $455-465 mln vs. $461.75 mln Capital IQ Consensus Estimate.
• "Our strong Q1 results reflected our continued focus on expanding our network geographic reach, our strategy to secure more content partner and other client commitments upfront and a great effort by our media sales teams", said Kurt Hall National CineMedia's Chairman and CEO. Mr. Hall continued, "With the strength of our Q1 and Q2 local and regional business and strong late Q2 national scatter activity, we appear to also be benefiting from the steady economic recovery and the impact of time shifting and programming fragmentation in the media marketplace. These macro trends also appear to be helping online and mobile video which has further expanded the video advertising marketplace in which we compete."

4:13 pm Fluor beats by $0.06, beats on revs; reaffirms FY13 EPS guidance (FLR) : Reports Q1 (Mar) earnings of $1.02 per share, $0.06 better than the Capital IQ Consensus Estimate of $0.96; revenues rose 14.2% year/year to $7.19 bln vs the $6.89 bln consensus.

New awards for the first quarter were at $6.5 billion, including $3.1 billion in Oil & Gas and $2.2 billion in Industrial & Infrastructure. Consolidated backlog at the end of the quarter was $37.5 billion, down 12% from a year ago mainly due to a downturn in the mining and metals market.

Guidance: Co reaffirms guidance for FY13, sees EPS of $3.85-$4.35 vs. $4.18 Capital IQ Consensus Estimate.

4:13 pm TeleComm Sys reports EPS in-line, misses on revs (TSYS) : Reports Q1 (Mar) earnings of $0.04 per share, excluding non-recurring items, in-line with the Capital IQ Consensus Estimate consensus of $0.04; revenues fell 5.2% year/year to $94.8 mln vs the $102.07 mln consensus.

"In the quarter we realized growth in our cybersecurity business, 9-1-1 services for network operators and state and local governments, field support of deployable systems, and in-building wireless projects. TCS navigation was included in the operating system of new products of our first wireless device customer. Our solid performance under the WWSS contract vehicle has transformed TCS into a major integrator of deployable C4ISR systems, and task order RFPs are now beginning to flow under the $2.6 billion CS2 and $10 billion GTACS contract vehicles."

4:13 pm Volcano beats by $0.02, misses on revs; guides FY13 EPS below consensus, lowers revs above consensus (VOLC) : Reports Q1 (Mar) earnings of $0.02 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus Estimate of ($0.00); revenues rose 3.1% year/year to $93.2 mln vs the $96.11 mln consensus.

Co issues downside guidance for FY13, sees EPS of $0.03-0.05 vs. $0.07 Capital IQ Consensus Estimate; co lowers FY13 revs guidance to $394-400 mln vs. $410.43 mln Capital IQ Consensus Estimate, down from $406-412 mln.

4:13 pm LTC Properties announces offering of 3 mln shares of its common stock (LTC) : Wells Fargo Securities, KeyBanc Capital Markets, BMO Capital Markets and RBC Capital Markets will act as joint book-running managers for the Offering. The co intends to use the net proceeds from the Offering to pay down amounts outstanding under its unsecured line of credit, to fund acquisitions and the current development pipeline and for general corporate purposes.

4:12 pm Vocera misses by $0.05, misses on revs; guides FY13 EPS below consensus, revs below consensus, several significant expansion deals with hospitals were not completed (VCRA) : Reports Q1 (Mar) loss of $0.07 per share, excluding non-recurring items, $0.05 worse than the Capital IQ Consensus Estimate of ($0.02); revenues fell 3.1% year/year to $22.4 mln vs the $24.3 mln consensus. Co issues downside guidance for FY13, sees EPS of $(0.05)-0.18, excluding non-recurring items, vs. $0.42 Capital IQ Consensus Estimate; sees FY13 revs of $100-110 mln vs. $122.8 mln Capital IQ Consensus Estimate.

• "We were disappointed with this quarter's results. Although the first quarter saw a very nice increase in new customer signings, several significant expansion deals for U.S. hospitals that we expected to sign in the quarter, were not completed. We believe this shortfall was driven by two factors: (1) increased financial scrutiny from our hospital customers as a result of lower utilization and reduced reimbursement rates under reform, and (2) inconsistent sales execution across market segments.
• "To address our sales execution issue, we are creating three new leadership positions: EVP -Worldwide Sales and Service, VP-US Healthcare Sales, and VP-International Sales. Based on these results and market dynamics, we're reducing our full year 2013 outlook."

4:12 pm Procera Networks Receives Multi-Million Dollar Follow-On Order for PL20000 From Tier 1 European Network Operator (PKT) :  

4:12 pm Procera Networks receives multi-million dollar order from North American MSO to deliver network intelligence (PKT) :  

4:12 pm Two Harbors Investment announces acquisition of company with certain MSR approvals (TWO) : Co announced that one of its wholly-owned subsidiaries has acquired a company which has approvals from the Federal National Mortgage Association (Fannie Mae), the Federal Home Loan Mortgage Corporation, (Freddie Mac) and the Government National Mortgage Association (Ginnie Mae) to hold and manage mortgage servicing rights (MSRs). The company will discuss the implications of this acquisition in greater length on its first quarter earnings conference call, which is scheduled for 9:00 a.m. EST on Wednesday, May 8, 2013.

4:11 pm Digital River beats by $0.13, beats on revs; guides Q2 EPS below consensus, revs below consensus; guides FY13 EPS below consensus, revs in-line (DRIV) : Reports Q1 (Mar) earnings of $0.33 per share, excluding non-recurring items, $0.13 better than the Capital IQ Consensus Estimate of $0.20; revenues rose 11.0% year/year to $113.7 mln vs the $102.61 mln consensus.

• Co issues downside guidance for Q2, sees EPS of $0.01-0.04, excluding non-recurring items, vs. $0.13 Capital IQ Consensus Estimate; sees Q2 revs of $89-92 mln vs. $93.35 mln Capital IQ Consensus Estimate.
  Co issues mixed guidance for FY13, sees EPS of $0.55-0.65, excluding non-recurring items, vs. $0.78 Capital IQ Consensus Estimate; sees FY13 rev growth of 2-5%, equates to ~$394-406 mln vs. $395.50 mln Capital IQ Consensus Estimate.

4:11 pm Gilead Sciences misses by $0.02, misses on revs; reaffirms FY13 revs guidance (GILD) : Reports Q1 (Mar) earnings of $0.48 per share, $0.02 worse than the Capital IQ Consensus Estimate of $0.50; revenues rose 10.9% year/year to $2.53 bln vs the $2.57 bln consensus.

• Co reaffirms guidance for FY13, sees FY13 product revs of $10.0-10.2 bln.
• Antiviral product sales increased 7 percent to $2.06 billion for the first quarter of 2013, up from $1.93 billion for the first quarter of 2012, reflecting sales growth of 8 percent in Europe and 7 percent in the U.S. The increase reflects strong underlying demand, specifically for Complera/Eviplera and Stribild, partially offset by a decrease in sales of Truvada (emtricitabine and tenofovir disoproxil fumarate).

4:11 pm Rudolph Tech receives customer acceptance of first JetStep system for advanced packaging applications (RTEC) :  

4:10 pm TTM Tech beats by $0.03, beats on revs; guides Q2 EPS in-line, revs below consensus (TTMI) : Reports Q1 (Mar) earnings of $0.13 per share, $0.03 better than the Capital IQ Consensus Estimate of $0.10; revenues rose 8.3% year/year to $325.4 mln vs the $320.73 mln consensus.

"While we experienced normal seasonality during the quarter, we were pleased to realize a year-over-year increase in revenue due to increased sales in our cellular phone and networking end markets. We were also encouraged to see an improvement in the aerospace and defense end market both sequentially and year-over-year, despite current defense budget challenges."

Co issues mixed guidance for Q2, sees EPS of $0.08-0.14 vs. $0.14 Capital IQ Consensus Estimate; sees Q2 revs of $320-340 mln vs. $340.74 mln Capital IQ Consensus Estimate.

4:10 pm TeleComm Sys announces $50 mln convertible senior notes exchange transaction (TSYS) : Co has entered into privately-negotiated exchange agreements with noteholders to retire $50 million in aggregate principal of its outstanding 4.5% Convertible Senior Notes (the "Original Notes") due in 2014. The Original Notes will be exchanged for $50 mln in aggregate principal of new 7.75% Convertible Senior Notes (the "New Notes") due in 2018. The closing of the exchange transactions is expected to occur on May 7, 2013. Following these transactions, $43.5 mln in aggregate principal amount of the Original Notes will remain outstanding. The initial conversion price of the New Notes is unchanged from the Original Notes and remains "0.348 per share of Class A common stock which is equivalent to a conversion rate of approximately 96.637 shares of Class A common stock per ",000 principal amount of New Notes. The company may redeem some or all of the New Notes at any time on or after June 30, 2014 at the redemption prices set forth in the indenture governing the New Notes plus accrued and unpaid interest to the redemption date.

4:10 pm FleetCor beats by $0.07, beats on revs; Raises FY13 EPS and rev guidance above consensus (FLT) : Reports Q1 (Mar) earnings of $0.90 per share, $0.07 better than the Capital IQ Consensus Estimate of $0.83; revenues rose 32.5% year/year to $193.7 mln vs the $182.35 mln consensus.

Guidance: Co raises guidance for FY13, sees EPS of $3.70-$3.80 vs. prior expectation of $3.61-$3.69 and vs $3.68 Capital IQ Consensus Estimate; sees FY13 revs of $810-$820 mln vs. prior expectation of $790-$810 mln and vs. $814.82 mln Capital IQ Consensus Estimate.

Commentary: "Given our strong first quarter results and our recently completed acquisitions, we are raising our financial guidance for 2013. Included in our updated guidance is the expectation that our two recent acquisitions, in Australia and New Zealand, will be accretive to both revenue and profit in 2013, and we expect the acquisitions to add approximately $0.04 in adjusted net income per share, including deal and restructuring costs, for the remainder of 2013."

4:09 pm GSI Technology comments on status of patent litigation With Cypress Semiconductor (CY); co believes initial determination of non-infringement was correct and it will be upheld (GSIT) : As previously announced, on October 25, 2012, Chief Administrative Judge Charles E. Bullock issued his initial determination in which he found that our SRAM devices, and products containing them, do not infringe the four patents asserted against GSI and others in the ITC proceeding and that Cypress had failed to establish the requisite domestic industry that practices those patents. That determination, as well as a supplemental determination finding the asserted patents not to be invalid, are currently under review by the full Commission. The target date for concluding the ITC investigation is June 25, 2013.

4:09 pm Semtech announces $400 million credit agreement (SMTC) : Co announced it has executed a new credit agreement consisting of a senior secured term loan facility in the principal amount of $150 million and a $250 million senior secured revolving credit facility. This new credit agreement replaces the existing $350 million credit facility. Based on current LIBOR rates, the after tax interest rate will be approximately 1.3 percent, which is approximately half the rate associated with the existing facility. Second quarter 2014 GAAP earnings will be impacted by approximately $8.7 million in non-cash costs associated with the early retirement of the existing long term debt.

4:09 pm Blue Nile beats by $0.01, reports revs in-line; guides Q2 EPS in-line, revs in-line; guides FY13 EPS in-line, revs in-line (NILE) : Reports Q1 (Mar) earnings of $0.07 per share, including stock based compensation expense of $0.05, $0.01 better than the Capital IQ Consensus Estimate of $0.06; revenues rose 16.8% year/year to $97.1 mln vs the $96.89 mln consensus.

• Co issues in-line guidance for Q2, sees EPS of $0.13-0.17 vs. $0.16 Capital IQ Consensus Estimate; sees Q2 revs of $100-105 mln vs. $103.64 mln Capital IQ Consensus Estimate.
• Co issues in-line guidance for FY13, sees EPS of $0.75-0.85 vs. $0.80 Capital IQ Consensus Estimate; sees FY13 revs of $440-470 mln vs. $455.30 mln Capital IQ Consensus Estimate.

4:08 pm Green Mtn Coffee announces its Keurig K150 Series Commercial Brewing System has been certified by the National Sanitation Foundation for foodservice use (GMCR) :  

4:08 pm Bottomline Tech beats by $0.07, reports revs slightly above consensus (EPAY) : Reports Q3 (Mar) core earnings of $0.32 per share, excluding non-recurring items, $0.07 better than the Capital IQ Consensus Estimate of $0.25; revenues rose 16.5% year/year to $64.4 mln vs the $63.8 mln consensus.

4:08 pm InvenSense beats by $0.01, beats on revs (INVN) : Reports Q4 (Mar) earnings of $0.15 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.14; revenues rose 66.9% year/year to $55.21 mln vs the $53.2 mln consensus. InvenSense ended the fiscal year of 2013 with $200.3 million in cash, cash equivalents and investments, compared to $157.8 million at the end of fiscal year 2012.

4:07 pm Capital One announces dividend increase of 20% to $0.30 per share (COF) :  

4:06 pm ACE Limited acquires personal lines insurer ABA Seguros in Mexico for ~$690 mln in cash, after a $175 million pre-closing dividend taken by the seller (Ally Financial) (ACE) :  

4:06 pm Avis Budget: Zipcar is expanding its airport access to eight new airports in North America (CAR) : The new airports include: Hartsfield-Jackson Atlanta International Airport (ATL),Austin-Bergstrom International Airport (:AUS), Los Angeles International Airport (:LAX), Palm Beach International Airport (PBI), Philadelphia International Airport (:PHL), Phoenix Sky Harbor International Airport (PHX), Mineta San Jose International Airport (:SJC), Toronto Pearson International Airport (:YYZ).

4:06 pm Callidus Software misses by $0.02, reports revs in-line; guides Q2 revs below consensus (CALD) : Reports Q1 (Mar) loss of $0.02 per share, $0.02 worse than the Capital IQ Consensus Estimate of ($0.00); revenues rose 15.9% year/year to $25.5 mln vs the $25.5 mln consensus. Co issues downside guidance for Q2, sees Q2 revs of $24.5-25.5 mln vs. $25.57 mln Capital IQ Consensus Estimate.

4:05 pm Guidance Software misses by $0.13, misses on revs; guides FY13 revs below consensus (GUID) : Reports Q1 (Mar) loss of $0.15 per share, ex-items, $0.13 worse than the Capital IQ Consensus Estimate of ($0.02); revenues rose 3.5% year/year to $26.9 mln vs the $30.48 mln consensus.

Co reports Product revenue of $7.5 million, compared to $10.5 million in the first quarter of 2012 and Services and maintenance revenue of $16.8 million, an increase of $2.5 million, or 18 percent, from $14.3 million in the first quarter of 2012.

Guidance: Co issues guidance for FY13, sees pre-tax EPS of ($0.20)-$0.00, may not compare to the $0.29 Capital IQ Consensus Estimate; sees FY13 revs of $133-$138 mln vs. $146.05 mln Capital IQ Consensus Estimate.

4:05 pm FBL Financial beats by $0.10, beats on revs (FFG) : Reports Q1 (Mar) earnings of $0.89 per share, excluding non-recurring items, $0.10 better than the Capital IQ Consensus Estimate of $0.79; revenues rose 5.3% year/year to $168.04 mln vs the $163.9 mln consensus.

4:05 pm Duke Energy notifies the Nuclear Regulatory Commission of plans to suspend its application for two proposed new nuclear units on its Harris site near New Hill in Wake County, North Carolina (DUK) :  

4:05 pm Thoratec misses by $0.05, misses on revs; guides FY13 EPS in-line, revs in-line (THOR) : Reports Q1 (Mar) earnings of $0.41 per share, excluding non-recurring items, $0.05 worse than the Capital IQ Consensus Estimate of $0.46; revenues fell 7.1% year/year to $117.7 mln vs the $122.5 mln consensus. Co issues in-line guidance for FY13, sees EPS of $1.76-1.86, excluding non-recurring items, vs. $1.83 Capital IQ Consensus Estimate; sees FY13 revs of $490-510 mln vs. $503.3 mln Capital IQ Consensus Estimate.

4:04 pm Neustar launches $250 mln share repurchase program (NSR) :  

4:04 pm Aehr Test Systems announces $1 mln in orders from leading IC manufacturer (AEHR) :  

4:04 pm ZAGG misses by $0.09, misses on revs; guides FY13 revs below consensus (stock is halted) (ZAGG) : Reports Q1 (Mar) earnings of $0.11 per share, $0.09 worse than the Capital IQ Consensus Estimate of $0.20; revenues fell 7.2% year/year to $51.5 mln vs the $66.52 mln consensus.

• Co issues downside guidance for FY13, sees FY13 revs of $274-280 mln vs. $315.78 mln Capital IQ Consensus Estimate.
• "This was a uniquely challenging quarter in which our results were impacted by a number of circumstances, some that were macro in nature and others that were company specific. Though the company experienced reduced sales, ZAGG also realized benefits to its financial activities through the pay down of our line of credit and the repurchase of company stock," said Randy Hales, president and CEO.
• "We are working internally to make necessary changes to build a superior company and increase shareholder value over the long-term. While the consequences of these changes in the near-term are challenging, I remain confident that we are building a stronger foundation for growth. Our creative product solutions, go-to-market strategies and diversification of our overall portfolio are what set ZAGG apart from the competition and our retailers have recognized that. In fact, next week a large retail customer will highlight us as one of its top suppliers in 2012 and the first ever in the mobile accessories industry."

4:03 pm Kraft Foods beats by $0.12, beats on revs; reaffirms FY13 EPS guidance (KRFT) : Reports Q1 (Mar) earnings of $0.76 per share, excluding non-recurring items, $0.12 better than the Capital IQ Consensus Estimate of $0.64; revenues rose 2.0% year/year to $4.55 bln vs the $4.49 bln consensus.

• Co reaffirms guidance for FY13, sees EPS of $2.75 vs. $2.83 Capital IQ Consensus Estimate. Organic Net Revenue growth in line with growth of the North American food and beverage market.

4:03 pm AthenaHealth beats by $0.15, beats on revs; guides FY13 EPS below consensus, revs above consensus (ATHN) : Reports Q1 (Mar) earnings of $0.38 per share, $0.15 better than the Capital IQ Consensus Estimate of $0.23; revenues rose 30.0% year/year to $125.6 mln vs the $121.05 mln consensus. Co issues mixed guidance for FY13, sees EPS of $1.05-1.15 vs. $1.22 Capital IQ Consensus Estimate; sees FY13 revs of $580-615 mln vs. $542.00 mln Capital IQ Consensus Estimate.

4:03 pm Body Central misses by $0.01, misses on revs (BODY) : Reports Q1 (Mar) earnings of $0.17 per share, $0.01 worse than the Capital IQ Consensus Estimate of $0.18; revenues fell 1.6% year/year to $81.4 mln vs the $85.75 mln consensus.

• Our first quarter results were consistent with our expectations for sales and earnings. While we have made progress towards improving our product assortment, we still expect sales challenges and margin pressure in the second quarter as we work through the legacy inventory and orders prior to transitioning to our fall floor set.

4:03 pm CB&I beats by $0.07, beats on revs (CBI) : Reports Q1 (Mar) earnings of $0.82 per share, excluding non-recurring items, $0.07 better than the Capital IQ Consensus Estimate of $0.75; revenues rose 87.4% year/year to $2.25 bln vs the $2.1 bln consensus.

4:03 pm First Marblehead regains compliance with NYSE listing standards (FMD) : Co confirmed that it has regained compliance with the NYSE continued listing standards. On November 7, 2012, the Company received notification from NYSE Regulation, Inc. that it was not in compliance with one of the continued listing standards of the NYSE. The applicable listing standard requires an average closing price of not less than $1.00 per share over a consecutive 30 trading-day period. The Company received confirmation on May 2, 2013 that it had cured the deficiency by having a closing price greater than $1.00 per share on the last trading day of April 2013 while maintaining an average share price greater than $1.00 over the 30 trading days preceding the end of that month.

4:03 pm Web.com beats by $0.03, reports revs in-line (WWWW) : Reports Q1 (Mar) earnings of $0.48 per share, excluding non-recurring items, $0.03 better than the Capital IQ Consensus Estimate of $0.45; non-GAAP revenues rose 7.4% year/year to $128.1 mln vs the $127.69 mln consensus.

4:03 pm American Campus Communities announces 6.7% increase of quarterly dividend to $0.36 per share (ACC) :  

4:03 pm Scientific Games selected by Delaware Lottery as Primary Vendor with 888 to operate internet gaming systems and services (SGMS) : Co announced that it has been selected with its partners as the primary vendor team to operate Internet Gaming Systems and Services for the Delaware State Lottery, subject to successful contract negotiations. This joint effort combines 888's decade-long experience being at the forefront of the online gaming industry with Scientific Games' proven ability to provide added value, turnkey solutions to government-sponsored (B2G) and commercial (B2B) gaming operators and Williams Interactive's premium iGaming products and services. The Lottery evaluation committee's recommendation followed a competitive selection process designed to identify service providers best suited to serve the needs of the Delaware Lottery. The contract will be for an initial term of five years and includes four additional one-year contract extension options.

4:02 pm Echelon beats by $0.04, beats on revs; guides Q2 EPS in-line, revs in-line (ELON) : Reports Q1 (Mar) loss of $0.04 per share, excluding non-recurring items, $0.04 better than the Capital IQ Consensus Estimate of ($0.08); revenues fell 37.6% year/year to $25.2 mln vs the $24.6 mln consensus. Co issues in-line guidance for Q2, sees EPS of $(0.11)-(0.05), excluding non-recurring items, vs. ($0.07) Capital IQ Consensus Estimate; sees Q2 revs of $22.5-25.5 mln vs. $24.3 mln Capital IQ Consensus Estimate.

4:02 pm American Intl beats by $0.46 (AIG) : Reports Q1 (Mar) earnings of $1.34 per share, $0.46 better than the Capital IQ Consensus Estimate of $0.88. Book value per share, excluding Accumulated other comprehensive income (AOCIF), of $59.39, up 12 percent from the prior-year first quarter. AIG Parent liquidity sources amounted to approximately $15.0 billion at March 31, 2013, including $5.5 billion allocated toward future maturities of liabilities and contingent liquidity stress needs of the Direct Investment book and Global Capital Markets.

4:01 pm Hain Celestial announces strategic acquisition of Ella's Kitchen Group; expected to be accretive in 2014 by $0.05-0.08 per share (HAIN) : Co announced the acquisition of Ella's Kitchen Group Limited and the formation of the Global Infant, Toddler & Kids Division under Hain Celestial US. Ella's Kitchen is a manufacturer and distributor of premium organic baby food under the Ella's Kitchen brand and the first company to offer baby food in convenient flexible pouches. Ella's Kitchen generated approximately $70 million in sales in calendar year 2012 and is expected to be accretive to Hain Celestial's earnings in fiscal year 2014 by $0.05 to $0.08 per diluted share. Details of the transaction were not disclosed.

4:01 pm Abraxas Petroleum Corp. Production for the quarter ended March 31, 2013 averaged 4,216 boepd (2,107 barrels of oil per day, 10.5 mmcf of natural gas per day, 359 barrels of NGLs per day) an increase of approximately 2% over the fourth quarter of 2012 (AXAS) : Co announced that production for the quarter ended March 31, 2013 averaged 4,216 boepd (2,107 barrels of oil per day, 10.5 mmcf of natural gas per day, 359 barrels of NGLs per day) an increase of approximately 2% over the fourth quarter of 2012. As previously reported, production for the month of January was substantially curtailed. Production for the month of March averaged 4,494 boepd (2,304 barrels of oil per day, 10.7 mmcf of natural gas per day, 403 barrels of NGLs per day). Abraxas recently sold several non-core Permian Basin leases in Martin County, Texas for approximately $590,000. The properties sold produce approximately 10 boepd across 480 net acres. Abraxas will retain a 5% override on approximately 80 of the 480 acres sold. The remainder of Abraxas' Oklahoma assets are scheduled to be auctioned at the Oil and Gas Clearinghouse Auction on May 8, 2013. The assets to be sold produce an average 507 mcfe/day. If successful, the asset sale, combined with the previous March Oil and Gas Clearinghouse Auction sale, will mark Abraxas' complete exit from both Louisiana and Oklahoma.

4:01 pm Skullcandy beats by $0.04, reports revs in-line (SKUL) : Reports Q1 (Mar) loss of $0.23 per share, $0.04 better than the Capital IQ Consensus Estimate of ($0.27); revenues fell 30.4% year/year to $37.1 mln vs the $37.27 mln consensus.

3:55 pm Commercial Vehicle Group announces closure of DeKalb, IL facility (CVGI) : Co announced its plans to permanently close its wire-harness assembly facility located in DeKalb, Illinois. The work currently being performed at DeKalb will be transferred to CVG facilities in Edgewood and Monona, Iowa. Seventy-five employees will be impacted by this closure, which is expected to be completed during the third quarter of 2013.

3:54 pm TripAdvisor announces acquisition of CruiseWise; financial terms not disclosed (TRIP) :  

3:50 pm SunPower beats by $0.12, beats on revs; will guide at analyst day on May 15 (SPWR) : Reports Q1 (Mar) earnings of $0.22 per share, excluding non-recurring items, $0.12 better than the Capital IQ Consensus Estimate of $0.10; Non-GAAP revenues fell 0.9% year/year to $575 mln vs the $510.05 mln consensus. 

• Co reported Q1 2013 GAAP gross margin of 9.3% versus 9.2% in Q1 of last year.
• Co reported Q1 2013 Non-GAAP gross margin of 22.7% versus 12.7% in Q1 of last year.
• "Our results reflect the benefits of our superior solar panel technology combined with strong performance from both our rooftop and ground mount teams...Regionally, North America posted excellent results in all end segments. In our power plant business, we started initial construction of the 579-megawatt antelope Valley Solar Projects for MidAmerican Solar and reached 90 percent completion on the California Valley Solar Ranch project owned by NRG Energy. With installation at CVSR expected to be finished by the end of the second quarter, we are on plan for full project completion by the end of the year. Demand in the residential lease business remained solid and once again exceeded our finance capacity in the first quarter."
• SunPower will provide the company's Q2 and FY13 outlook at its Analyst Day to be held on May 15, 2013 at 10:00 a.m. Eastern Time. 

Briefing Note: Related Peers Include: JASO, SPWR, TSL, STP, FSLR, LDK, CSIQ, YGE, EMKR, SOL, TAN, JKS, CSUN, DTSI, HOKU, ASTI, WFR

3:42 pm Enterprise Products announces plans to expand crude oil storage and distribution infrastructure serving Southeast Texas (EPD) : Co announced plans to significantly expand its crude oil storage and distribution infrastructure serving the Southeast Texas refinery market. The expansion will be completed in phases with final completion expected in the fourth quarter of 2014. Upon completion, Enterprise will be positioned to provide refiners with access to an integrated system offering supply diversification, significant storage capacity and a high-capacity distribution system that will be pipeline-connected to Southeast Texas refineries having an aggregate capacity of ~ 3.6 million barrels per day. In addition, Enterprise's Crude Oil Houston storage facility, which will be expanded to over 6 million barrels of capacity, will have access to Enterprise's marine terminal at Morgan's Point on the Houston Ship Channel.

3:34 pm Earnings Calendar (:SUMRX) : Today after the close look for the following companies to report:

• INVN, QLGC, TPX, ADNC, BERY, CPT, ELX, FBHS, GSIT, HAYN, OMCL, OPLK, PCCC, PWER, SPF, TSYS, ACLS, CARB, EPAY, GILD, HI, POWI, RTEC, HAIN, NSR, THOR, TTMI, DRIV, GEOS, GHDX, MTD, SWIR, AGNC, AIV, ATHN, CALD, CATM, DCT, FFG, FLT, GUID, HME, IMPV, KMPR, KRG, LNKD, MFLX, NFG, ONNN, OPEN, SPWR, TDC, WWWW, XL, NBIX, CUB, DNB, ELON, MOVE, NILE, PRO, NAVG, PRSS, WTW, ACTV, BCOR, HMA, MASI, SAAS, SCOR, KRFT, BRKR, CCO, FLR, RP, SWN, AHS, AIG, AREX, BBG, CEC, CHEF, CUBE, MHK, MRC, NCMI, SEM, UEIC, VOLC, EGO, CHMT, ZAGG, CBI, GMED, MCHX, MYL, VCRA, ALSK, AVD, BAGL, BODY, CPIX, ESC, GTY, HTGC, KOG, MTZ, PKT, ARNA, CNQ, EBS, SKUL, HIL, DOLE, ADUS

Tomorrow before the open look for the following companies to report:

• NWL, ADP, LRN, SE, SEP, CBM, MSG, GBDC, AXL, BPL, CBOE, MCO, YRCW, KVHI, DUK, FBN, WCG, KOP, LNT, NGLS, NRF, PPC, REGN, RUTH, UPL, TREX, DW, GTXI, HST, ZEUS, NVE, PNW, TDS, USM, ICFI, BBEP, POM, SUP, XLS, SMP

3:01 pm RLI Corp increases quarterly dividend 6.25% to $0.34 from $0.32 per share (RLI) :  

2:55 pm NYMEX Energy Closing Prices (:COMDX) :

• June crude oil rose $3.02 to $94.02/barrel
• Crude oil advanced for the first time since Monday as the European Central Bank announced its decision to lower its key interest rate by 25 basis points. Investors also reacted to weekly initial claims data that showed jobless claims falling to the lowest level since Jan of 2008. The energy component lifted off its session low of $91.26 and touched a session high of $94.10 moments before settling with a 3.3% gain.
• June natural gas fell 30 cents to $4.03/MMBtu
• Natural gas, on the other hand, fell sharply on inventory data that showed a build of 43 bcf when a much smaller build of 28-30 bcf was anticipated. It continued to trend lower for the remainder of the session and settled with a 6.9% loss.
• June heating oil rose 7 cents to $2.86/gallon
• June RBOB gasoline rose 6 cents to $2.78/gallon

2:52 pm eBay sets new session high in recent trade at 53.70, its 50 sma/ema are at 53.80/53.83 (EBAY) :  

2:34 pm CBOT Agriculture and Ethanol/ICE Sugar Closing Prices (:COMDX) :

• July corn rose 15 cents to $6.62/bushel
• July wheat rose 11 cents to $7.30/bushel
• July soybeans rose 2 cents to $13.74/bushel
• June ethanol rose 6 cents to $2.51/gallon
• July sugar (#16 (U.S.)) rose 0.32 of a penny to 19.67 cents/lbs

2:32 pm Verizon: 53.2% VZ shareowners vote 'YES' on proxy to allow long-term shareowners to nominate board candidates (VZ) : A majority of Verizon shareowners approved a Proxy Access proposal (Item #7) that amends the company's bylaws and allows shareholders to nominate a limited number of directors for election to the Board. The proxy, proposed by the Association of BellTel Retirees says shareholders should be able to nominate a candidate for Verizon's board, so long as the shareholder (or a group of shareholders) own 3% of Verizon common stock for a period of 3 years or more. 53.2% of shareowners voted in favor of the measure giving the non-profit retiree association its 10th proxy victory in 15 years.

2:30 pm StanCorp Fin issues statement on ISS recommendation (SFG) : Co announced that Institutional Shareholder Services ("ISS") revised its proxy analysis and vote recommendation to StanCorp shareholders. ISS now recommends a vote FOR Item 3 - Proposal to Re-approve and Amend the Amended 2002 Stock Incentive Plan. The Board of Directors of StanCorp continues to recommend that shareholders vote their shares FOR Item 3 - Proposal to Re-approve and Amend the Amended 2002 Stock Incentive Plan. StanCorp's 2013 Annual Meeting of Shareholders will be held on May 13, 2013.

2:25 pm Crude oil futures put in a small rally here, hitting a new session high of $93.89/barrel; now at $93.87, up 3.1% (:COMDX) :  

2:22 pm Dollar Climbs to 82.20: 10-yr: unch..1.639%..USD/JPY: 98.01..EUR/USD: 1.3059 (:SUMRX) : The Dollar Index has held on session highs near 82.20 for most of the day all of the action came following the ECB rate cut. Today's gains have the index higher for the first time in seven sessions with action on track for its best close in a week. Click here to see a daily Dollar Index chart. 

• EURUSD is -120 pips at 1.3065 as sellers have been in control since today's ECB rate cut and Mario Draghi presser. The European Central Bank lowered its key rate 25 bps to a record low 0.50% in an effort to revive economic activity in the region. Comments from Mario Draghi's accompanying press conference have weighed as he suggested the central bank is 'technically ready' for negative deposit rates. Traders will be watching the 1.3000 level closely over the days ahead as support is helped by both the 50- and 200-day moving averages. The EU Economic Forecasts will be released.
• GBPUSD is -20 pips at 1.5535 as action has managed to come off the lows. Sterling ran to a more than two-month high of 1.5590 in early action, but was sent lower as traders offered the currency in tandem with the euro. The 1.5555 area will be key over the coming days as bulls look to retake the 100-day moving average. Britain's Services PMI is due out tomorrow.
• USDCHF is +80 pips at .9350 and has regained the important .9300 level. The .9400 area continues to act as resistance with both the 50- and 200-day moving averages lending a hand.
• USDJPY is +75 pips at 98.05 as trade gains for the first time in six days. Action was once again able to hold the 97.00 level despite the Bank of Japan minutes showing some members have begun to question the aggressive central bank policies. The 100.00 area remains a key hurdle on the upside. Japanese banks are closed for Constitution Day.
• AUDUSD is -20 pips at 1.0255 as trade continues to press key support in the 1.0200 region. Today's disappointing building approvals and Chinese HSBC Final Manufacturing PMI weighed early, but sellers were unable to break the key support level. Australian data is limited to PPI.
• USDCAD is flat at 1.0080 as trade checks up on the 100-day moving average. Today's action has been rather limited with trade taking place in just a 30 pip range. Reports indicate a new head of the Bank of Canada will be named around 4 PM ET.  

1:58 pm COMEX Metals Closing Prices (:COMDX) :

• June gold rose $21.80 to $1467.50/ounce
• Gold rose for the third time this week as the European Central Bank announced its decision to lower its key interest rate by 25 basis points to a record low of 0.50%. Despite a stronger dollar index, the yellow metal climbed as high as $1473.30 and spent the remainder of the session trading just below that level. It eventually settled with a 1.5% gain.
• July silver rose $0.51 to $23.84/ounce
• Silver also traded higher but pulled back from its session high of $24.19 set moments before equity markets opened. Although it dipped to a session low of $23.69 in late morning action, silver managed to book a 2.2% gain.
• July copper rose 2 cents to $3.10/lb

1:27 pm Dow +121 and S&P +15 join Nasdaq Comp +44 at minor new session highs (SPY) :  

1:09 pm Nasdaq 100 / Comp push to new session / multi-year highs -- Dow +114, S&P +14.4 (:TECHX) :  

1:01 pm Delcath confirms trading of common stock halted (DCTH) : Co announced that the NASDAQ Stock Market halted trading of the Company's common stock this afternoon, May 2, 2013. The Oncologic Drugs Advisory Committee (:ODAC) to the U.S. Food and Drug Administration (:FDA) is meeting today to discuss Delcath's New Drug Application (:NDA) for the marketing approval of Melblez(TM) Kit (Melblez (melphalan) for Injection for use with the Delcath Hepatic Delivery System), the Company's proprietary drug/device combination product for the treatment of patients with unresectable ocular melanoma metastatic to the liver. The Prescription Drug User Fee Act (:PDUFA) goal date for completion of the FDA's review and decision regarding approval of the Melblez Kit NDA is September 13, 2013.

1:00 pm Repros Therapeutics reports second pivotal Androxal study fully enrolled ahead of schedule (RPRX) : Co announced it has fully enrolled the 180 subject second pivotal study (ZA-302) for Androxal one month ahead of schedule. Androxal is being studied as an oral therapy for the treatment of secondary hypogonadism. The Company expects to have topline results from the study during the fourth quarter of this year.

12:55 pm AVEO Pharma and Astellas confirm FDA Oncologic Drug Advisory Committee votes tivozanib application did not demonstrate favorable benefit-to-risk evaluation (stock halted) (AVEO) : Co and Astellas Pharma confirmed that the FDA's Oncologic Drugs Advisory Committee voted that the application for investigational agent tivozanib did not demonstrate a favorable benefit-to-risk evaluation for the treatment of advanced renal cell carcinoma (:RCC) in an adequate and well-controlled trial (13 to 1, 0 abstentions). "While we are disappointed with the outcome of the ODAC vote, we remain confident in the efficacy, safety and tolerability of tivozanib in RCC patients," said Tuan Ha-Ngoc, president and chief executive officer of AVEO. "We are committed to the RCC patient community and will work closely with the FDA to address the issues discussed by the panel today as the Agency continues its ongoing review of the New Drug Application for tivozanib." According to the timelines established by the Prescription Drug User Fee Act (:PDUFA), the review of the NDA is expected to be complete by July 28, 2013.

12:23 pm Notable movers of interest (:SCANX) : The following are some of today's most notable movers of interest, categorized by market capitalization (large cap over $10 billion and mid cap between $2-10 billion) and ranked by % change (all stocks over 100K average daily volume).

Large Cap Gainers

• V (179.25 +7.97%): Beat on EPS by $0.11, beat on revs; reaffirmed 2013 rev guidance, raised 2013 EPS guidance; tgt raised to $180 from $170 at FBR Capital; tgt to $187 from $172 at Nomura, tgt to $185 from $175 at Credit Suisse, tgt to $185 from $180 at Barclays.
• STX (39.76 +7.64%): Beat on EPS by $0.03, beat on revs; sees Q4 revs $3.3-3.45 bln vs $3.36 bln Capital IQ Consensus Estimate; sees margins in-line with prior two quarters; upgraded to Buy from Hold at Needham; tgt $45; tgt to $25 from $20 at JPMorgan, tgt to $40 from $35 at BMO.
• PRU (63.84 +7.69%): Reported Q1 after-tax adjusted operating income for the financial services businesses earnings of $2.28 per share, may not be comparable to the Capital IQ Consensus Estimate of $1.88, missed on revs.

Large Cap Losers

• CTRX (54.1 -5.1%): Beat on EPS by $0.01, missed on revs; reaffirmed FY13 EPS, revs guidance.
• TS (42.07 -4.34%): Reported EPS in-line, missed on revs.
• STO (23.4 -3.35%): Reported adjusted earnings were NOK 42.4 bln, compared to NOK 59.2 bln in the first quarter of 2012; adjusted earnings after tax were NOK 12.0 bln, compared to NOK 16.8 bln in the first quarter of 2012.

Mid Cap Gainers

• GNRC (38.17 +9.81%): Beat on EPS by $0.28, beat on revs; guided Q2 revs above consensus; raised FY13 revs in-line; proposed special cash dividend of up to $5 per share to shareholders.
• POL (23.54 +9.03%): Beat on EPS by $0.05, reported revs in-line.
• SSNC (32.77 +8.47%): Beat on EPS by $0.02, reported revs in-line; guided Q2 revs in-line; guided FY13 revs in-line.

Mid Cap Losers

• AUO (4.45 -8.9%): Priced follow-on offering of 74 mln ADSs, each representing 10 common shares of the co, at $4.40 per ADS.
• HK (5.81 -7.04%): Missed on EPS by $0.01, reported revs in-line.
• TGI (74.52 -6.47%): Beat on EPS by $0.09, beat on revs; guided FY14 EPS and revs below consensus.

12:14 pm June crude oil pushes to new session high of $93.18; now up 2.3% at $93.10 (:COMDX) :  

12:07 pm European Markets Closing Prices (:SUMRX) : European markets are now closed; stock markets across Europe performed as follows:

• UK's FTSE: + 0.2%
• Germany's DAX: + 0.6%
• France's CAC: + 0.1%
• Spain's IBEX: -0.2%
• Portugal's PSI: -0.2%
• Italy's MIB Index: -0.1%
• Irish Ovrl Index: + 0.5%
• Greece ASE General Index: + 1.0%

12:02 pm Qualcomm hovering near its session high at 62.85 (QCOM) : Note that its 200 day sma, broken below last week, comes into play at 62.97 (200 ema at 63.17).

12:02 pm Eastman Board of Directors approves $300 mln share repurchase (EMN) : The new stock repurchase authorization is in addition to the remaining amount under the $300 million of stock repurchases authorized by the Board in February 2011.

12:01 pm Perficient acquires TriTek Solutions for ~$18.5 mln; raises FY13 revenue guidance to reflect acquisition (PRFT) : Co announced it has acquired northeastern U.S.-based TriTek Solutions, an IBM-focused enterprise content management and business process management consulting firm that generated $19 million in 2012 services revenue. The consideration paid in the transaction is approximately $18.5 million and includes $13.2 million in cash and approximately $5.3 million worth of Perficient common stock.

The transaction will increase Perficient's current annualized revenues to approximately $360 million and is expected to be accretive to adjusted earnings per share immediately. With the acquisition, the company is raising its full year 2013 revenue guidance to a range of $358-378 mln (vs $352.35 mln Capital IQ Consensus Estimate) from the previously provided range of $345-365 mln.

11:57 am June crude oil rallies to new session high of $92.78; now up 1.8% at $92.68 (:COMDX) :  

11:57 am National Cinemedia unit closed on an amended senior secured credit facility (NCMI) : The amended senior secured credit facility increases NCM LLC's borrowings under its term loans from $265 million to $270 million in order to pay costs and expenses incurred with the amended credit facility and for general corporate purposes. Pricing on the new term loans decreased by 50 basis points to the LIBOR index plus 2.75%. In addition, the amended senior secured credit facility reduces the applicable margin on $110 million of NCM LLC's revolving credit facility by 25 basis points to the LIBOR index plus 2.00%.

11:43 am Cypress Semi and ASML confirmed earlier that the Japan Fair Trade Commission cleared ASML acquisition of Cymer (CY) : Clearance of the merger has previously been granted by the U.S. Department of Justice, the U.S. Committee on Foreign Investment in the United States (:CFIUS), as well as the Taiwanese, German and Israeli antitrust authorities. Furthermore, Cymer stockholders have approved the merger agreement. Completion of the merger now remains subject to closing conditions and receipt of approval under competition laws in South Korea. Cymer and ASML continue to expect the transaction to close in the first half of 2013.

11:40 am Raytheon confirmed earlier it has realigned two business headquarters locations (no finc details given) (RTN) : The decisions stem from the company consolidation announced March 25, 2013, intended to streamline operations, increase productivity and achieve stronger alignment with its customers' priorities.

11:39 am Beam (+4%) breaks to new all time high after beating Q1 estimates this morning (BEAM) : Former Fortune Brands spun off FBHS and sold golf division (Titelist, Foot Joy) in 2011.

11:38 am Stocks/ETFs that traded to new 52 week highs/lows this session - New highs (184) outpacing new lows (41) (:SCANX) : Stocks that traded to 52 week highs: AAT, AB, ACHC, ACT, ADS, AEL, AFL, AKAM, AMRB, AMT, ANAT, APD, APH, ATK, ATO, AVA, AVIV, AXP, AYR, BAK, BAM, BBW, BDX, BEAM, BKBK, BMR, BOKF, BRFS, BSI, BTI, BYD, CBS, CCK, CCU, CEB, CHDN, CI, CLFD, CNK, CNQR, CPA, CPLP, CUZ, CVD, DAVE, DCO, DDR, DEI, DIS, DKL, DORM, DSGX, DXCM, ELS, ENH, EVC, EXH, EXLP, EXR, FBIZ, FIS, FLY, FORR, FORTY, FRT, GAS, GIL, GM, GRT, GTN, HAR, HARL, HCN, HDB, HHC, HNP, HOS, HPT, HR, HRL, HST, IBKR, IFT, IIJI, IRIX, IRM, JCTCF, KIM, LGF, LMT, LNKD, LVS, LXP, MAS, MDCA, MDCI, MDSO, MDU, MGA, MGM, MN, MSG, MTSC, NAVR, NCT, NGS, NNN, NOC, NR, NTL, NU, NWY, O, OCR, OGE, OHI, OII, OIS, OSTK, OUTD, OXM, OZM, P, PATK, PAYX, PFBX, PHI, PMTI, POR, PRAA, PRU, PRXL, PSA, PVTB, PZZA, REG, REGI, RF, RGC, RLOC, RNR, RPAI, RTN, RUTH, RWC, RYL, SAFM, SAIA, SFI, SFLY, SILC, SKM, SMI, SMMF, SNI, SPF, SPG, SPN, SRE, SSNC, SSS, SSW, STMP, STRZA, STX, TARO, TCBK, TCO, TEG, TEO, TIF, TOWR, TSM, V, VIPS, WPC, WPPGY, WRI, WRLS, WSH, WWW, WYNN, YELP, Z

Stocks that traded to 52 week lows: AFFY, ALVR, ANV, ASTM, CDI, CERE, DCTH, DRTX, DSCO, ELMD, ENG, EPAX, EVEP, FALC, FNBN, FRO, GNK, GROW, GSV, HUSA, IFON, IVAN, JAKK, NURO, OGXI, OIBR, OKS, PACT, PDII, QKLS, SBLK, SLTM, SQM, SURG, TGC, TNK, UNIS, VOLC, WLT, XIDE, YZC

ETFs that traded to 52 week highs: EWS, IWF, MES, QQQ, SMH, SPY, XLY

ETFs that traded to 52 week lows: none

11:34 am S&P +13.8 nears recently established all time high at 1597.57 -- session high 1597.07 (SPY) : The outperforming Nasdaq 100 +34 and Nasdaq Comp +36 have set new multi-year highs.

11:23 am Facebook notches fresh session high of 28.57, its two month high from March is at 28.67 (FB) :  

11:19 am Amazon.com attempting to reclaim 200 day (AMZN) : Weaker off the open but held at yesterday's low of 245.75 (session low 245.78) with it currently attempting to reclaim its 200 day sma at 252.06.

11:16 am Stock indices run to new highs -- Dow +98, S&P +13, Nasdaq Comp +33 (SPY) :  

10:52 am Euro Weakens on ECB Action: 10-yr: unch..1.636%..USD/JPY: 97.90..EUR/USD: 1.3064 (:SUMRX) : The Dollar Index holds on session highs near 82.20 as buyers moved into the greenback following this morning's European Central Bank rate decision. Today's bid has the Index on track for its first gain in seven sessions as trade looks to retest the 50-day moving average (82.55). 

• The euro has been offered since today's ECB rate decision where the central bank cut its key rate 25 bps to a record low 0.50% while also lowering its marginal lending facility 50 bps to 1.00%. Comments from Mario Draghi caused the selling as he suggested the ECB is 'technically ready' for negative deposit rates. The 1.3000 support level should be watched closely over the coming days as both the 50- and 200-day moving averages will provide help in the vicinity.
• The pound has erased its early gains that developed following the stronger than expected Construction PMI as trade piggybacks that of the euro. Recent action has struggled near the 100-day moving average (1.5555) as action now holds on session lows. Attention now turns to next week's Bank of England rate decision.
• The yen is weaker for the first time in six days as traders began to pile on following the ECB decision. The currency slumped to a session low of 98.40 before seeing some profit-taking. The minutes from the most recent Bank of Japan meeting had caused the yen to strengthen in early trade after it was suggested some members were concerned over the bold action being taken by the central bank.  

10:40 am Stock indices still hovering near highs/resistance zones -- Dow +72, S&P +9.6, Nasdaq Comp +25 (:TECHX) : Bias remain firmer with no pressure developing thus far as the indices hover near resistances (10:21) and the A/D Line has yet to confirm new index highs. Seeing some intraday relative sector weakness in recent trade in Energy XLE, Oil Service OIH, Utility UTIL, Defense PPA, Coal KOL, Steel SLX, Gold Miners GDX, Pharma PPH. Relative strength in Reg Bank KRE, Bank KBE, Housing XHB, Discretionary XLY, Transports IYT, Rail

10:31 am Natural gas futures drop to a new LoD following inventory data; now -3.7% at $4.16/MMBtu (:COMDX) :  

10:21 am Stock indices extend to secondary resistances -- Dow +71, S&P +9, Nasdaq Comp +22 (SPY) : Noted second level resistances in The Technical Take at 1591/1592 S&P (session high 1592), 3321/3330 Nasdaq Comp (session high 3322) and 14785/14796 Dow (session high 14775) with these levels approached/tested in recent trade.

10:21 am AOL displays relative strength as price attempts to breakout above 3-month resistance along the $40-level (AOL) :  

10:17 am AU Optronics prices follow-on offering of 74 mln ADSs, each representing 10 common shares of the co, at $4.40 per ADS (AUO) :  

10:14 am Three major averages edge to new highs -- Dow +70, Nasdaq Comp +22, S&P +8.8 (SPY) :  

10:12 am Thinly traded Delia*s is trading higher after confirming Walter Killough will serve as CEO thru August 2 and appointed Tracy Gardner as Chief Creative Officer (DLIA) : Co also announced that it has named Michael Zimmerman Chairman of the Board of Directors, replacing Carter S. Evans, who will remain on the Board.... Gardner was with J.Crew from 2004 to 2010, most recently as President of Retail & Direct.

10:12 am Sector relative strength (:TECHX) : Sectors displaying some relative strength in recent trade (outperforming S&P) include: Housing XHB, Industrial XLI, Transports IYT, Biotech IBB (GILD +5.3%, SGEN +2.2%, REGN +1.9%), Crude Oil USO, Energy XLE.

10:09 am Shire plc and Acceleron conclude collaboration on ACE-031 (SHPG) : The clinical development of ACE-031 was suspended in February 2011 and since then the companies have conducted preclinical studies to determine whether to resume clinical studies. The companies have now decided not to restart the development of this program. Acceleron remains focused on the eleven phase 2 clinical studies currently underway across its three investigational protein therapeutics - sotatercept, dalantercept and ACE-536.

10:09 am American Water announces expansion in Virginia with purchase of Dale Service Corporation for ~$27.7 mln (AWK) : Co announced that its Virginia American Water subsidiary has signed an agreement to purchase Dale Service Corporation, a wastewater utility company. The company will also file an application with the Virginia State Corporation Commission (SCC) for approval of the acquisition. The total value of the transaction is approximately $27.7 million. This agreement marks the entry of Virginia American Water, which is the largest investor-owned water utility in Virginia, into the wastewater services market.

10:02 am Minor new high for S&P +6.5 and Nasdaq Comp +18 -- Dow +45 and A/D Line have thus far not confirmed (SPY) :  

9:55 am Amazon.com slumps lower off the opening back towards yesterday's distribution low of 245.75 (AMZN) :  

9:54 am TeleComm Sys announces it received 13 U.S. patents and one foreign patent in the first quarter of 2013 (TSYS) : Co announced that the U.S. Patent and Trademark Office (:USPTO) has issued TCS 11 patents during the first quarter of 2013 and two in the last quarter of 2012. TCS was also issued one additional foreign patent in 2012. The 13 new U.S. patents describe innovations in messaging, wireless data, mobile devices, public safety, GIS/mapping and solid state drive technologies and further strengthen these areas of TCS' intellectual property.

9:54 am MGM Resorts surges after reporting, pauses its 23 month close high from Feb 2012 at 14.74 -- session high 14.77 (MGM) : The 23 month intraday peak from Feb 2012 is at 14.94.

9:52 am Sprint Nextel: SoftBank announces registration statement for Sprint transaction declared effective by SEC (S) : SoftBank announced that the Form S-4 Registration Statement relating to its agreed transaction with Sprint Nextel has been declared effective by the SEC. The Form S-4 contains Sprint's definitive proxy statement related to soliciting the required approval of the SoftBank merger by Sprint stockholders. Sprint is expected to commence the mailing of the definitive proxy statement to its stockholders on May 3rd. SoftBank encourages Sprint stockholders to review the proxy statement and to vote FOR the adoption of the SoftBank merger agreement at the Sprint special stockholders' meeting to be held on June 12, 2013.

9:40 am S&P +5.7 cuts yesterday's decline in half in early trade at 1589 -- session high 1589 (SPY) :  

9:37 am Solid performance off the open -- Dow +53, S&P +6.4, Nasdaq Comp +14 (SPY) : Early sector strength in Telecom IYZ, Health XLV, Biotech IBB, Auto, Casino (MGM +6%, LVS +2.8%, CZR +1.6%, BYD +1.4%, WYNN +1.3%, MCRI +1.3%).

9:36 am AU Optronics announces follow-on offering of 74 mln ADSs, each representing 10 common shares of the co, par value NT$10 per share, at $4.4 per ADS (AUO) : Co intends to use the net proceeds from the offering to fund purchases of raw materials and components from overseas. Citigroup Global Markets Limited will act as the Global Coordinator for the offering and Citigroup Global Markets Limited and UBS AG (Hong Kong branch) will act as joint bookrunners for the offering. Australia and New Zealand Banking Group Limited, Hong Kong Branch, ING Bank N.V., Mizuho Securities Asia Limited and Standard Chartered Securities (Hong Kong) Limited will act as the Co-Managers of the offering.

9:33 am Corner Store (CST Brands) begins trading after being spun off from Valero (VLO) (CST) :  

9:32 am GW Pharma opens at $9.20 after prcing 3.5 mln ADS IPO at $8.90 (:GWPH) :  

9:31 am Alcoa to further expand North American automotive sheet capacity (AA) : Co announced a second major North American expansion to meet the growing demand for light, durable and recyclable aluminum sheet for automotive production. Alcoa will invest $275 million over the next three years to expand and convert capacity at its rolling mill in Alcoa, Tenn., to support automotive producers' plans to use more aluminum sheet to increase fuel efficiency, safety, durability and performance of cars and light trucks. Alcoa previously announced a $300 million expansion of its Davenport, Iowa plant which is set to be completed by the end of this year.

9:31 am Kinder Morgan Partners to expand capacity on Sweeny Lateral pipeline (KMP) : Co announced it has entered into a long-term contract to support the expansion of its Sweeny Lateral pipeline that the co is building from the Kinder Morgan Crude Condensate pipeline to Phillip 66's (PSX) Sweeny Refinery in Brazoria County, Texas. The expansion will increase the capacity on the 27-mile, 12-inch diameter lateral pipeline from an initial 30,000 barrels per day (bpd) to 100,000 bpd. Kinder Morgan will add new pumps and an additional 120,000-barrel storage tank at its Wharton Pump Station in Wharton County, Texas, and increase the truck offload capabilities at its DeWitt Station in DeWitt, County, Texas, to facilitate the increase in capacity.

9:27 am On The Wires (:WIRES) :

• RDA Microelectronics (RDA) announced sampling availability of its RDA6861 front-end module designed for quad-band GSM/EDGE and WCDMA/CDMA/LTE handheld cellular devices and smartphones.
• Move (MOVE) announced the acquisition of Doorsteps, the website providing tools and resources to consumers in their path to home ownership.
• Cardium Therapeutics (CXM) announced a publication, "Mechanistic, Technical, and Clinical Perspectives in Therapeutic Stimulation of Coronary Collateral Development by Angiogenic Growth Factors" in the April issue of Molecular Therapy.
• Terreno Realty (TRNO) announced a lease at its industrial property in Doral, Florida.
• FICO (FICO) announced that the FICO Adeptra Mobile Services Platform will be offered as a service in the new FICO Analytic Cloud, for creating, customizing and deploying analytic-driven applications and services.
• iStreamPlanet has signed a strategic video contribution and distribution agreement with Tata Communications (TCL) to enable live video streaming onto connected devices anywhere in the world.
• Hill International (HIL) announced that its subsidiary Engineering S.A. has received a contract from Petrobras (PBR) to provide specialized technical services in connection with its Rio de Janeiro State Petroleum Complex. The 10-month contract has an estimated value to Hill of ~R$6.4 mln ($3.2 mln).

9:26 am On The Wires (:WIRES) :

• Dealertrack Technologies (TRAK) announced that the number of active lenders connected to its Dealertrack Credit Application Network now exceeds 1,300 lenders.
• 3M Unitek (MMM) announced the availability of the 3M True Definition Scanner for use in orthodontic practice.
• Coastal Contacts (COA) announced that its web sites have now attracted more than two million "fans" on Facebook (FB).
• InnerWorkings (INWK) announced a new print management agreement with Young & Rubicam Mexico.
• Bank Mandiri has signed an agreement with Diebold (DBD) to add 1,421 Opteva 529 ATMs to its existing Diebold ATM fleet and network.
• Chairman and CEO of Kips Bay Medical (KIPS) announced that on April 30, 2013, the Mayo Clinic performed its first implant of an eSVS Mesh at its Rochester, Minnesota facility.
• ITT Exelis (XLS) has been awarded a contract by NASA's Jet Propulsion Laboratory, Pasadena, Calif., to provide specialized antennas for the Constellation Observing System for Meteorology, Ionosphere & Climate-2 program.
• Shareowners of UPS (UPS) elected a Board of Directors for a one-year term and ratified the appointment of Deloitte & Touche as the co's independent registered public accountants.
• Quantum Fuel Systems Technologies Worldwide (QTWW) entered into a Master Development Agreement with ZHRO Solutions to develop fully-integrated compressed natural gas storage and fuel delivery systems for aftermarket conversion of medium and heavy duty diesel fleets to run on natural gas. Agrement provides for an advanced payment of $1.0 mln to Quantum.

9:21 am CVR Energy beats by $0.42, beats on revs; announces $0.75/share Q1 dividend (CVI) : Reports Q1 (Mar) earnings of $1.90 per share, $0.42 better than the Capital IQ Consensus Estimate of $1.48; revenues rose 19.5% year/year to $2.35 bln vs the $2.19 bln consensus. The co also announced a first quarter 2013 cash dividend of 75 cents per share. The dividend, as declared by CVR Energy's Board of Directors, will be paid on May 17, 2013, to stockholders of record on May 10, 2013.

9:16 am Gold and silver are surging higher following Draghi comments, both just hit new session highs (:COMDX) : June gold is now +1.8% at $1472.30/oz, July silver is +3.3% $24.12/oz.

9:16 am Descartes acquires Scandinavia-based KSD Software for ~ $33 mln in cash (DSGX) : Co acquired KSD Software Norway AS, a provider of electronic customs filing solutions for the EU. The all cash purchase price for the acquisition was NOK 190 mln (~$33 mln at May 2, 2013), with Descartes acquiring ~NOK 11.5 mln in working capital (~Co acquired KSD Software Norway AS, a Scandinavia-based provider of electronic customs filing solutions for the EU. The all cash purchase price for the acquisition was NOK 190 mln (~$33 mln at May 2, 2013), with Descartes acquiring ~NOK 11.5 mln in working capital (~$2 mln at May 2, 2013). To complete the acquisition, Descartes used ~USD $13 mln of cash on hand and $20 mln from an acquisition line of credit. mln at May 2, 2013).

9:15 am PG&E misses by $0.06, misses on revs; reaffirms FY13 EPS guidance (PCG) : Reports Q1 (Mar) earnings of $0.63 per share, excluding non-recurring items, $0.06 worse than the Capital IQ Consensus Estimate of $0.69; revenues rose 0.9% year/year to $3.67 bln vs the $3.75 bln consensus.

Co reaffirms guidance for FY13, sees EPS of $2.55-2.75, excluding non-recurring items, vs. $2.64 Capital IQ Consensus Estimate.

9:14 am Insys Therapeutics prices 4 mln share IPO at $8.00 per share, below the $16-18 expected range (INSY) :  

9:09 am Hyperion Therapeutics receives orphan drug exclusivity from FDA (HPTX) : Co announced that the FDA yesterday notified the company that RAVICTI Liquid has qualified for orphan drug exclusivity. The orphan exclusivity is for seven years from the date of the approval on February 1, 2013. "Orphan drug exclusivity further strengthens the protections for RAVICTI. Additionally, as we recently announced, we were issued a patent that relates to use of RAVICTI with optimal measurement timing and target levels for blood ammonia in urea cycle disorder patients. It has a term that expires in March 2032 and is now listed in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, known as the Orange Book."

9:04 am AutoNation announces total retail new vehicle unit sales of 22,515 in April 2013 (AN) : Co announced that its total retail new vehicle unit sales in April 2013, as reported to the applicable automotive manufacturers, were 22,515, an increase of 10% as compared to April 2012. Same-store retail new vehicle unit sales in April 2013 were 21,950, an increase of 7% as compared to April 2012. Total retail new vehicle unit sales for AutoNation's operating segments were as follows: 7,588 for Domestic, up 20% versus April 2012, 10,853 for Import, up 5% versus April 2012, and 4,074 for Premium Luxury, up 5% versus April 2012. There were 25 selling days in April 2013 compared to 24 selling days in April 2012.

9:04 am Hyperion Therapeutics exercises option to acquire rights to BUPHENYL and AMMONUL from Valeant Pharmaceuticals (VRX) (HPTX) : As a result of a March 2012 agreement between co and Medicis Pharmaceutical Corporation, now a subsidiary of Valeant, Valeant has 20 days to formally notify co whether it intends to retain rights to AMMONUL.  If Valeant elects not to retain AMMONUL, co is obligated to pay $22 million to Valeant; if Valeant elects to retain AMMONUL, Valeant must pay co $13 million.

9:03 am Delta Air Lines April PRASM -2% (DAL) : Consolidated passenger unit revenue (:PRASM) for the month of April decreased 2% YoY due to demand softness in the domestic entity and the 1-2 point negative impact in the Pacific from the yen devaluation. This result is in line with previous guidance; Delta still expects a modest year over year improvement in May and June unit revenues. Delta completed 99.9 percent of its flights in April and ran an on-time arrival rate of 85.6 percent.

9:02 am Intel Board elects Brian Krzanich as CEO, Renee James elected President (INTC) : Co announced that the board of directors has unanimously elected Brian Krzanich as its next chief executive officer (CEO), succeeding Paul Otellini. Krzanich will assume his new role at the company's annual stockholders' meeting on May 16. Krzanich, Intel's chief operating officer since January 2012, will become the sixth CEO in Intel's history. As previously announced, Otellini will step down as CEO and from the board of directors on May 16. The board of directors elected Renee James, 48, to be president of Intel. She will also assume her new role on May 16, joining Krzanich in Intel's executive office.

9:02 am Atossa Genetics signs distribution agreement with Millennium HealthCare (MHCC) (ATOS) : Co announced that its Medical Device subsidiary signed an agreement with Atossa Genetics (ATOS) for the distribution of Atossa's ForeCYTE Breast Health devices, which consist of the patented MASCT pump and ForeCYTE patient collection kits. Millennium has submitted an initial order for 10,000 ForeCYTE collection kits, which it intends to market to managed-care networks, healthcare clinics and physician practices in the New York Metro Area and Northern New Jersey.

9:02 am Spark Networks prices follow-on public offering of 2.14 mln shares of common stock at $6.25 per share (LOV) :  

9:00 am AGL Resources announced earlier that is has closed on sale of Compass Energy Services; co expects to report a pre-tax gain on the sale of ~ $9 mln to $11 mln during 2Q13, with est diluted EPS impact of $0.05-0.06 (GAS) : Co announced that it has closed on the sale of Compass Energy Services and its wholly-owned subsidiary, a non-regulated retail natural gas business supplying commercial and industrial customers, to a wholly owned subsidiary of Integrys Energy Services. AGL Resources received an initial cash payment of $12 million plus estimated working capital at closing. Under the terms of the purchase and sale agreement, AGL Resources will be eligible to receive additional cash consideration of up to $8 million (but no less than $3 million), based upon the financial performance of Compass over the next five years. AGL Resources expects to report a pre-tax gain on the sale of Compass of approximately $9 million to $11 million during the second quarter of 2013, with an estimated diluted earnings per share impact of $0.05 to $0.06.

8:57 am European Markets Update: FTSE +0.1%, DAX +0.4%, CAC +0.6% (:SUMRX) : European indices have climbed into positive territory after the European Central Bank cut its key interest rate by 25 basis points to 0.50%. In addition, the central bank lowered its marginal lending facility rate to 1.0% from 1.5%. Regional economic news was plentiful as Spain's Manufacturing PMI rose to 44.7 from 44.2 (44.5 consensus). Italy's Manufacturing PMI climbed to 45.5 from 44.5 (44.8 forecast). Meanwhile, the country's PPI was unchanged month-over-month (-0.2% expected). French Manufacturing PMI remained unchanged at 44.4, in-line with expectations. German Manufacturing PMI increased to 48.1 from 47.9 (47.9 expected). As a result, the Eurozone Manufacturing PMI climbed to 46.7 from 46.5 (46.5 forecast). Also of note, the United Kingdom's Construction PMI rose to 49.4 from 47.2 (48.0 consensus).

In news, Italian Prime Minister Enrico Letta said the country's new government plans to continue the economic reforms started by the prior government.

• The United Kingdom's FTSE is adding 0.1% as miners show strength. Glencore International is jumping 4.6%. On the downside, drug maker Shire is off by 4.0% after its revenue fell short of estimates.
• Germany's DAX is higher by 0.4% with financials outperforming. Commerzbank is rising 3.5% and Deutsche Bank trades with a gain of 2.3%.
• In France, the CAC is rising 0.6%. Cap Gemini is the top index performer as the tech company trades with a gain of 5.6% after raising its guidance.

8:55 am On The Wires (:WIRES) :

• Kennedy Wilson (KW) announced the acquisition of The Pointe at Redwood Shores, two Class A, two-story office buildings totaling 89,455 rentable square feet, located in Redwood City, California for ~ $22 mln.
• General Motors (GM) has selected a variety of Goodyear (GT) tires as original equipment fitments for 2014 Chevrolet Silverado and GMC Sierra models.
• Arotech (ARTX) has secured $4.0 mln in new contract funding in recent months for training and simulation products and services.
• Dominion Virginia Power, a subsidiary of Dominion (D), has selected Old Dominion University to be the first participant in the co's Solar Partnership Program.
• Attunity (ATTU) has signed a multi-year reseller agreement with a technology corp for the resale of Attunity Replicate.
• AOL Canada (AOL) announced the launch of StyleList Quebec.
• FIS (FIS) announced that it will supplement its outsourced ATM management and debit card processing for Karnataka Bank with additional ATMs. Once the two new ATM projects are fully implemented, FIS will manage ~ 11,000 ATMs across India.
• NOOK Media, a subsidiary of Barnes & Noble (BKS) introduced NOOK Book Two-for-One Weekends, an in-store only, 'Buy One Get One Free' offer on a select list of popular, bestselling eBooks.
• CIT Group (CIT) provided a $96 mln senior secured credit facility to Harvest Partners.
• RGS Energy, a division of Real Goods Solar (RSOL), has completed the installation of solar power systems at four Stop & Shop grocery stores in New York.

8:53 am Sirius XM Radio intends to offer $500 mln of senior notes due 2020 (SIRI) : Co intends to use the net proceeds from any such offering for general corporate purposes, which may include, from time to time and as market conditions warrant, share repurchases and the repurchase, redemption, defeasance, tender or repayment of our outstanding indebtedness, including any borrowings outstanding under our revolving credit facility. Pending application of these amounts as provided above, co currently expects to maintain any excess amount as cash on hand.

8:45 am Boulder Brands beats by $0.03, beats on revs; sees FY13 at high end of prior range (BDBD) : Reports Q1 (Mar) earnings of $0.07 per share, excluding non-recurring items, $0.03 better than the Capital IQ Consensus Estimate of $0.04; revenues rose 34.6% year/year to $106.7 mln vs the $105.46 mln consensus.  Organic net sales for the Natural segment increased 42.6% in the quarter. The Company's gluten-free brands -- Udi's and Glutino -- reported organic net sales growth of 62.4% and 34.2%, respectively, in the quarter, which was driven by an acceleration in distribution gains and continued strength in the gluten-free category growth. The Company's Earth Balance portfolio registered a net sales gain of 17.9% in the first quarter of 2013 compared to the first quarter of 2012. 

Co issues in-line guidance for FY13, sees FY13 revs at high end of $450-460 mln previous range vs. $456.93 mln Capital IQ Consensus Estimate; also sees adj. EBOTDA at high end of $72-77 mln pior range.

Boulder Brands has acquired Davies Bakery, a UK-based gluten-free bakery and bread manufacturer, from Frank Roberts & Sons for approximately ?2.5 million. The Davies Bakery subsidiary of Frank Roberts & Sons manufactures and sells gluten-free bread and baked goods in the UK for its own brand, Yes!YouCan, and co-packages for private label customers.

8:41 am HCA misses by $0.03, revenue inline with prior guidance, but below consensus; reaffirms FY13 EPS guidance, revs guidance (HCA) : Reports Q1 (Mar) earnings of $0.79 per share, ex-items, $0.03 worse than the Capital IQ Consensus Estimate of $0.82; revenues rose 0.4% year/year to $8.44 bln, inline with its $8.44 bln guidance from 4/15, below the $9.38 bln consensus.

Other Metrics: Same facility equivalent admissions declined 0.7 percent while same facility admissions increased 0.1 percent. Same facility revenue per equivalent admission increased 0.8 percent.

Guidance: Co reaffirms guidance for FY13, sees EPS of $3.00-3.30 vs. $3.15 Capital IQ Consensus Estimate; sees FY13 revs of $33.5-$34.5 bln vs. $37.82 bln Capital IQ Consensus Estimate.

8:37 am Magellan Midstream beats by $0.03, misses on revs; guides Q2 EPS below consensus; guides FY13 EPS above consensus (MMP) : Reports Q1 (Mar) earnings of $0.51 per share, excluding non-recurring items, $0.03 better than the Capital IQ Consensus Estimate of $0.48; revenues fell 12.4% year/year to $432.4 mln vs the $515.03 mln consensus.

Co issues downside guidance for Q2, sees EPS of $0.52, excluding non-recurring items, vs. $0.55 Capital IQ Consensus Estimate. Co issues upside guidance for FY13, sees EPS of $2.25, excluding non-recurring items, vs. $2.22 Capital IQ Consensus Estimate.

Management is raising its 2013 DCF guidance by $10 million to $580 million. Management remains committed to its goal of increasing annual cash distributions by at least 10% for 2013 with the potential for even higher distribution growth this year if favorable business trends continue and growth projects are placed into service as currently projected. Further, management still projects at least 10% annual distribution growth for 2014.

8:34 am Vringo granted multiple telecom infrastructure patents (VRNG) : Co announced that multiple patent applications in Vringo's telecom infrastructure portfolio have been granted. The granted European Patents have left the European Patent Office and are now in the jurisdiction of various national offices. These patents will be validated nationally in the relevant member states in due course. The European Patent Office has also sent a notice of intention to grant European Patent No. 1,719,352, entitled "Packet Switched Handover in a Mobile Communication System, During which a Mobile Node Receives Packets from a Source Node and a Target Node".

8:33 am IntercontinentalExchange reports 18% increase in April daily futures volume (ICE) : Co reported futures volume for April 2013. ICE's average daily volume (:ADV) for futures and options was 3,843,846 contracts, an increase of 18% from the prior April. Total volume in April 2013 was 85 million contracts.

8:33 am ICG beats by $0.13, misses on revs (ICGE) : Reports Q1 (Mar) loss of $0.08 per share, $0.13 better than the Capital IQ Consensus Estimate of ($0.21); revenues rose 33.4% year/year to $46.3 mln vs the $48.78 mln consensus. "Our profitability goal for 2013 is particularly notable given the significant investments we are making in growth initiatives such as sales and marketing. Our strong balance sheet allows us to support these initiatives and execute on our capital allocation focus of owning more of our companies, supporting accretive tuck-in acquisitions and share repurchases."

8:33 am National Retail Properties beats by $0.03, beats on revs (NNN) : Reports Q1 (Mar) funds from operations of $0.49 per share, $0.03 better than the Capital IQ Consensus Estimate of $0.46; revenues rose 17.7% year/year to $92.6 mln vs the $88.49 mln consensus. Portfolio occupancy was 97.8% at March 31, 2013, as compared to 97.9% at December 31, 2012, and 97.5% at March 31, 2012

8:32 am NewLead announces long-term time charter for the Panamax Newlead Victoria (NEWL) : Co announced that it has entered into a five-year time charter contract with 60% profit sharing for its 2002-built panamax vessel, the Newlead Victoria. The five-year time charter of the Newlead Victoria is expected to commence in June 2013. The escalating net daily charter-out rate will be:

• $11,700 until Dec 29, 2014
• $12,723.75 until Dec 29, 2015
• $12,918.75 until Dec 29, 2017
• $13,016.25 until Jun 29, 2018

8:31 am Gilead Sciences reports interim data from Phase 2 LONESTAR study; plans to initiate Phase 3 study evaluating eight and 12 weeks of therapy with sofosbuvir and ledipasvir for the treatment of chronic hepatitis C (GILD) : Co announced plans to initiate a third Phase 3 clinical trial of the co's investigational fixed-dose combination tablet of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C virus (:HCV) infection. The study, called ION-3, will evaluate the once-daily fixed-dose combination of sofosbuvir and ledipasvir for eight weeks with and without ribavirin (:RBV) and for 12 weeks without RBV in 600 non-cirrhotic, treatment-naive genotype 1 HCV-infected patients. The design of ION-3 was based on interim results from the Phase 2 LONESTAR study, which evaluated eight- and 12-week courses of therapy with the once-daily fixed-dose combination of sofosbuvir and ledipasvir with and without RBV in 60 treatment-naive, non-cirrhotic patients. In this study, 19/19 patients in the 12-week arm had a sustained virologic response four weeks after completing therapy (SVR4) and 40/41 in the eight-week arms had a sustained virologic response eight weeks after stopping therapy (SVR8), with one relapse occurring in the arm receiving sofosbuvir/ledipasvir without RBV. Two additional cohorts in the LONESTAR study evaluated a 12-week course of the fixed-dose combination of sofosbuvir and ledipasvir with or without RBV in 40 patients who had previously failed therapy with an HCV-specific protease inhibitor-based regimen. Half of these treatment-experienced patients have documented, compensated cirrhosis. Ninety-five percent of patients in both arms achieved SVR4, one cirrhotic patient in the sofosbuvir and ledipasvir arm relapsed and one patient in the sofosbuvir and ledipasvir plus RBV arm was lost to follow-up.

8:31 am Market View: Front-month Jun. E-mini index futures remain bid above fair values following the 8:30 a.m. ET batch of economic data released- ESM3 currently trades @ 1585.00 +7.75 (+0.49%) (:TECHX) :  

8:27 am On The Wires (:WIRES) :

• Atlas Air Worldwide Holdings (AAWW) confirmed the placement of its eighth Boeing (BA) 47-8 Freighter into ACMI service. The aircraft will fly on behalf of Etihad Cargo, the cargo arm of Etihad Airways, pursuant to a multiyear aircraft, crew, maintenance and insurance agreement that commences in May 2013.
• Cancer Genetics (CGIX) has launched a proprietary urogenital cancer array, UroGenRA, intended for kidney cancer diagnosis and subtyping in its own laboratory.
• Brocade (BRCD) announced testing results performed by ESG Lab for EMC VSPEX Proven Infrastructure solutions enabled with the Brocade VDX Ethernet fabric data center network switches for cloud-optimized configurations of 100 virtual machines and 500 virtual desktop instances.
• St. Jude Medical (STJ) announced first enrollment of its MultiPoint Pacing clinical study to build upon its first- to-market Quadripolar Pacing System. Patients will be implanted with the Quadra Assura MP cardiac resynchronization therapy defibrillator and Quartet lead to assess pacing in multiple locations in the heart.
• 2K, a publishing label of Take-Two Interactive Software (TTWO), and Firaxis Games announced the availability of Haunted Hollow, their first title to be designed exclusively for Apple's (AAPL) iPad and iPhone.
• Insulet (PODD) has entered into an agreement with Eli Lilly (LLY) in which Insulet will develop a new version of the OmniPod insulin pump specifically designed to deliver Humulin R U-500 insulin, (regular U-500 [Concentrated] insulin human injection, USP [rDNA origin]), a concentrated form of insulin used by people with highly insulin resistant type 2 diabetes.
• GE Capital's (GE) Equipment Finance business has signed a three-year agreement to provide financing for commercial purchases of Global Electric Motorcars, owned by Polaris Industries (PII).
• FMC Technologies (FTI) has been awarded a two year extension to an existing contract by Island Offshore Management AS to provide Light Well Intervention services.

8:25 am Atlas Air Worldwide beats by $0.06, misses on revs; guides FY13 EPS in-line (AAWW) : Reports Q1 (Mar) earnings of $0.22 per share, $0.06 better than the Capital IQ Consensus Estimate of $0.16; revenues rose 5.0% year/year to $377.3 mln vs the $391.18 mln consensus.

Co issues in-line guidance for FY13, sees EPS of $4.80 vs. $4.80 Capital IQ Consensus Estimate.
.
Outlook

• Co expects to generate strong earnings and cash flow in 2013. Led by ACMI, each of our business segments is expected to be profitable for the year. incorporating our share repurchase activity, .
• Both adjusted and reported full-year 2013 EPS guidance assume the repurchase of $50.0 million of our outstanding stock during the year.
• Co's expectation for full year 2013 operating performance is unchanged from the outlook we issued last quarter.
• Co now expects to fly fewer block hours in our Commercial Charter segment in 2013 than previously forecast.
• Co also expects lower operating expenses as a result of continuous improvement initiatives that drive productivity improvements and operating efficiencies. Similar to the first quarter, adjusted and reported full-year earnings in 2013 will reflect strong growth from the company's 747-8Fs in ACMI, driven by an increase in the number of -8F aircraft in ACMI service compared with 2012, including the incremental placement with Etihad Airways we announced today.
• Market growth during 2013 should be seasonal and second-half weighted.
• Co continues to anticipate a sequential increase in our quarterly earnings throughout the year, with ~75% of adjusted earnings per share and 66% of reported earnings per share occurring in the second half.
• Based on our revised view, block-hour volumes in 2013 are now expected to total approximately 175,000 hours.
• ACMI segment flying should account for about 135,000, or 77%, of expected 2013 block hours, with about 22,000, or 13%
• Commercial Charter and 18,000, or 10%
• in AMC Charter. Passenger charter flying should account for more than 10,000 AMC Charter block hours in 2013.
• Based on anticipated deliveries of 747-8Fs in our outstanding order, the average number of -8Fs in service in 2013 should increase to more than eight from 4.3 in 2012.
• In addition, co now anticipates that maintenance expense will total ~$172 mln in 2013, about 60% of which should be incurred in the first half of the year.

8:22 am Royal Gold announces at end of calendar year 2012, precious metals reserves on properties subject to the co's interests, net of depletion, were ~ 82.8 mln ounces of gold and 1.15 bln ounces of silver vs reserves of ~84.5 mln ounces of gold and 1.2 b;m ounces of silver estimated as of Dec 31, 2011. (RGLD) : Co announced updated estimates for ore reserves and mineralized material1 as of December 31, 2012, and calendar 2013 production estimates with respect to properties in its portfolio. These figures are provided by the operators, or obtained by Royal Gold through publicly available information, for properties on which the Company holds royalties and similar interests.

At the end of calendar 2012, precious metals reserves on properties subject to the Company's interests, net of depletion, were approximately 82.8 mln ounces of gold and 1.15 bln ounces of silver. This compares to reserves of approximately 84.5 mln ounces of gold and 1.2 bln ounces of silver estimated as of December 31, 2011. The reserve reductions were due mainly to production depletion.

8:22 am Gapping down (:SCANX) : In reaction to disappointing earnings/guidance: GLUU -4.7%, CNW -4.5%, (light volume), TS -4.3%, (light volume), GNK -4.3%, IRDM -3.8%, LF -3.4%, (light volume), RLGY -2.9%, STO -2.7%, GOLD -2.7%, SHPG -2.2%, CACI -2.2%, GTAT -1.8%, CSOD -1.8%, CTRX -1.8%, K -1.7%, (light volume), CZR -1.6%, IP -1.4%, LNC -0.4% (light volume).

M&A news: ELN -1.7% (Royalty Pharma Submits Formal Cash Offer For Elan; Offer Price Reflects $1 Billion Dutch AuctionStrikePrice of $11.25 per Elan Share).

A few metals/mining stocks trading lower: HMY -2%, AU -1.7%, BBL -1%, BHP -0.7%.

Other news: IEC -7% (announced it will restate certain financial statements), NVDQ -3.7% (discloses their 3.9 mln share offering was priced at $12.90 per share), MGM -3.6% (Macau data out this morning), MCO -0.6% ( top shareholder Berkshire Hathaway disclosed selling 1,746,700 shares at $59.50-61.50 on 4/29-5/1, worth ~$105.6 mln ), .

Analyst comments: RPTP -1.2% (downgraded to Neutral from Outperform at Wedbush), PODD -1.1% (Insulet downgraded to Market Perform from Outperform at Raymond James), SCTY -0.9% (downgraded to Neutral from Buy at Goldman)

8:21 am CenterPoint misses by $0.03, reports revs in-line; lowers FY13 EPS below consensus (CNP) : Reports Q1 (Mar) earnings of $0.34 per share, $0.03 worse than the Capital IQ Consensus Estimate of $0.37; revenues rose 14.6% year/year to $2.39 bln vs the $2.37 bln consensus.

Co lowers guidance for FY13, sees EPS of $1.17-1.25 vs. $1.26 Capital IQ Consensus Estimate, down from $1.22-1.30.

"Our regulated gas distribution unit and competitive natural gas sales and services unit performed well offsetting a first quarter decline in our electric utility. In the midstream business, our field services unit continues to benefit from its contracting strategy and the earnings from recent acquisitions, which partially offset expected declines in our interstate pipelines. I am also pleased to announce that we closed on our midstream partnership yesterday."

8:19 am Sinclair Broadcast prices 18 mln share offering at $27.25 per share (SBGI) :  

8:15 am Royal Gold misses by $0.02, misses on revs (RGLD) : Reports Q3 (Mar) earnings of $0.37 per share, excluding non-recurring items, $0.02 worse than the Capital IQ Consensus Estimate of $0.39; revenues rose 6.5% year/year to $74.1 mln vs the $75.94 mln consensus.

"The 7% increase in revenue for the quarter was largely driven by increased production at Andacollo and Holt, and the continued ramp up at Wolverine. These increases were partially offset during the period by production declines at Pe?asquito and Voisey's Bay, as well as lower gold and other metal prices. The average price of gold for the quarter was $1,632 per ounce compared with $1,691 per ounce for the comparable period, a decrease of 3%."

8:14 am Gapping up (:SCANX) : In reaction to strong earnings/guidance: REGI +13.5%, HDSN +11.1%, YELP +10.3%, NIHD +8.6%, ISSI +7.7% (light volume), GNRC +7.5%, MWW +7.2%, BZH +6.6%, PGTI +5.5%, MDAS +4.8%, LQDT +4.5% (light volume), MDC +4.1%, (light volume), STX +4%, JDSU +3.8%, GM +3.4%, EL +2.9%, (light volume), DX +2.6%, V +2.5%, SFLY +2.4%, SNY +2.3%, MET +2.2%, NXST +2.1% (announces secondary offering of 3.5 mln shares of co's Class A common stock by selling stockholders and repurchse of its common stock), ATML +1.9%, RDS.A +1.9%, TTS +1.8% (light volume), SI +1.7%, CI +1.7%, ANR +1.7%, FB +1.6%, SNN +1.5% (light volume), LVS +1.3%, LOCK +1.3%, CBS +1.1%, NLY +0.4% (light volume).

Financial related names showing strength: DB +2.5%, BBVA +2.1%, SAN +2%, ING +1.8%, CS +1.4%, BCS +1%, BAC +0.8%, C +0.7%, HBC +0.5%.

A few oil/gas related names showing strength: MHR +2.8%, PER +2.5%, CVRR +2.2%, BP +1.1%, HAL +0.8%, TOT +0.7%.

Other news: IFT +33.2% (secured 15-year, $300 million revolving credit facility; acquired 93 life settlement policies with a total face value of ~$340 mln), A +3.6% (still checking), TKC +1.8% ( dismisses case without prejudice), WDC +1.6% (following STX results), BUD +1.6% and CCL +1.4% (still checking for anything specific).

Analyst comments: ACI +2.9% (upgraded to Equal-Weight from Underweight at Morgan Stanley), REGN +0.3% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities), AGN +0.2% (upgraded to Buy from Neutral at Lazard)

8:13 am Asian Markets Close: Nikkei -0.8%, Hang Seng -0.3%, Shanghai -0.2% (:SUMRX) : Markets across Asia ended mostly lower after returning to work following the Labor Day holiday. India's Sensex (+1.2%) was the exception as traders continued to gobble up shares in anticipation of a rate cut at tomorrow's Reserve Bank of India meeting. China's Shanghai Composite (-0.2%) saw little reaction to the weaker than expected HSBC Final Manufacturing PMI (50.4 actual v. 50.6 expected, 50.5 previous). Elsewhere, the latest Bank of Japan minutes showed some members have expressed concerns over the bold action being taken by the central bank. Data from the region saw Australia's building approvals plunge 5.5% MoM (+1.2Z% MoM expected), Hong Kong's retail sales jump 10.2% YoY (12.2% YoY expected), and Thailand's consumer confidence ease to 83.7 (84.8 previous). Looking at the currencies...USDCNY fell to a 19-yr low of 6.1555; USDINR ticked up to 53.78; USDJPY is stronger at 97.85; AUDUSD is lower near 1.0250. In Japan, the Nikkei closed -0.8% to fall for the fourth straight session. Real estate names were under pressure as Sumitomo Realty & Development shed 1.3% and Mitsui Fudosan lost 0.7%. Meanwhile, exporters were mixed as Toyota Motor lost 1.1% and Canon added 0.2%.

In Hong Kong, the Hang Seng finished -0.3% as trade slipped off its best level in more than a month. Casino operators were under pressure despite gaming revenue jumping 13% YoY. Galaxy Entertainment fell 3.6% while Sands China gave up 1.1%...In China, the Shanghai Composite settled -0.2% as traders returned after a three-day holiday. Real estate names were strong as Poly Real Estate added 2.1%. Elsewhere, alcohol producers were pressured with Kweichow Moutai sinking 1.7%.

In India, the Sensex closed +1.2% ahead of tomorrow's Reserve Bank of India rate decision. Lenders were strong as State Bank of India and HDFC gained 1.6% and 1.9% respectively. Elsewhere, IT names also saw gains with Tata Consultancy up 4% and Infosys higher by 2.3%. Click here to see a daily Sensex chart.

In Australia, the ASX finished -0.7% as miners and financials were both weak. Heavyweights BHP Billiton and Rio Tinto gave up 1.2% and 2.0% respectively. Meanwhile, all of the 'big four' banks ended lower with ANZ and CBA both falling 0.6% to lead to the downside.

In Taiwan, the Taiex settled +0.4% as Acer added 0.6%...In South Korea, the Kospi closed -0.3% as BS Financial dropped 4.1%.

In other regional markets...Indonesia -1.3%...Thailand -0.5%...Vietnam -0.3%...Malaysia -0.2%...Philippines +0.3%...Singapore +1.0%

8:12 am GP Strategies reports EPS in-line, misses on revs (GPX) : Reports Q1 (Mar) earnings of $0.26 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.26; revenues rose 8.3% year/year to $101.4 mln vs the $103.29 mln consensus.

EBITDA was $9.5 million for first quarter of 2013 compared to $9.2 million for first quarter of 2012. Gross profit was $16.2 million, or 16.0% of revenue, for the first quarter of 2013 compared to $15.6 million, or 16.7% of revenue, for the first quarter of 2012.

8:12 am Rofin-Sinar Technologies misses by $0.02, misses on revs; guides JunQ EPS below consensus, revs below consensus (RSTI) : Reports Q2 (Mar) earnings of $0.26 per share, $0.02 worse than the Capital IQ Consensus Estimate of $0.28; revenues rose 1.3% year/year to $131.2 mln vs the $135.0 mln consensus. Co issues downside guidance for Q3 (Jun), sees EPS of $0.26-0.28 vs. $0.37 Capital IQ Consensus Estimate; sees Q3 revs of $132-137 mln vs. $139.2 mln Capital IQ Consensus Estimate.

• During Q2, co experienced significantly higher sales in its MACRO product lines, mainly driven by the machine tool industry, while its MICRO & MARKING business declined as expected, triggered by weaker sales to the electronics and semiconductor industries.
• "Due to the timing of revenue recognition, we achieved an overall result that was in line with the lower end of our guidance for the second quarter."
• "On a geographical basis, North American and Asian order entry softened compared to the second quarter of last year, while European order entry reached its highest level since 3Q11. We expect a stable environment for laser material processing even when global business conditions are taken into consideration."

8:11 am DineEquity beats by $0.15, misses on revs (DIN) : Reports Q1 (Mar) earnings of $1.14 per share, $0.15 better than the Capital IQ Consensus Estimate of $0.99; revenues fell 33.6% year/year to $163.1 mln vs the $165.91 mln consensus.

FY13 guidance

• Applebee's domestic system-wide same-restaurant sales performance to range between negative 1.5% and positive 1.5%
• IHOP's domestic system-wide same-restaurant sales performance to range between negative 1.5% and positive 1.5%
• Applebee's franchisees to develop between 40 and 50 new restaurants, the majority of which are expected to be opened in the U.S. IHOP franchisees and its area licensee to develop between 50 and 60 new restaurants, the majority of which are expected to be domestic openings
• Franchise segment profit is expected to be between $312-325 mln

8:11 am Lincoln Educational Services beats by $0.02, reports revs in-line; guides Q2 EPS below consensus, revs below consensus; reaffirms FY13 EPS guidance, revs guidance (LINC) : Reports Q1 (Mar) loss of $0.29 per share, long-lived asset non-cash impairment charges, $0.02 better than the Capital IQ Consensus Estimate of ($0.31); revenues fell 14.1% year/year to $90.1 mln vs the $90.27 mln consensus. 


Guidance
Co issues downside guidance for Q2, sees EPS of $(0.35)-(0.30) vs. ($0.16) Capital IQ Consensus Estimate; sees Q2 revs of $86.0-90.0 mln vs. $92.34 mln Capital IQ Consensus Estimate.

Co reaffirms guidance for FY13, sees EPS of $(0.05) -0.05 vs. ($0.05) Capital IQ Consensus Estimate; sees FY13 revs of $395-405 mln vs. $390.72 mln Capital IQ Consensus Estimate.

Guidance Assumptions:

• Guidancefor the second quarter of 2013 is based on a decrease in starts of 8% to 12% as compared to the second quarter of 2012.
• Co expects the reduction in starts in the second quarter as a result of the continued loss of ability to benefit students and our elimination of our fully online program in the first half of 2012.
• Excluding the impact of these items, student starts from continuing operations are expected to increase by 7% as compared to the second quarter of 2012.

Commentary/OutlooK
"...Our confidence in the second half of 2013 is based on the overall performance of our verticals. Enrollment in our automotive and skilled trade schools remain strong and we expect further improvement leading up to our crucial third quarter which benefits from the high school recruiting season. Enrollment in our healthcare vertical remains challenged and we are experiencing significant weakness in our former Southwestern Colleges. These schools have experienced significant challenges over the past two years with their graduation and default rates..."

8:11 am Investment Tech beats by $0.07, reports revs in-line (ITG) : Reports Q1 (Mar) earnings of $0.24 per share, $0.07 better than the Capital IQ Consensus Estimate of $0.17; revenues fell 3.2% year/year to $132.1 mln vs the $131.23 mln consensus.

• Average daily trading volume in the U.S. of 193 million shares, up from 190 million in the first quarter of 2012. POSIT average daily U.S. volume was 89 million shares compared to 96 million shares in the first quarter of 2012. Total average daily volume traded through POSIT Alert rose 25% compared with the first quarter of 2012.
• The overall revenue capture rate per share in the U.S. rose to $0.0046, up from $0.0043 in the fourth quarter of 2012. This marked the first sequential increase in average U.S. revenue capture since the first quarter of 2011.

8:10 am Stillwater Mining: Clinton Group warns of possible vote and meeting manipulation by SWC at today's annual meeting (SWC) : Clinton Group, a stockholder of Stillwater Mining that is seeking to replace the existing Stillwater board with independent professionals, announced that it believes that Stillwater is continuing its attempt to manipulate and mislead stockholders in advance of the Stillwater 2013 Annual Meeting and to interfere with the stockholders' right to elect a board of directors. Stockholders have had the opportunity to review the Company's proxy materials and Board candidates for 44 days and to consider Clinton's viewpoints and nominees for almost as long. The vast majority of the Company's stockholders have cast a ballot. During this entire process, Clinton believes the incumbent Board of Directors has not been transparent and fully honest with its stockholders and has sought to manipulate the election process in its favor in an effort to remain in office and to preserve the tenure of the Company's Chief Executive Officer, Frank McAllister, on whose watch stockholders have lost more than $900 million. Clinton urges stockholders to demand that votes be counted today and that the preliminary results be announced publicly at the conclusion of today's Meeting.

8:10 am IdaCorp beats by $0.12, beats on revs; reaffirms FY13 EPS guidance (IDA) : Reports Q1 (Mar) earnings of $0.67 per share, $0.12 better than the Capital IQ Consensus Estimate of $0.55; revenues rose 9.9% year/year to $264.9 mln vs the $255.12 mln consensus. Co reaffirms guidance for FY13, sees EPS of $3.20-3.35 vs. $3.26 Capital IQ Consensus Estimate.

8:10 am Inventure Foods misses by $0.04, misses on revs (SNAK) : Reports Q1 (Mar) earnings of $0.05 per share, $0.04 worse than the Capital IQ Consensus Estimate of $0.09; revenues rose 3.2% year/year to $48.5 mln vs the $49.6 mln consensus. EBITDA increased 23% to $3.1 mln.

Commentary: "We experienced some disappointments in our first quarter results, largely driven by a slowing in the T.G.I. Friday's brand and increased brand investment, which we referred to in our last call, resulting in lower than expected earnings for the quarter. However, we maintain our outlook to achieve positive revenue and earnings growth for the full year. We continue to see strong growth in our healthy/natural portfolio of products, which now makes up 68% of total net revenues. Our healthy/natural portfolio net revenues grew due to sustained demand for our frozen fruit products and continued growth of our Boulder Canyon products..."

8:10 am Goldcorp misses by $0.08, misses on revs; reaffirms Fy13 guidance (GG) : Reports Q1 (Mar) earnings of $0.31 per share, excluding non-recurring items, $0.08 worse than the Capital IQ Consensus Estimate of $0.39; revenues fell 16.2% year/year to $1.01 bln vs the $1.34 bln consensus.

Gold sales in the first quarter were 595,100 ounces on production of 614,600 ounces. This compares to sales of 545,700 ounces on production of 524,700 ounces in the first quarter of 2012. Silver production totaled 5.6 million ounces compared to silver production of 6.6 million ounces in the prior year's first quarter. Operating costs were $1,135 per ounce of gold on an all-in sustaining cost basis, $565 per ounce on a by-product basis and $710 on a co-product basis.

The Company today reconfirmed guidance for 2013 of between 2.55 and 2.80 million ounces at total cash costs of between $1,000 and $1,100 per ounce on an all-in sustaining cost basis; $525 to $575 per ounce of gold on a by-product basis and $700 to $750 per ounce on a co-product basis. Capital spending guidance of $2.8 billion for 2013 has also been reconfirmed.

8:09 am Fluor awarded contract for Dow (DOW) U.S. Gulf Coast investments (FLR) : Co announced that it was awarded a contract by Dow Chemical (DOW) to execute a significant portion of its U.S. Gulf Coast investments. Fluor's scope includes the engineering, procurement and construction of a propane dehydrogenation unit, an ethane cracker, and associated power, utilities and infrastructure facility upgrades to support each unit. The facilities will be constructed in Dow's Oyster Creek facility in Freeport, Texas. Fluor booked the undisclosed contract value into backlog in the first quarter of 2013.

8:06 am Harman beats by $0.18, reports revs in-line; guides FY13 EPS above consensus, revs in-line (HAR) : Reports Q3 (Mar) earnings of $0.79 per share, excluding non-recurring items, $0.18 better than the Capital IQ Consensus Estimate of $0.61; revenues fell 3.1% year/year to $1.06 bln vs the $1.06 bln consensus. For FY13, co raises EPS guidance to $3.00 from prior guidance of $2.70-2.90 and vs. $2.80 Capital IQ Consensus Estimate; sees FY13 revs at the mid-to-high-end of its prior guidance of $4.175-4.250 bln vs. $4.21 bln Capital IQ Consensus Estimate.

8:06 am Kellogg misses by $0.03, misses on revs; reaffirms FY13 EPS guidance; announces $1 bln buyback (K) : Reports Q1 (Mar) earnings of $0.99 per share, $0.03 worse than the Capital IQ Consensus Estimate of $1.02; revenues rose 12.2% year/year to $3.86 bln vs the $3.94 bln consensus. Internal net sales, which exclude the effects of foreign currency translation, acquisitions, dispositions, and integration costs, rose by 2.2% over the same period. First quarter 2013 operating profit was $503 million, a reported decrease of 4.5%; underlying internal operating profit, which excludes the effects of FX, acquisitions, dispositions, mark-to-market accounting, and integration costs, decreased by 5.8%. As expected, the decline in underlying internal operating profit was largely due to the recognition of considerable cost-of-goods-sold inflation in the quarter. Results in the first quarter included a majority of the inflation, net of cost savings, that the company expects to recognize for the full year.

Co reaffirms guidance for FY13, sees EPS of $3.82-3.91, excluding non-recurring items, vs. $3.87 Capital IQ Consensus Estimate.  

The co also announced that the Board of Directors approved a share repurchase authorization of $1 billion, which expires in April of 2014. This authorization supersedes the existing authorization and is intended to allow the co to repurchase shares to offset the impact of proceeds from the exercise of options through the end of 2013, and to begin the company's 2014 purchase plan.

8:05 am Palomar Medical misses by $0.05, beats on revs (PMTI) : Reports Q1 (Mar) loss of $0.06 per share, $0.05 worse than the Capital IQ Consensus Estimate of ($0.01); revenues rose 22.1% year/year to $23.2 mln vs the $20.3 mln consensus.

8:03 am CECO Environ. announces new orders totaling $17 mln (CECE) : Co announced that it has received several new orders totaling $17 million. These new global orders were from natural gas and traditional power customers located in Asia, Australia and the United States, as well as from oil refinery, chemical and large industrial customers in the United States, China, and Germany.

8:03 am AP Pharma announces Barry Quart appointed Chief Executive Officer (APPA) : Dr. Quart was most recently President and Chief Executive Officer of Ardea Biosciences.

7:59 am Exterran beats by $0.06 (EXLP) : Reports Q1 (Mar) earnings of $0.31 per share, excluding non-recurring items, $0.06 better than the Capital IQ Consensus Estimate of $0.25; revenues rose 20% year/year to $106.1 mln vs the $106.0 mln consensus.

7:58 am Macau Gaming Inspection and Coordination Bureau reported April gross gaming rev (GGR) +13% YoY to $3.54 bln (MPEL) : Macau Gaming Inspection and Coordination Bureau reports April gross gaming revenue (GGR) +13.2% to 28.3 bln patacas ($3.54 bln), vs. +22% in April 2012. GGR is +14.4% YTD.

Macau GGR grew 13.5% in 2012 and 42% in 2011. The mass market segment has remained strong while the VIP segment has been volatile.

Casino stocks with exposure to Macau: AERL (VIP market exposure only) and MPEL are both Macau pure plays; WYNN ~72% of Q4 net rev and ~73% of Q1 adj. EBITDA came from Macau; LVS: ~61% of Q4 net rev and ~54% of Q4 adj. EBITDA came from Macau; MGM: ~29% of 3Q12 net rev and ~35% of adj. EBITDA.

7:50 am Ameren misses by $0.06, misses on revs; guides FY13 EPS in-line (AEE) : Reports Q1 (Mar) earnings of $0.22 per share, excluding non-recurring items, $0.06 worse than the Capital IQ Consensus Estimate of $0.28; revenues rose 4.5% year/year to $1.48 bln vs the $1.63 bln consensus. Co issues in-line guidance for FY13, sees EPS of $2.00-2.20 vs. $2.12 Capital IQ Consensus Estimate.

7:49 am Spirit Aerosystems beats by $0.09, beats on revs; reaffirms FY13 guidance (SPR) : Reports Q1 (Mar) earnings of $0.57 per share, $0.09 better than the Capital IQ Consensus Estimate of $0.48; SPR also provides non-GAAP EPS of $0.61, which excludes severe weather expense. It's not clear which is comparable to consensus but it's a beat either way.

Revenues rose 13.9% year/year to $1.44 bln vs the $1.41 bln consensus. Co reiterates prior FY13 guidance. Co continues to expect EPS of $1.90-2.10 vs. $2.12 Capital IQ Consensus Estimate; excluding severe weather adjustments, non-GAAP EPS is expected to be between $2.20 - $2.40, co sees FY13 revs of $5.80-6.00 bln vs. $5.98 bln Capital IQ Consensus Estimate.

• Coincident with the arrival of Mr. Larry Lawson, Spirit's newly named CEO, Spirit will not be issuing further financial guidance at this time, pending the completion of a comprehensive strategic and financial review. The co expects to report its progress on these initiatives in the coming quarters.
• "As the first quarter demonstrates, Spirit's performance across core programs remains strong with large commercial aircraft deliveries increasing 9% and deliveries across all programs increasing 11% YoY.
• Spirit's backlog at the end of Q1 was approximately $36 bln.

7:47 am General Motors beats by $0.11, reports revs in-line (GM) : Reports Q1 (Mar) earnings of $0.67 per share, $0.11 better than the Capital IQ Consensus Estimate of $0.56; revenues fell 2.4% year/year to $36.9 bln vs the $36.76 bln consensus.  

Beginning this quarter, the co will report segment revenues and profits based on the geographic region in which a vehicle is sold. Previously, segment results included the impacts of inter-segment sales and profits. Prior year segment results have been reclassified so all information is shown on a comparable basis. Financial results for Chevrolet Europe continue to be recorded in GM International Operations. Consolidated results are unaffected by this change.

GM North America reported EBIT-adjusted of $1.4 billion, compared with $1.6 billion in the first quarter of 2012.

GM Europe reported an EBIT-adjusted of $(0.2) billion, compared with $(0.3) billion in the first quarter of 2012.

GM International Operations reported EBIT-adjusted of $0.5 billion, compared with $0.5 billion in the first quarter of 2012.

GM South America broke even on an EBIT-adjusted basis, compared with EBIT-adjusted of $0.2 billion in the first quarter of 2012.

GM Financial earnings before tax was $0.2 billion for the quarter, compared to $0.2 billion in the first quarter of 2012.

GM ended the quarter with very strong total automotive liquidity of $35.3 billion. Automotive cash and marketable securities was $24.3 billion compared with $26.1 billion at year-end 2012.

7:44 am On The Wires (:WIRES) :

• Affiliates of Apollo Global Management (APO) and Apex Energy have formed a strategic partnership to invest in oil and gas properties in the Appalachian Basin, with a primary focus on the Marcellus Shale.
• GT Crystal Systems, a subsidiary of GT Advanced Technologies (GTAT), has agreed with Motorola Solutions (MSI) to be the exclusive supplier of sapphire screens for Motorola's new MP6000 multi-plane bioptic imager. GT Crystal Systems will fabricate the 24 square inch sapphire components in its manufacturing facility located in Salem, Mass.

7:44 am Monster Worldwide reports EPS in-line, revs in-line; guides Q2 EPS in-line; Board authorizes share repurchase program of up to $200 mln (MWW) : Reports Q1 (Mar) earnings of $0.08 per share, excluding non-recurring items, in-line with the Capital IQ Consensus Estimate consensus of $0.08; revenues fell 9.3% year/year to $212 mln vs the $210.5 mln consensus.

Co issues in-line guidance for Q2, sees EPS of $0.06-0.10 vs. $0.08 Capital IQ Consensus Estimate.

7:44 am Beam beats by $0.10, beats on revs; reaffirms guidance (BEAM) : Reports Q1 (Mar) earnings of $0.64 per share, excluding non-recurring items, $0.10 better than the Capital IQ Consensus Estimate of $0.54; revenues rose 8.2% year/year to $577.7 mln vs the $565.93 mln consensus.

• "We compete in a dynamic, profitable and growing industry with excellent fundamental trends across our markets... As we look ahead, we continue to see our global market growing in the range of 3% for the year. With the success of our investments to further strengthen our premium brand equities, drive growth through innovation and enhance our routes to market, we feel very well positioned to continue outperforming our global market in 2013 and to drive sustainable, profitable long-term growth. At the bottom line, the timing of costs that was a tailwind in Q1 will be a headwind that we expect will result in a moderate EPS growth rate over the next couple of quarters.
• "Our first quarter results combined with our inherent strengths reinforce our confidence in our outlook for the full year, and we're reaffirming our target to deliver high-single-digit growth in diluted EPS before charges/gains for 2013."
• The company also reaffirmed its target to generate free cash flow for 2013 in the range of $300-350 million, which incorporates continued investment to increase distillation capacity and produce more aged spirits to support long-term growth.

7:43 am Hillshire Brands beats by $0.02, misses on revs; guides FY13 EPS at high end of prior range (HSH) : Reports Q3 (Mar) earnings of $0.35 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus Estimate of $0.33; revenues fell 0.9% year/year to $924 mln vs the $953.31 mln consensus, driven by a decline in the Foodservice/Other segment. MAP investment increased to 4.2% of revenue versus 3.4% in the prior year's third quarter. Operating income was also impacted by planned increases in SG&A as transition service agreements expired and the co approached targeted staffing levels. 

Co issues guidance for FY13, sees EPS of high end of $1.60-1.70 vs. $1.73 Capital IQ Consensus Estimate.

7:41 am Circor beats by $0.01, reports revs in-line; guides Q2 EPS in-line, revs in-line (CIR) : Reports Q1 (Mar) earnings of $0.52 per share, excluding non-recurring items, $0.01 better than the Capital IQ Consensus Estimate of $0.51; revenues fell 4.2% year/year to $205.4 mln vs the $204.35 mln consensus.

Co issues in-line guidance for Q2, sees EPS of $0.64-0.70, excluding non-recurring items, vs. $0.67 Capital IQ Consensus Estimate; sees Q2 revs of $214-220 mln vs. $217.94 mln Capital IQ Consensus Estimate.

7:40 am Moody's: top shareholder Berkshire Hathaway disclosed selling 1,746,700 shares at $59.50-61.50 on 4/29-5/1, worth ~$105.6 mln (MCO) : The sales were reported in an SEC filing out late last night. Berkshire still holds ~26.7 mln. (:INSID)

7:40 am Nu Skin beats by $0.09, beats on revs; guides Q2 EPS in-line, revs above consensus; raises FY13 EPS above consensus, raises FY13 revs above consensus (NUS) : Reports Q1 (Mar) GAAP earnings of $0.90 per share, $0.09 better than the GAAP Capital IQ Consensus Estimate of $0.81; revenues rose 19.1% year/year to $550.1 mln vs the $508.06 mln consensus.

Co issues guidance for Q2, sees EPS of $0.91-0.95 vs. $0.92 Capital IQ Consensus Estimate; sees Q2 revs of $570-580 mln vs. $539.63 mln Capital IQ Consensus Estimate.

Co issues raised guidance for FY13, sees EPS of $4.18-4.30 from prior guidance of $3.77-3.92 vs. $3.99 Capital IQ Consensus Estimate; sees FY13 revs of $2.51-2.54 bln from prior guidance of $2.30-2.35 bln vs. $2.35 bln Capital IQ Consensus Estimate.

First-quarter revenue in North Asia was $188.2 million, compared to $182.2 million for the same period in 2012. The region's results were negatively impacted 8 percent by foreign currency fluctuations. In Greater China, first-quarter revenue increased 90 percent to $175.7 million, compared to $92.6 million in the prior-year period.  Revenue in the Americas improved 15 percent to $76.5 million, compared to $66.3 million in the prior-year period. The company's operating margin was 15.0 percent for the quarter, compared to 15.5 percent in the prior year. The decrease in operating margin was primarily a result of planned brand-building efforts in Greater China and Japan as well as increased research and development expenditures.

Outlook: "Given the strength of our business, as well as the optimism we have for the upcoming ageLOC weight management system, we are significantly raising our 2013 guidance," said Ritch Wood, chief financial officer. "Our increased guidance accounts for a stronger-than-expected currency headwind, which we now forecast will negatively impact revenue for the year by approximately 5 percent, an increase of 1 to 2 percent from our previous guidance."

7:40 am Enpro Industries misses by $0.07, reports revs in-line (NPO) : Reports Q1 (Mar) adjusted earnings of $0.56 per share, $0.07 worse than the Capital IQ Consensus Estimate of $0.63; revenues fell 8.0% year/year to $286.9 mln vs the $289.13 mln consensus.

Outlook
"Although we see no indication of sustained improvement, we expect seasonal growth in some markets during the second quarter...These seasonal factors are likely to support an increase in sales compared to the first quarter. Profits and profit margins should improve as volumes increase and as we continue to benefit from previously implemented cost reductions and efficiency programs..."

"...Longer term, we remain cautious...In North America, we believe low levels of growth are likely in most of our markets during 2013. In Europe, we anticipate little if any growth as weak economic conditions persist in many of our markets. In these circumstances, we will continue to ensure that our cost structure is in line with activity levels in all markets."

7:39 am Sally Beauty misses by $0.03, misses on revs (SBH) : Reports Q2 (Mar) earnings of $0.36 per share, $0.03 worse than the Capital IQ Consensus Estimate of $0.39; revenues rose 1.0% year/year to $898.2 mln vs the $919.68 mln consensus.

7:39 am Airgas increases quarterly cash dividend by 20% to $0.48 per share from $0.40 per share (ARG) :  

7:37 am Halcon Resources misses by $0.01, reports revs in-line (HK) : Reports Q1 (Mar) earnings of $0.05 per share, $0.01 worse than the Capital IQ Consensus Estimate of $0.06; revenues rose 608.9% year/year to $190.7 mln vs the $191.59 mln consensus. "We are making progress on all fronts -- significant operational improvements in the Williston Basin, dramatic improvements in lease operating expense, the recent unveiling of a new core Eagle Ford play in East Texas and encouraging flowback data from our first well in the Utica/Point Pleasant play."

7:36 am Lexington reports FFO in-line, revs in-line; reaffirms FY13 FFO guidance (LXP) : Reports Q1 (Mar) funds from operations of $0.25 per share, excluding non-recurring items, in-line with the Capital IQ Consensus Estimate consensus of $0.25; revenues rose 24.1% year/year to $97.06 mln vs the $96.14 mln consensus. Co reaffirms guidance for FY13, sees FFO of $1.01-1.04 vs. $1.01 Capital IQ Consensus Estimate.

7:36 am Repligen reports Q1 results, revs rose 28% YoY to $16.5 mln, provides guidance for 2013 (RGEN) : Co reports Q1 EPS of $0.07 vs $0.04 in the year ago period. Revenue rose 28.3% YoY to $16.5 mln. There are no analyst estimates. Bioprocessing product revenue for Q1 was $11.9 mln, a 28% YoY increase. Total revenue for the full year 2013 is expected to be $63-$65 mln, including the receipt of royalties from Bristol-Myers Squibb on its US sales of Orencia, which the co will no longer receive after December 31, 2013. Bioprocessing product revenue for 2013 is expected to be $46-$48 mln, reflecting product sales growth of 10%-15%. Net income for the full year 2013 is expected to be $18-$20 mln.

7:35 am Denbury Resources beats by $0.04, beats on revs (DNR) : Reports Q1 (Mar) earnings of $0.33 per share, excluding non-recurring items, $0.04 better than the Capital IQ Consensus Estimate of $0.29; revenues fell 9.6% year/year to $583.1 mln vs the $543.71 mln consensus. Co sees 2013 total production of 68,700-71,700 BOE/d.

7:34 am Gibraltar Industries misses by $0.08, misses on revs (ROCK) : Reports Q1 (Mar) earnings of $0.04 per share, excluding non-recurring items, $0.08 worse than the Capital IQ Consensus Estimate of $0.12; revenues rose 2.4% year/year to $196.8 mln vs the $205.17 mln consensus. Q1 results exclude after-tax special charges of $4.9 mln, or $0.16 per diluted share, resulting primarily from costs related to the co's successful re-financing of its senior subordinated notes, which lowered the interest rate by 175 basis points.

Commentary:
"We experienced positive developments in some key areas of our business in the first quarter as expected...However, the unusually cold and stormy weather patterns that affected many parts of the country, particularly in March, along with increased pricing pressures in some of our industrial markets and tighter inventory control in some of our sales channels, resulted in a slower start in 2013 than we had expected. As a result, despite increased sales from recent acquisitions, Gibraltar's 2.4% net sales growth for the quarter fell two percentage points short of our guidance. Although the year started more slowly than we anticipated, we continue to be optimistic that 2013 will show solid full-year improvement over 2012 as basic fundamentals in several of our end markets continue to move in a positive direction..."

Outlook
"In spite of the current industrial end market weakness which is expected to continue into the third quarter of 2013 and the slower-than-expected start to the year, we continue to expect 2013 revenues and earnings to be an improvement over 2012 as we benefit from our fourth-quarter 2012 acquisition activity, lower interest expense, improved West Coast operational performance and overall end-market demand improvement..."

7:34 am Exterran Holdings beats by $0.18, beats on revs (EXH) : Reports Q1 (Mar) earnings of $0.21 per share, excluding non-recurring items, $0.18 better than the Capital IQ Consensus Estimate of $0.03; revenues rose 31.9% year/year to $811.37 mln vs the $761.89 mln consensus.

7:34 am Aircastle beats by $0.15, beats on revs (AYR) : Reports Q1 (Mar) earnings of $0.40 per share, $0.15 better than the Capital IQ Consensus Estimate of $0.25; revenues rose 6.9% year/year to $176.2 mln vs the $163.79 mln consensus.

7:33 am Harvard Biosci misses by $0.03 (HBIO) : Reports Q1 (Mar) income of $0.03 per share, excluding non-recurring items, $0.03 worse than the Capital IQ Consensus Estimate of $0.06; revenues fell 8% year/year to $26.1 mln vs the $28.9 mln consensus.

7:32 am CME Group volume averaged 11.6 mln contracts per day in April 2013, up 8% from April 2012 (CME) : Total volume for April 2013 was more than 254 million contracts, of which 87% was traded electronically. In April 2013, CME Group metals volume averaged a record 532,000 contracts per day, up 62% from April 2012, driven by monthly records across various products including copper. CME Group energy volume averaged 1.9 million contracts per day in April 2013, up 20% compared with the prior April. CME Group foreign exchange volume averaged 898,000 contracts per day, up 18% from April 2012, with continued strength in Japanese Yen. CME Group equity index volume in April 2013 averaged 2.7 million contracts per day, up 16% from the same period last year.

7:32 am Belden beats by $0.04, reports revs in-line; guides Q2 EPS below consensus, revs below consensus; guides FY13 EPS in-line, revs in-line (BDC) : Reports Q1 (Mar) earnings of $0.84 per share, $0.04 better than the Capital IQ Consensus Estimate of $0.80; revenues rose 15.4% year/year to $507.5 mln vs the $509.6 mln consensus.

• Co issues downside guidance for Q2, sees EPS of $0.90-0.95 vs. $0.96 Capital IQ Consensus Estimate; sees Q2 revs of $530-540 mln vs. $541.30 mln Capital IQ Consensus Estimate.
• Co issues in-line guidance for FY13, sees EPS of $3.49-3.69 vs. $3.60 Capital IQ Consensus Estimate; sees FY13 revs of $2.07-2.12 bln vs. $2.11 bln Capital IQ Consensus Estimate.

7:32 am Palatin Technologies announces notification of patent allowance on melanocortin receptor-specific peptides for sexual dysfunction (PTN) : Co announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. Patent Application Serial Number 12/952,238. The application includes composition of matter claims on a new class of melanocortin receptor- specific peptides for sexual dysfunction and other indications.

7:31 am Tractor Supply announces 30% dividend increase to $0.26 per share (TSCO) :  

7:31 am AcelRx presents positive clinical data for the Sufentanil NanoTab PCA System at ASRA Medical meeting (ACRX) : Co reported additional clinical results for its lead product candidate, the Sufentanil NanoTab PCA System for the treatment of moderate-to-severe acute pain in the hospital setting. These data are being presented in five posters at the American Society of Regional Anesthesia and Pain Medicine (:ASRA) spring meeting held May 2 to May 5, 2013. New analyses from the Phase 3 comparison trial of the NanoTab System to intravenous patient-controlled analgesia (IV PCA) with morphine demonstrate that sufentanil delivered via the NanoTab System has a significantly greater pain intensity reduction in the first four hours after starting treatment than IV PCA morphine (p

7:31 am Zogenix reports positive top-line results from extended Relday Phase 1 clinical trial; initiates efforts to secure strategic development and commercialization partner (ZGNX) : The extended Phase 1 clinical trial included a 100 mg dose of Relday, following previously reported positive results with 25 and 50 mg doses. The results for the 100 mg dose showed that risperidone blood concentrations in the therapeutic range were achieved on the first day of dosing, and maintained throughout the one-month period. In addition, dose proportionality has now been established across the full dose range that would be anticipated to be used in clinical practice (50 to 100 mg). The 100 mg dose was safe and well-tolerated, with no unexpected adverse events, including injection site reactions, as compared to the initial Phase 1 clinical trial with the 25 and 50 mg doses. The adverse events were generally mild to moderate and consistent with other risperidone products.

7:30 am Nxstage Medical reports EPS in-line, revs in-line; guides Q2 EPS below consensus, revs in-line (NXTM) : Reports Q1 (Mar) loss of $0.08 per share, in-line with the Capital IQ Consensus Estimate consensus of ($0.08); revenues rose 8.2% year/year to $61.6 mln vs the $61.1 mln consensus. Co issues guidance for Q2, sees EPS of ($0.07)-($0.08) vs. ($0.06) Capital IQ Consensus Estimate; sees Q2 revs of $64-65.5 mln vs. $64.75 mln Capital IQ Consensus Estimate.

7:29 am Euro Slips Ahead of ECB Rate Decision: 10-yr: -02/32..1.640%..USD/JPY: 97.33..EUR/USD: 1.3155 (:SUMRX) : The Dollar Index sports modest gains near 81.70 as traders await this morning's European Central Bank Rate decision. The gains for the greenback come after yesterday's selling dropped it to its worst level in more than two months as the FOMC suggested it could increase or decrease its bond buying as conditions warrant. 

• EURUSD is -20 pips at 1.3165 ahead of the ECB decision where analysts are expecting the central bank to cut its Minimum Bid Rate 25 bps to a record low 0.50%. Italian (45.5 actual v. 44.9 expected) and Spanish (44.7 actual v. 44.6 expected) Manufacturing PMI data were released overnight with both posting better than expected results. Traders will continue to watch the 1.3200 level as a close above there would mark the best in two months.
• GBPUSD is +20 pips at 1.5575 as trade looks for a seventh day of gains after Construction PMI (49.4 actual v. 48.1 expected) was the latest number to top estimates. Action continues to contend with the 100-day moving average while a breakout sets up a potential test of 1.5700.
• USDCHF is +15 pips at .9285 as trade looks to rebound after five days of selling. Today's bid comes even after SVME PMI posted a better than expected 50.2 (49.1 expected). The .9300 area remains key.
• USDJPY is +5 pips at 97.35 amid another quiet day for the pair. Action has been confined to a 30 pip range as traders await the next catalyst. The minutes from the Bank of Japan's latest meeting show some members have expressed concerns over the bold action being taken by the central bank. The 96.00 area remains important in terms of near-term support.
• AUDUSD is -35 pips at 1.0245 following some disappointing data. Building approvals plunged 5.5% MoM (+1.2% MoM expected), and that has trade sliding back down towards the 1.0200 support level. Not helping matters was China's HSBC Final Manufacturing PMI easing to 50.4 (50.6 expected, 50.5 previous). USDCNY fell to a 19-yr low of 6.1555. Click here to see a weekly AUDUSD chart. 
• USDCAD is -10 pips at 1.0070 as action has been confined to a tight 20 pip range. The recent slide has dropped the pair onto support aided by the 100-day moving average. Canada's trade balance is due out this morning.     

7:27 am ANSYS beats by $0.02, misses on revs; guides Q2 EPS below consensus, revs below consensus; guides FY13 EPS below consensus, revs below consensus (ANSS) : Reports Q1 (Mar) earnings of $0.71 per share, excluding amort of intangible assets and stock based comp, $0.02 better than the Capital IQ Consensus Estimate of $0.69; revenues rose 6.4% year/year to $199.5 mln vs the $204.02 mln consensus.

Guidance:
Co issues downside guidance for Q2, sees EPS of $0.69-0.72 vs. $0.74 Capital IQ Consensus Estimate; sees Q2 revs of $204.6-210.6 mln vs. $214.73 mln Capital IQ Consensus Estimate.

Co issues downside guidance for FY13, sees EPS of $2.96-3.04 vs. $3.05 Capital IQ Consensus Estimate; sees FY13 revs of $855.0-875.0 mln, excluding non-recurring items, vs. $890.76 mln Capital IQ Consensus Estimate.

Commentary: "...Our Q1 results reflect a resilient business in a less than robust, and somewhat unpredictable, global economy. Most major metrics of the business performed as anticipated, highlighted by solid margins and earnings, a record deferred revenue and backlog balance of $399 million, and all-time high first quarter cash flows from operations of $95 million..."

7:25 am On The Wires (:WIRES) :

• Accenture (ACN) has signed a seven-year business process outsourcing agreement to provide SSAB with finance & accounting, customer care and procurement services.
• DaVita HealthCare Partners (DVA) has reached two milestones as of the end of the first quarter of 2013 - owning or operating more than 2,000 centers, and employing more than 50,000 teammates.
• Level 3 Communications (LVLT) announced its subsidiary, Level 3 Colombia S.A., has been awarded the international ISO 9001 quality certification for its Network Management and Administration services.
• DG (DGIT) MediaMind and Mi9 announced a strategic partnership that will allow online advertisers to automatically generate and deliver customized ads to hundreds of audience segments based on any combination of geographic, behavioral or demographic data.
• Neonode (NEON) has signed a multi-year license agreement with an undisclosed Tier One in-car--entertainment and electronic equipment manufacturer.

7:23 am Fifth & Pacific reports EPS in-line, beats on revs; reaffirms FY13 adj. EBITDA (FNP) : Reports Q1 (Mar) loss of $0.16 per share, excluding non-recurring items, in-line with the Capital IQ Consensus Estimate consensus of ($0.16); revenues rose 17.3% year/year to $371.8 mln vs the $357.32 mln consensus.

"We were pleased with the performance of kate spade and Lucky Brand during the quarter, where both brands had solid increases in net sales and adjusted EBITDA. kate spade posted a 63% increase in total net sales and a 22% increase in direct-to-consumer comparable sales, driven by strong performance in all channels of its business. Excluding the impact of $25 million in net sales associated with kate spade Japan, net sales for kate spade increased 34%. Adjusted EBITDA for kate spade was ahead of plan in the quarter, despite the planned dilution on adjusted EBITDA margin resulting from the reporting impact of the kate spade Japan acquisition, the launch of Kate Spade Saturday, the expansion of jack spade and the start-up of operations for the brand in Asia... At Lucky Brand, total net sales increased 16% in the first quarter, driven primarily by the timing impact of wholesale shipments, while direct-to-consumer comparable sales increased 2% in the quarter. Lucky continued to generate strong full price selling in the quarter which resulted in direct--to-consumer gross margin improvement of approximately 210 basis points compared to last year. Performance at Juicy Couture in the first quarter was consistent overall with our expectation as gross margins were down significantly compared to 2012. Total net sales for the brand were down (11%) in the quarter and direct-to-consumer comparable sales decreased (2%). We believe that the underlying issues at Juicy are being corrected under the direction of its new CEO, Paul Blum, and his team. For fiscal 2013, we continue to forecast adjusted EBITDA, net of foreign currency transaction adjustments, in the range of $120 to $150 million [consensus $135 mln]."

7:23 am OM Group beats by $0.11, beats on revs (OMG) : Reports Q1 (Mar) earnings of $0.15 per share, $0.11 better than the Capital IQ Consensus Estimate of $0.04; revenues fell 21.9% year/year to $364.3 mln vs the $287.45 mln consensus. Sales were lower YoY, primarily due to lower cobalt prices in the Advanced Materials business and lower rare-earth pricing effects in the Magnetic Technologies business. Excluding the Advanced Materials business and the effects of rare-earth pricing, net sales in the 2013 first quarter were $278 million, 3% lower than the first quarter of 2012 but 8% higher sequentially than the fourth quarter of 2012. Magnetic Technologies volumes improved from last quarter, and Battery Technologies achieved record sales. Specialty Chemicals sales levels were down slightly on lower demand caused by weak macroeconomic conditions in certain key end markets.

7:21 am Ceva misses by $0.02, misses on revs (CEVA) : Reports Q1 (Mar) earnings of $0.13 per share, $0.02 worse than the Capital IQ Consensus Estimate of $0.15; revenues fell 19.9% year/year to $12.1 mln vs the $12.59 mln consensus.

Royalty revenue for the first quarter 2013 was $7.1 mln, a decrease of 22% compared to $9.1 mln reported for the first quarter of 2012.  

"Our licensing and related revenue was slightly below what we forecasted primarily due to recognizing partial revenue in the quarter of an important agreement we signed with a tier-one customer in the mobile infrastructure space. We anticipate recognizing the remaining revenues to be generated from this agreement during future periods. Our royalty revenue was primarily impacted by softness in the consumer electronics space while 3G smartphones powered by our DSPs outpaced the seasonal trend. During the first quarter we repurchased approximately 130,000 shares of our common stock for an aggregate consideration of approximately $2 mln. At the end of the quarter, our cash balance, marketable securities and bank deposits totaled $157 mln."

7:20 am European Markets : FTSE...6411.23...-10.10...-0.20%.  DAX...7933.33...+19.60...+0.30%.

7:20 am Asian Markets : Nikkei...13694.04...-105.30...-0.80%.  Hang Seng...22668.30...-68.70...-0.30%.

7:20 am Actavis beats by $0.11, misses on revs; raises FY13 EPS guidance (ACT) : Reports Q1 (Mar) earnings of $1.99 per share, excluding non-recurring items, $0.11 better than the Capital IQ Consensus Estimate of $1.88; revenues rose 24.4% year/year to $1.90 bln vs the $1.97 bln consensus. Co raises prior guidance for FY13, co now sees EPS of $8.10-8.50, excluding non-recurring items, vs. $8.11 Capital IQ Consensus Estimate.

7:20 am CDI Corp misses by $0.10, reports revs in-line; guides Q2 revs below consensus (CDI) : Reports Q1 (Mar) earnings of $0.13 per share, $0.10 worse than the Capital IQ Consensus Estimate of $0.23; revenues fell 4.0% year/year to $269.46 mln vs the $271.75 mln consensus. Co issues downside guidance for Q2, sees Q2 revs of $260-270 mln vs. $274.88 mln Capital IQ Consensus Estimate.

7:20 am EarthLink reports EPS in-line, revs in-line; guides FY13 revs above consensus (ELNK) : Reports Q1 (Mar) loss of $0.07 per share, excluding non-recurring items, in-line with the Capital IQ Consensus Estimate consensus of ($0.07); revenues fell 7.1% year/year to $320 mln vs the $317.21 mln consensus.

Co issues upside guidance for FY13, sees FY13 revs of $1.26-1.27 bln vs. $1.24 bln Capital IQ Consensus Estimate.

7:19 am Marsh McLennan beats by $0.05, misses on revs (MMC) : Reports Q1 (Mar) earnings of $0.74 per share, $0.05 better than the Capital IQ Consensus Estimate of $0.69; revenues rose 2.5% year/year to $3.13 bln vs the $3.18 bln consensus.

7:17 am H&E Equipment Srvs reports EPS in-line, beats on revs (HEES) : Reports Q1 (Mar) earnings of $0.14 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.14; revenues rose 22.3% year/year to $212.4 mln vs the $196.34 mln consensus.

Additional metrics:

• Rental revenues increased 26.4%, or $15.7 million, to $75.4 million on higher rates and a larger fleet compared to a year ago.
• New equipment sales increased to $53.3 million, reflecting a 30.1% increase from a year ago.
• Gross margins were 30.4% as compared to 30.3% a year ago.
• Rental gross margins increased to 44.6% in the first quarter compared to 42.4% a year ago.
• Average time utilization (based on original equipment cost) was 67.9% compared to 69.5% a year ago. Average time utilization (based on units available for rent) was 63.6%
• compared to 65.8% last year.
• Average rental rates increased 10.2% compared to a year ago and 2.1% compared to the fourth quarter of 2012.
• Dollar utilization was 33.9% in the first quarter compared to 32.3% a year ago.
• Average rental fleet age at March 31, 2013 was 37.6 months compared to an industry average age of 48 months.

7:17 am S&P futures vs fair value: +1582.30. Nasdaq futures vs fair value: +2873.20. :

7:17 am Teva Pharma beats by $0.01, reports revs in-line (TEVA) : Reports Q1 (Mar) earnings of $1.12 per share, excluding non-recurring items, $0.01 better than the Capital IQ Consensus Estimate of $1.11; revenues fell 3.9% year/year to $4.9 bln vs the $4.86 bln consensus.

Net revenues in the United States in the first quarter were $2.4 bln, a decrease of 11% compared to the first quarter of 2012, driven primarily by the decline in Provigil sales due to generic competition that began in the second quarter of 2012.

Non-GAAP gross profit margin was 58.6% in the quarter, compared to 60.9% in the first quarter of 2012. Generic medicines net revenues in the first quarter were $2.3 bln (including API revenues of $186 mln), a decrease of 12% compared to $2.6 bln in the first quarter of 2012. 

Net revenues in Europe in the first quarter were $1.5 bln (30% of total revenues), an increase of 11% compared to the first quarter of 2012, or 10% in local currency terms. Net revenues in the Rest of the World in the first quarter totaled $966 mln, a decrease of 3% compared to the first quarter of 2012.

"During the quarter, we were pleased by the overall performance of our specialty products and results of our OTC joint venture. Our generic operations, which are a core component of our business, performed in line with our expectations and were particularly strong in Western and Eastern Europe."

7:17 am Iridium Communications misses by $0.02, misses on revs (IRDM) : Reports Q1 (Mar) earnings of $0.17 per share, $0.02 worse than the Capital IQ Consensus Estimate of $0.19; revenues fell 4.6% year/year to $89.19 mln vs the $97.3 mln consensus. The Company affirmed its full-year 2013 outlook for total billable subscriber growth, total service revenue growth-OEBITDA. The Company continues to expect: 

• Total billable subscriber growth between 15-20% for the full-year 2013
• Total service revenue growth between 8-10% for the full-year 2013
• Total service revenue growth between 8-10% for the full-year 2013

7:16 am Alliant Tech beats by $0.25, beats on revs; guides FY14 EPS above consensus, revs below consensus (ATK) : Reports Q4 (Mar) earnings of $2.22 per share, excluding non-recurring items, $0.25 better than the Capital IQ Consensus Estimate of $1.97; revenues fell 12.0% year/year to $1.15 bln vs the $1.09 bln consensus. Co issues mixed guidance for FY14, sees EPS of $7.50-7.90 vs. $7.39 Capital IQ Consensus Estimate; sees FY14 revs of $4.05-4.15 bln vs. $4.17 bln Capital IQ Consensus Estimate.

7:16 am Manchester United reports EPS in-line, beats on revs (MANU) : Reports Q3 (Mar) earnings of GBP0.02 per share, in-line with the Capital IQ Consensus Estimate consensus of GBP0.02; revenues rose 29.5% year/year to GBP91.7 mln vs the GBP84.97 mln consensus.

7:16 am FLY Leasing beats by $0.54, beats on revs (FLY) : Reports Q1 (Mar) earnings of $1.37 per share, $0.54 better than the Capital IQ Consensus Estimate of $0.83; revenues rose 9.5% year/year to $114.4 mln vs the $103.62 mln consensus.

7:15 am H&E Equipment Srvs reports EPS in-line, beats on revs (HEES) : Reports Q1 (Mar) earnings of $0.14 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.14; revenues rose 22.3% year/year to $212.4 mln vs the $196.34 mln consensus.

7:14 am Cardinal Health beats by $0.07, reports revs in-line; guides FY13 EPS in-line; raises dividend 10% (CAH) : Reports Q3 (Mar) earnings of $1.02 per share, excluding the evaluation of the deferred tax liability as a result of an agreement with tax authorities of $64 mln, $0.07 better than the Capital IQ Consensus Estimate of $0.95; revenues fell 8.8% year/year to $24.55 bln vs the $24.72 bln consensus.

Co issues in-line guidance for FY13, sees EPS of $3.49-3.53, excluding non-recurring items, vs. $3.50 Capital IQ Consensus Estimate.

Cardinal Health also announced that its board of directors approved a 10 percent increase in the company's quarterly dividend to $0.3025 per share, or $1.21 per share on an annualized basis. The quarterly dividend is payable on July 15, 2013 to shareholders of record at close of business on July 1, 2013.

7:14 am Select Income REIT beats by $0.06, beats on revs (SIR) : Reports Q1 (Mar) funds from operations of $0.76 per share, $0.06 better than the Capital IQ Consensus Estimate of $0.70; revenues rose 59.1% year/year to $43.9 mln vs the $40.6 mln consensus.

7:13 am Elizabeth Arden reports EPS in-line, beats on revs; reaffirms FY13 EPS guidance, revs guidance (RDEN) : Reports Q3 (Mar) earnings of $0.02 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.02; revenues rose 10.5% year/year to $264.48 mln vs the $261.19 mln consensus. Co reaffirms guidance for FY13, sees EPS of $2.30-2.50 vs. $2.41 Capital IQ Consensus Estimate; sees FY13 revs growth of 9-11%, or roughly $1.349-1.374 bln vs. $1.37 bln Capital IQ Consensus Estimate.

7:12 am Group 1 Auto beats by $0.12, beats on revs (GPI) : Reports Q1 (Mar) earnings of $1.16 per share, excluding non-recurring items, $0.12 better than the Capital IQ Consensus Estimate of $1.04; revenues rose 18.0% year/year to $1.96 bln vs the $1.92 bln consensus.

7:11 am ITT Industries beats by $0.04, reports revs in-line; reaffirms FY13 EPS guidance, revs guidance (ITT) : Reports Q1 (Mar) earnings of $0.47 per share, excluding non-recurring items, $0.04 better than the Capital IQ Consensus Estimate of $0.43; revenues rose 7.1% year/year to $608.2 mln vs the $610.23 mln consensus.

Co reaffirms guidance for FY13, sees EPS of $1.80-1.90 vs. $1.88 Capital IQ Consensus Estimate; sees FY13 revs of +9-11% calc to ~$2.427-2.472 bln vs. $2.46 bln Capital IQ Consensus Estimate.

On a GAAP basis, segment operating margins were flat year-over-year. Adjusted segment operating margins, which exclude special items, expanded by 130 basis points, reflecting net operating productivity and expanded sourcing initiatives partially offset by the Bornemann Pumps operations and the funding of strategic investments.

"We also are seeing the results of our effective capital deployment as we drive key customer-focused strategic actions such as expanding our automotive capabilities in China and successfully integrating Bornemann. At the same time, our focus on operational excellence is helping us improve margins, productivity and key customer metrics such as on-time delivery. All of these efforts position us well to continue to deliver results during this period of continuing uncertainty in the global economic environment."

7:10 am Alpha Natural Resources beats by $0.09, reports revs in-line (ANR) : Reports Q1 (Mar) loss of $0.47 per share, excluding non-recurring items, $0.09 better than the Capital IQ Consensus Estimate of ($0.56); revenues fell 31.1% year/year to $1.33 bln vs the $1.33 bln consensus.

On an annualized basis shipment volumes during the quarter were pacing ahead of the midpoint of prior full-year guidance for both Eastern and Western thermal coals. Due primarily to strong shipment volumes and the benefits of our restructuring efforts, Alpha's cost of coal sales per ton were also better than the midpoint of previous guidance. In particular, very strong production at the Pennsylvania longwall mines drove unit costs lower across all Eastern tons. While Eastern unit costs were favorable in Q1, per ton costs are expected to normalize to the $69-73 as longwall production levels vary, and production cutbacks implemented thus far impact shipment volumes and product mix in future quarters. As a result of the strong operational execution, timing of scheduled interest payments on senior notes and a disciplined approach to capital expenditures in Q1, Alpha generated $21 mln of free cash flow (non-GAAP measure defined as cash flow from operations of $65 mln, less capital expenditures of $44 mln). This solid financial performance enabled Alpha to maintain liquidity of ~$2.1 billion as of March 31, 2013, including ~$1 billion in cash, cash equivalents and marketable securities.

2013 Outlook
Alpha now expects to ship between 83-93 mln tons during 2013, including 19-22 mln tons of Eastern metallurgical coal, 27 to 31 mln tons of Eastern steam coal, and 37 to 40 mln tons of Western steam coal out of the PRB. As of April 19, 2013, 73% of the midpoint of anticipated 2013 metallurgical coal shipments were committed and priced at an average per ton realization of $103.93. Based on the midpoint of guidance, 100% of anticipated Eastern steam coal shipments were committed and priced at an average per ton realization of $61.96; and 99% of the midpoint of anticipated PRB shipments were committed and priced at an average per ton realization of $12.74.

7:10 am Xcel Energy beats by $0.03, reports revs in-line; reaffirms FY13 EPS guidance (XEL) : Reports Q1 (Mar) earnings of $0.48 per share, $0.03 better than the Capital IQ Consensus Estimate of $0.45; revenues rose 7.9% year/year to $2.78 bln vs the $2.78 bln consensus.

• Co reaffirms guidance for FY13, sees EPS of $1.85-1.95 vs. $1.90 Capital IQ Consensus Estimate.
• "We recently reached settlements in South Dakota and Texas. However, several parties filed adverse recommendations in our electric rate case in Minnesota and our natural gas rate case in Colorado. We believe our requested rate increases in both states are necessary to continue to provide excellent customer service and reliability, recover our costs of investments in our utility business, maintain strong credit ratings and access the capital markets. We will continue to work with the various parties and commissions to reach constructive outcomes."

7:09 am Elan: Royalty Pharma submits formal cash offer for Elan; offer price reflects $1 bln Dutch AuctionStrikePrice of $11.25 per Elan share (ELN) : Echo Pharma Acquisition issued an offer document dated 2 May 2013. In the Offer Document, Royalty Pharma confirms the Offer Price set forth in its Rule 2.5 Announcement of 15 April. The Offer Price reflects Elan's $1 billion Dutch Auction share repurchase clearing price of $11.25 per Elan Share, the lowest possible price in the range set by the Elan Board. Royalty Pharma believes this clearing price validates Royalty Pharma's earlier statement that the Dutch Auction price range was set artificially high. Of the 22 share repurchases by companies that used a Dutch auction process in the last two years, only Elan's Dutch Auction and one other cleared at the bottom of the range. Eleven of these cleared at the highest price of their respective ranges, eight others cleared at or above the mid-point, and one below the mid-point of their respective ranges.

7:09 am Incyte beats by $0.06, beats on revs (INCY) : Reports Q1 (Mar) loss of $0.12 per share, $0.06 better than the Capital IQ Consensus Estimate of ($0.18); revenues rose 96.4% year/year to $71.1 mln vs the $68.16 mln consensus. The increase in total revenues from the first quarter of 2012 to the first quarter of 2013 was primarily related to increased Jakafi product revenue and $5.9 mln of Jakavi product royalties from Novartis.

Cash Position
As of March 31, 2013, cash, cash equivalents and marketable securities totaled $270.2 mln compared to $228.4 mln as of December 31, 2012.

7:07 am Gartner misses by $0.02, reports revs in-line; reaffirms FY13 EPS, revs guidance (IT) : Reports Q1 (Mar) earnings of $0.39 per share, excluding non-recurring items, $0.02 worse than the Capital IQ Consensus Estimate of $0.41; revenues rose 10.2% year/year to $406.8 mln vs the $409.32 mln consensus.

Co reaffirms guidance for FY13, sees EPS of $1.96-2.10 vs. $2.05 Capital IQ Consensus Estimate; sees FY13 revs of $1.775-1.82 bln vs. $1.8 bln Capital IQ Consensus Estimate.

"We continue to see robust demand for our services across all three segments. Research Contract Value grew 14% on an FX neutral basis with all geographies, industries, and client sizes growing at double digit rates. Our Events business grew 20% with equally strong growth in both attendee and exhibitor revenue in Q1. While Consulting had a slightly slower start than we expected, our backlog and pipeline for Q2 are strong. We remain highly confident we will achieve the guidance we set for the current year."

7:07 am Symmetry Medical misses by $0.09, misses on revs; reaffirms FY13 EPS guidance, revs guidance (SMA) : Reports Q1 (Mar) earnings of $0.06 per share, $0.09 worse than the Capital IQ Consensus Estimate of $0.15; revenues fell 1.8% year/year to $98.9 mln vs the $104.26 mln consensus.

• OEM Solutions revenue of $76.7 million, up 4% year-over-year
• Gross margin of 25.4% compared to 25.0% year ago

Guidance:
Co reaffirms guidance for FY13, sees EPS of $0.64-0.76 vs. $0.71 Capital IQ Consensus Estimate; sees FY13 revs of $420-440 mln vs. $433.60 mln Capital IQ Consensus Estimate.

Commentary: "...While we are disappointed with our Symmetry Surgical sales results, we believe we have identified the issues and are implementing corrective actions that we expect will gradually reinvigorate growth in Symmetry Surgical by year end. Despite these segment specific challenges, we are maintaining our overall 2013 guidance."

7:07 am Myriad Genetics to present new molecular data for patients with prostate cancer at the American Urological Association 2013 Annual Meeting; PROLARIS signature consistently demonstrated additional prognostic utility beyond what is available from standard clinical parameters (MYGN) : Co highlighted new clinical data on the PROLARIS 46-gene cell cycle progression (:CCP) signature in patients with prostate cancer that will be presented at this year's American Urological Association in San Diego. The clinical studies being presented at AUA focus on PROLARIS test results in patients who underwent radical prostatectomy or who were treated with external beam radiation therapy. In both of these prospectively-designed studies, the PROLARIS signature consistently demonstrated additional prognostic utility beyond what is available from standard clinical parameters such as Gleason score, prostate specific antigen (PSA) level and clinical stage. Results from this prospectively-designed clinical study show that in patients who underwent radical prostatectomy, PROLARIS (:CCP) score correlated significantly with organ confined, local invasive and systemic tumor growth, and these correlations remained after adjusting for Gleason score, PSA level and clinical stage. Results from this prospectively-designed clinical study show that in patients who underwent external beam radiation therapy, the PROLARIS (:CCP) score was significantly associated with survival outcome after radiation therapy and provided prognostic information beyond what was available from clinical parameters including Gleason score, PSA level and clinical stage.

7:06 am MWI Veterinary Supply beats by $0.02, misses on revs; raises FY13 EPS in-line, raises bottom end of FY13 revs in-line (MWIV) : Reports Q2 (Mar) earnings of $1.19 per share, $0.02 better than the Capital IQ Consensus Estimate of $1.17; revenues rose 11.0% year/year to $563.1 mln vs the $571.07 mln consensus.

Co issues in-line guidance for FY13, raises EPS to $4.79-4.89 from prior guidance of $4.73-4.87 versus 4.88 Capital IQ Consensus Estimate; raises bottom end of FY13 revs to $2.32-2.36 bln from prior guidance of $2.31-2.36 bln vs. $2.36 bln Capital IQ Consensus Estimate.

"Our revenue growth was strong and our gross profit as a percentage of total revenues exceeded our expectations. We are very pleased with the initial results from the diagnostic lines and are now the only distributor to carry all of these products. The success we had this quarter is due in large part to the tremendous efforts by our team members and the service they provide to our customers."

7:05 am CME Group reports EPS in-line, revs in-line (CME) : Reports Q1 (Mar) earnings of $0.73 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.73; revenues fell 7.2% year/year to $719 mln vs the $712.29 mln consensus. First-quarter 2013 average daily volume was 12.5 million contracts, up 1 percent from first-quarter 2012, and was the highest quarterly average daily volume since third-quarter 2011.  Clearing and transaction fee revenues were $593 million, down 4 percent compared with the same period last year.  First-quarter total average rate per contract was $0.785 cents, down 3 percent compared with first-quarter 2012. 

7:05 am NJ Resources beats by $0.01, beats on revs; reaffirms FY13 EPS above consensus (NJR) : Reports Q2 (Mar) earnings of $1.64 per share, excluding non-recurring items, $0.01 better than the Capital IQ Consensus Estimate of $1.63; revenues rose 56.8% year/year to $960.9 mln vs the $559.93 mln consensus.

Co reaffirms guidance for FY13, sees EPS of $2.60-2.75 vs. $2.58 Capital IQ Consensus Estimate.

7:04 am PPL Corp beats by $0.01, misses on revs; lowers FY13 EPS below consensus (PPL) : 26Reports Q1 (Mar) earnings of $0.71 per share, excluding non-recurring items, $0.01 better than the Capital IQ Consensus Estimate of $0.70; revenues fell 40.2% year/year to $2.46 bln vs the $3.46 bln consensus.

Co issues downside guidance for FY13, lowers EPS to $2.15-2.40 from $2.25-2.50 vs. $2.41 Capital IQ Consensus Estimate.

"Additionally, we are announcing today a reduction in future equity needs," Spence said. PPL has removed approximately $100 million per year in previously planned equity offerings from its financing plans for 2013 and beyond.

7:04 am AVEO Pharma is halted; FDA Advisory Committee to review Tivozanib for the treatment of advanced renal cell carcinoma (AVEO) : Co conference call will be held today at 4:30pm ET.

7:03 am Conns opens two new Homeplus stores in Las Cruces, New Mexico and Tulsa, Oklahoma (CONN) :  

7:03 am CB&I announces award of execution phase of air quality control program; award valued at ~ $300 mln (CBI) : Co announced it has been awarded a contract for the execution phase of an air quality control program for 13 existing coal-fired units at five sites. The units represent more than 9,000 megawatts (MW) of electric generating capacity. This award is valued at approximately $300 million.

7:03 am Santarus: CYCLOSET (bromocriptine mesylate) included in American Association of Clinical Endocrinologists comprehensive diabetes management algorithm (SNTS) : Co announced the inclusion of CYCLOSET (bromocriptine mesylate) as a therapy for patients with type 2 diabetes in a new comprehensive diabetes management algorithm published by the American Association of Clinical Endocrinologists (:AACE). The AACE created the algorithm to guide primary care physicians, endocrinologists and other health care professionals in the treatment of prediabetes and type 2 diabetes patients. For patients with entry hemoglobin A1c (HbA1c) = 7.5%, the AACE algorithm recommends dual therapy to include CYCLOSET as one option in combination with metformin or another first-line agent. CYCLOSET is also listed as a treatment option for patients that need triple therapy and for those patients without symptoms that present with an HbA1c > 9.0%.

7:02 am West Pharm beats by $0.01, misses on revs; guides FY13 EPS above consensus, reaffirms FY13 revs guidance (WST) : Reports Q1 (Mar) earnings of $0.87 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.86; revenues rose 7.3% year/year to $339.4 mln vs the $344.2 mln consensus. Co issues guidance for FY13, raises EPS guidance to $3.05-3.20 vs. $3.13 Capital IQ Consensus Estimate; reaffirms FY13 revs of $1.36-1.40 bln vs. $1.38 bln Capital IQ Consensus Estimate.

7:02 am Rentech acquires Wood Chip Processor Fulghum Fibres for $112 mln, including assumed debt; also enters growing wood pellet industry with contracts to supply over four mln metric tons to utilities from two plants (RTK) : Take-or-pay contracts are in place with two utilities to supply a combined total of 445,000 metric tons of wood pellets annually over ten years. To supply the pellets, co plans to convert two decommissioned wood fibre mills in Eastern Canada into pellet mills that will employ a total of approximately 65 full-time employees and help to create jobs for construction and wood supply from sustainable Crown forests in Ontario. These two facilities are expected to generate $3 mln of operating income and "5 mln of EBITDA when fully operational, with combined total project cost estimated at $70 mln. Rentech has contracted for the handling and transport of the pellets. The two plants would make Rentech the largest producer of industrial wood pellets utilizing fibre from Eastern Canada, a source of supply that is highly desired due to its location and wood quality.

7:01 am Star Bulk Carriers announces proposed $75 mln backstopped equity rights offering of ~14 mln shares (SBLK) : For each subscription right, a Record Date Holder will be entitled to purchase 2.5957 common shares at a subscription price of $5.35 per share, which we refer to as the subscription privilege. The per share subscription price was determined by our Board.

7:00 am Canadian Solar expects solar module shipments for Q1 to be in the range of ~ 335 MW to 345 MW, which exceeds the previous guidance of 290-310 MW (CSIQ) : The shipment guidance compares to shipments of 404 MW in the fourth quarter of 2012 and 343 MW in the first quarter of 2012. The co now expects its gross margin for the first quarter of 2013 to range from 9% to10% compared to the previous guidance of 8-10%, and compared to 5% in the fourth quarter of 2012 and 7.7% in the first quarter of 2012.

6:59 am Plains Exploration beats by $0.23, beats on revs (PXP) : Reports Q1 (Mar) earnings of $1.05 per share, excluding non-recurring items, $0.23 better than the Capital IQ Consensus Estimate of $0.82; revenues rose 135.0% year/year to $1.23 bln vs the $1.2 bln consensus.

• Total daily sales volumes averaged 170.4 thousand barrels of oil equivalent, a 92% increase per diluted share compared to first-quarter 2012
• Oil daily sales volumes averaged 129.2 thousand barrels, a 158% increase per diluted share compared to first-quarter 2012
• Phobos discovery well announced, encountering ~250 net feet of high-quality lower Tertiary oil pay in the Gulf of Mexico

6:58 am Liquidity Services reports EPS in-line, misses on revs; guides Q3 EPS below consensus; reaffirms FY13 EPS guidance (LQDT) : Reports Q2 (Mar) earnings of $0.48 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.48; revenues rose 3.7% year/year to $130.32 mln vs the $140.14 mln consensus. Co issues downside guidance for Q3, sees EPS of $0.49-0.54 vs. $0.55 Capital IQ Consensus Estimate. Co reaffirms guidance for FY13, sees EPS of $1.90-2.02 vs. $1.96 Capital IQ Consensus Estimate.

6:45 am On The Wires (:WIRES) :

• JAKKS Pacific (JAKK) has expanded its worldwide agreement with Lucasfilm to include the Revenge of the Sith 501st Legion Clone Trooper and Shock Trooper to its 31" Giant Figure lineup.
• R. R. Donnelley & Sons (RRD) has been awarded a multi-year multi-million dollar agreement to provide catalog services to AmeriMark Direct and its Dr Leonard's Healthcare business. The agreement extends and significantly expands the cos' relationship.

6:42 am Applied Industrial beats by $0.02, reports revs in-line; reaffirms FY13 EPS guidance (AIT) : Reports Q3 (Mar) earnings of $0.69 per share, $0.02 better than the Capital IQ Consensus Estimate of $0.67; revenues rose 2.7% year/year to $621.7 mln vs the $623.5 mln consensus.

• Co reaffirms guidance for FY13, sees EPS of $2.70-2.90 vs. $2.77 Capital IQ Consensus Estimate.
• "While some economic uncertainty persisted in our third quarter, we translated modest sales growth into solid earnings -- benefiting from our business investments, efficiency gains and disciplined cost controls. While overall our third quarter sales trend remained similar to the prior quarter, we did see month-over-month increases in sales per day in our U.S. service center and fluid power businesses. Consistent with the current levels of various economic production and capacity utilization indices, we remain optimistic about the industrial economy for the 2013 calendar year."

6:42 am CBIZ misses by $0.02, misses on revs; reaffirms FY13 EPS guidance, revs guidance (CBZ) : Reports Q1 (Mar) earnings of $0.37 per share, $0.02 worse than the Capital IQ Consensus Estimate of $0.39; revenues rose 6.3% year/year to $234.8 mln vs the $239.25 mln consensus. Co reaffirms guidance for FY13, sees EPS of +12-15% YoY to ~0.65-0.67 vs. $0.65 Capital IQ Consensus Estimate; sees FY13 revs of +7-9% YoY to ~$829.7-835.1 mln vs. $824.76 mln Capital IQ Consensus Estimate.

Commentary: "...Organic revenue growth was slower than expected in the first quarter primarily due to weather-related closures we experienced in several major offices in the Midwest and Northeast regions combined with a late start to tax-related work within our Financial Services group. Some of this work was deferred until April and we expect to recover the balance of this revenue throughout the remainder of the year. We continue to expect improving trends in organic revenue growth this year with total revenue growth in a range of 7% to 9% compared with 2012..."

6:39 am Catamaran beats by $0.01, misses on revs; reaffirms FY13 EPS, revs guidance (CTRX) : Reports Q1 (Mar) earnings of $0.42 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.41; revenues rose 87.5% year/year to $3.22 bln vs the $3.52 bln consensus.

Co reaffirms guidance for FY13, sees EPS of $1.81-1.88, excluding non-recurring items, vs. $1.87 Capital IQ Consensus Estimate; sees FY13 revs of $14.2-14.6 bln vs. $14.51 bln Capital IQ Consensus Estimate.

PBM Revenue Q1 2013 PBM revenue increased $1.5 billion, or 89%, to $3.2 billion, compared to $1.7 billion in Q1 2012. The increase in revenue is primarily due to the recent merger with Catalyst, which was completed on July 2, 2012, as well as increased prescription claim volume as a result of implementation of new customer contracts in 2013. HCIT Revenue HCIT revenue increased $2.2 million, or 6%, to $38.2 million in Q1 2013 compared to $36.0 million in Q1 2012. The increase was primarily due to an increase in revenues earned from transaction processing and revenues generated from the HCIT customer base acquired from Catalyst.

6:37 am Becton Dickinson beats by $0.04, reports revs in-line; guides FY13 EPS above consensus (BDX) : Reports Q2 (Mar) earnings of $1.39 per share, $0.04 better than the Capital IQ Consensus Estimate of $1.35; revenues rose 3.7% year/year to $2 bln vs the $1.99 bln consensus. Excluding the medical device tax that went into effect in January 2013 under the U.S. healthcare reform law, adjusted diluted earnings per share from continuing operations were $1.44, which represents growth of 9.9 percent.

• The Company is raising its previously communicated guidance for the full fiscal year 2013 on revenues and earnings per share growth. On a currency-neutral basis, revenue growth is expected to be between 4.5 and 5.0 percent, or an increase of 50 basis points. Reported revenue growth guidance remains consistent with the Company's previously guided range of 3.5 to 4.0 percent. Sees EPS of $5.72-5.75 vs. $5.71 Capital IQ Consensus Estimate.

6:37 am Manulife Financial reports EPS in-line (MFC) : Reports Q1 (Mar) earnings of CAD$0.32 per share, excluding non-recurring items, in-line with the Capital IQ Consensus Estimate consensus of CAD$0.32.

6:36 am Valeant Pharma beats by $0.05, misses on revs; raises FY13 EPS guidance, reaffirms revs (VRX) : Reports Q1 (Mar) earnings of $1.30 per share, $0.05 better than the Capital IQ Consensus Estimate of $1.25; revenues rose 24.8% year/year to $1.07 bln vs the $1.09 bln consensus.

2013 First Quarter

• Product Sales $1.039 bln, an increase of 38% over the prior year
• Organic growth (same store sales) was 6%, excluding the impact from generics, primarily BenzaClin and Cesamet
• Pro forma organic growth was 4%, excluding the impact from generics, primarily BenzaClin and Cesamet

Commentary: "Despite a slow January due to the integration of the Valeant and Medicis sales organizations, we delivered another solid quarter of strong growth in Cash EPS and adjusted cash flow to our shareholders...We were particularly pleased with the strong organic growth of our emerging market segment, which was primarily driven by Poland, Russia, Brazil, South East Asia, and South Africa, as well as the continued growth in many of our promoted brands."

Guidance:

• Co raises guidance for FY13, sees EPS of $5.55-5.85 vs. $5.59 Capital IQ Consensus Estimate which is above its prior guidance of $5.45-5.75
• Co reaffirms FY13 revs of $4.4-4.8 bln vs. $4.61 bln Capital IQ Consensus Estimate.

6:34 am Beazer Homes misses by $0.08, beats on revs (BZH) : Reports Q2 (Mar) loss of $0.78 per share, excluding non-recurring items, $0.08 worse than the Capital IQ Consensus Estimate of ($0.70); revenues rose 50.3% year/year to $287.9 mln vs the $254.34 mln consensus. ASP +12.7% to $285K; LTM orders/month/community 2.7 vs. 2.0 last year; adj. gross margin +160 bps to 19.1%.

6:34 am Strayer Education beats by $0.13, misses on revs; guides Q2 EPS above consensus (STRA) : Reports Q1 (Mar) earnings of $1.59 per share, $0.13 better than the Capital IQ Consensus Estimate of $1.46; revenues fell 8.0% year/year to $137.5 mln vs the $139.56 mln consensus.  

• Total enrollments at Strayer University for the 2013 spring term decreased 9% to 46,130 students compared to 50,896 students for the same term in 2012. Across the Strayer University campus and online system, continuing student enrollments decreased 8%, while new student enrollments decreased 14%.
• Co issues upside guidance for Q2, sees EPS of $1.37-1.39 vs. $1.35 Capital IQ Consensus Estimate.

6:32 am Quanta Services beats by $0.09, beats on revs; guides Q2 EPS in-line, revs in-line; guides FY13 EPS in-line, revs in-line (PWR) : Reports Q1 (Mar) earnings of $0.38 per share, excluding non-recurring items, $0.09 better than the Capital IQ Consensus Estimate of $0.29; revenues rose 19.4% year/year to $1.59 bln vs the $1.4 bln consensus.

Co issues in-line guidance for Q2, sees EPS ex items of $0.35-0.37 vs. $0.35 Capital IQ Consensus Estimate; sees Q2 revs of $1.45-1.55 bln vs. $1.5 bln Capital IQ Consensus Estimate.

Co raised guidance for FY13, raises EPS ex items to $1.37-1.57 from prior guidance of $1.23-1.53 vs. $1.43 Capital IQ Consensus Estimate; raises FY13 revs to $5.9-6.3 bln from prior guidance of $5.7-6.2 bln vs. $6.16 bln Capital IQ Consensus Estimate.

"We are off to a great start this year with record revenues, record profits and record backlog for the first quarter of 2013. Equally important, our employees continue to operate at high levels of safety and efficiency in a tight labor market...We expect the performance of our electric power segment to remain strong this year while our natural gas and pipeline segment builds momentum throughout the remainder of 2013, which bodes well for our overall business outlook for 2014 and beyond."

Outlook: The overall outlook for Quanta's business is positive. However, regulatory and permitting challenges may impact project timing. Therefore, Quanta's financial outlook for revenues and margins reflects management's efforts to properly align these uncertainties with the backlog the company is executing on and the opportunities expected to materialize in 2013. In addition, the company's outlook for 2013 reflects a reduction in emergency restoration revenues to more normalized levels, as 2012 results included record emergency restoration service revenues of over $250 million. Lastly, the company has not assumed any uncommitted mainline pipe construction work in its 2013 financial outlook. The following forward-looking statements are based on current expectations, and actual results may differ materially.

6:32 am Yahoo! acquires mobile app Astrid; financial terms not disclosed (YHOO) :  

6:30 am MDC Holdings beats by $0.16, beats on revs (MDC) : Reports Q1 (Mar) earnings of $0.45 per share, $0.16 better than the Capital IQ Consensus Estimate of $0.29; revenues rose 78.1% year/year to $331.75 mln vs the $316.45 mln consensus.  Gross margin from home sales for the 2013 first quarter increased to 17.4% from 14.1% for the year-earlier period. On a sequential basis, our 2013 first quarter gross margin from home sales was up 70 basis points as compared to 16.7% for the 2012 fourth quarter. The increase was attributable to the Company's continued increases in pricing and decreased incentives in most of its markets over the prior 12 months.

6:29 am Western Refining misses by $0.02, beats on revs (WNR) : Reports Q1 (Mar) earnings of $0.94 per share, excluding non-recurring items, $0.02 worse than the Capital IQ Consensus Estimate of $0.96; revenues fell 6.5% year/year to $2.19 bln vs the $2.15 bln consensus. Special items excluded in the first quarter of 2013 were $23.8 mln which primarily consisted of $22.0 mln in charges associated with the extinguishment of debt.

6:29 am Integra reports Q1 in-line wih April 10 warning; lowers FY13 guidance, in-line (IART) : Reports Q1 (Mar) earnings of $0.39 per share, excluding non-recurring items, vs. co's $0.30-0.40 April 10 warning and $0.02 better than the Capital IQ Consensus Estimate of $0.37; revenues rose 0.3% year/year to $196.7 mln vs $194-197 mln April 10 warning and the $195.2 mln consensus.

Co issues in-line guidance for FY13, lowers EPS to $2.40-2.70, excluding non-recurring items, from $3.08-3.27 vs. $2.56 Capital IQ Consensus Estimate; lowers FY13 rev to $840-852 mln from $865-880 mln vs. $847.08 mln Capital IQ Consensus Estimate.

The co reduced its revenue in the quarter by $2.9 million because of product returned in the voluntary recall announced on April 10, 2013, and estimates that it was unable to satisfy customer demand for an additional $6 million to $7 million.

"The recent voluntary product recall and related product shortages created a near-term challenge, driving our outlook for 2013 lower. However, we remain committed to delivering on our long-term strategy, including sustainable margin improvement and accelerating top line growth, and look forward to realizing our growth and margin objectives in the years to come."

6:26 am EPL Oil & Gas beats by $0.07, beats on revs (EPL) : Reports Q1 (Mar) earnings of $0.91 per share, excluding non-cash costs, primarily attributable to unrealized losses on derivative instruments, $0.07 better than the Capital IQ Consensus Estimate of $0.84; revenues rose 84.5% year/year to $182.3 mln vs the $165.61 mln consensus.

Production
Oil production for the first quarter of 2013 averaged 17,327 Barrels per day, which was above the co's guidance range and a new record high for the Company. Oil production volumes were 85% higher than in the comparable quarter last year, primarily as a result of the recent Hilcorp acquisition of oil-weighted properties that closed late last year and the continued focus on oil-weighted projects.

Natural gas production averaged 32.1 mln cubic feet per day in the first quarter of 2013, which was on the high end of the co's guidance range. EPL has continued its focus on oil development opportunities which have higher revenue generation capability than natural gas.

6:24 am NW Natural Gas misses by $0.09; reaffirms FY13 EPS guidance (NWN) : Reports Q1 (Mar) earnings of $1.40 per share, $0.09 worse than the Capital IQ Consensus Estimate of $1.49. Co reaffirms guidance for FY13, sees EPS of $2.15-2.35 vs. $2.27 Capital IQ Consensus Estimate.

The decrease in net income was primarily due to impacts from the 2012 Oregon rate case, including a decrease in utility margin related to the revenue timing impact of changes in fixed monthly charges and the decoupling baseline in rates, neither of which is expected to impact annual revenues or net income. In addition, the overall revenue reduction was also tied partly to the lower authorized return on equity from the rate case. Partly offsetting these decreases were utility margin gains from customer growth and gas reserve investments, as well as higher net income from gas storage operations.

6:19 am On The Wires (:WIRES) :

• Northern Trust (NTRS) has established an office in Frankfurt, Germany.
• Salesforce.com (CRM) has signed an agreement with NTT Europe to establish a European data centre in the U.K.
• Acacia Research (ACTG) announced that its Criminal Activity Surveillance subsidiary has entered into a license and settlement agreement with Pelco, resolving patent litigation that was pending in the U.S. District Court for the Eastern District of California. Also, co's subsidiary has acquired the rights to an automotive illumination patent portfolio from Rambus (RMBS). Rambus received an initial upfront payment and is expected to receive subsequent payments.
• China Automotive Systems (CAAS) announced that its subsidiary, Jingzhou Henglong Automotive Parts, has entered into a multi-year agreement to supply the SAIC-GM-Wuling JV with its rack and pinion power steering systems.
• TomTom (TMOAY) has made its traffic information, TomTom Traffic, available in Russia.
• Fiserv (FISV) announced the extension of its strategic partnership with Investance, a global management consulting firm, into the European, Middle Eastern and African regions to help financial institutions transform their control and reconciliations technology and processes.

6:16 am Swift Energy beats by $0.03, beats on revs (SFY) : Reports Q1 (Mar) earnings of $0.16 per share, $0.03 better than the Capital IQ Consensus Estimate of $0.13; revenues rose 7.6% year/year to $146.2 mln vs the $136.49 mln consensus. Adjusted cash flow for the first quarter of 2013 increased 5% to $72.6 million, or $1.67 per diluted share, compared to $69.1 million, or $1.61 per diluted share, for the first quarter of 2012, and decreased 21% when compared to adjusted cash flow of $91.4 million, or $2.13 per diluted share, for the fourth quarter of 2012.

Swift Energy produced 2.82 million barrels of oil equivalent during the first quarter of 2013, a 1% increase over first quarter 2012 production of 2.80 MMBoe, and down 9% compared to fourth quarter 2012 production of 3.11 MMBoe.

"Swift Energy delivered strong operational results during the first quarter. Our refined drilling and completion techniques in the Eagle Ford shale and the strong performance of our base production in Lake Washington resulted in higher than forecast production volumes. We're encouraged by our progress so far this year. "Near term, our focus remains on improving performance, cost efficiencies and results throughout our active operational areas. We are also taking steps to introduce new, high value opportunities to our operations through horizontal drilling in the Louisiana Wilcox, horizontal drilling in the Southwestern Colorado Niobrara and Subsalt exploration in South Louisiana. Finally, as demonstrated by the sale of our Brookeland field, we will be looking at monetizing assets we control that are not a focus of our operations to bring forward unrecognized value in our portfolio."

6:16 am NII Holdings names Steve Shindler CEO (NIHD) : Co announced that its Board of Directors has appointed Steven M. Shindler to the permanent position of chief executive officer, effective immediately. Mr. Shindler had been holding the dual role of chairman of the Board and interim chief executive officer while the Board conducted an extensive search for a chief executive. In connection with Mr. Shindler's appointment on a permanent basis, the Board of Directors is considering whether to separate the positions of chairman of the Board and chief executive officer. Although the Board believes many factors are relevant to this decision and continues to consider these factors, the Board currently expects to separate the positions of chairman and chief executive officer and to appoint a non-executive chairman in the near future.

6:14 am Acorda Therapeutics misses by $0.11, misses on revs; reaffirms FY13 AMPYRA sales guidance (ACOR) : Reports Q1 (Mar) adj. earnings of $0.09 per share, $0.11 worse than the Capital IQ Consensus Estimate of $0.20; revenues rose 1.0% year/year to $71.9 mln vs the $80.77 mln consensus.

For the quarter ended March 31, 2013, the co reported AMPYRA net revenue of $62.3 million, compared to $57.4 million in net revenue for the same quarter in 2012. AMPYRA revenue is recognized following shipment of the product from the Company's distribution facility to its network of specialty pharmacies. AMPYRA net sales were lower in the first quarter compared to the fourth quarter of 2012, affected by several recurring first quarter factors. These included patients switching healthcare plans resulting in a delay in refilling prescriptions, inventory stocking in the fourth quarter and increased discounts and allowances resulting from Medicare patients entering the "donut hole" at the start of the new year. Sales rebounded strongly in March, and the Company is reiterating 2013 AMPYRA net sales guidance of $285-$315 million.

6:11 am MEDNAX beats by $0.01, reports revs in-line; guides Q2 EPS below (MD) : Reports Q1 (Mar) earnings of $1.10 per share, $0.01 better than the Capital IQ Consensus Estimate of $1.09; revenues rose 19.0% year/year to $502.7 mln vs the $503.3 mln consensus. MEDNAX's revenue growth attributable to contributions from recently acquired practices was 16.8%, while overall same-unit revenue grew by 2.2% when compared to the prior year period, or 3.2% when adjusted to exclude the leap-year impact of an extra day in the 2012 first quarter results. Same-unit growth from net reimbursement-related factors was 2.0%. This was principally due to continued modest improvements in reimbursements received from third-party commercial payors as a result of the Company's ongoing contract renewal processes, partially offset by a shift in payor mix to government payors, from commercial payors, year-over-year. The%age of services reimbursed under government programs shifted by 140 basis points toward a higher%age of services reimbursed under government programs for the 2013 first quarter, when compared with the prior-year period. On a sequential basis, same-unit payor mix remained unchanged. Same-unit growth attributable to patient volume grew by 0.2% for the 2013 first quarter when compared to the prior-year period, driven by growth in our other pediatric physician services, primarily newborn nursery and pediatric intensive care services, as well as anesthesia services, partially offset by a decline in our office-based pediatric cardiology services. Volume in our neonatal and maternal-fetal medicine services was essentially flat. For the 2013 first quarter, compared to the 2012 period, same-unit neonatal intensive care unit (:NICU) patient days were essentially flat, or up 1.1%, when adjusted to exclude the leap-year impact of an extra day in the 2012 first quarter results.

Co issues downside guidance for Q2, sees EPS of $1.32-1.37 vs. $1.39 Capital IQ Consensus Estimate. "This outlook assumes that total same-unit revenue growth for the three months ended June 30, 2013 will grow by 1.5% to 3.5% from the prior-year period. This same-unit growth forecast is expected to be divided evenly between patient volume, assuming growth across all MEDNAX physician specialties and net reimbursement growth, including improvements from commercial payor contracts, offset by variability in the mix of our services reimbursed under government payor programs. As a reminder, we have experienced increases in the%age of patient services being reimbursed under government payor programs in recent periods. Regarding the Medicaid parity rule, we do expect this rule to have a positive impact on our practices. However, our 2013 second quarter forecast does not include the benefit of Medicaid parity, given the uncertainty surrounding the timing and frequency of any payments."

6:05 am CIGNA beats by $0.29, beats on revs; raises FY13 EPS in-line with consnsus (CI) : Reports Q1 (Mar) earnings of $1.72 per share, excluding non-recurring items, $0.29 better than the Capital IQ Consensus Estimate of $1.43; revenues rose 20.6% year/year to $8.18 bln vs the $7.86 bln consensus. Co issues in-line guidance for FY13, raises EPS ex items to $6.00-6.45 from prior guidance of $5.85-6.30 vs. $6.36 Capital IQ Consensus Estimate.

First quarter premiums and fees increased approximately 20% relative to first quarter 2012, due to an additional month of HealthSpring premium reflecting the timing of the acquisition on January 31, 2012.

"Cigna's strong first quarter results reflect continued execution of our strategy to deliver value to our customers and clients around the world...Our diversified portfolio of individual and employer-based solutions that focus on quality and affordability, positions us well for continued growth through 2013 and beyond."

5:53 am Ford Motor adding 2,000-plus jobs at Kansas City assembly to support F-150 demand, Ford Transit launch (F) : Ford is adding 900 jobs and a third crew in the third quarter to build F-150. U.S. sales of Ford's F-Series trucks increased 24 percent in April and 19 percent year to date. Ford also is adding another 1,100 jobs starting in the fourth quarter to prepare for the introduction of the all-new Ford Transit full-size van in 2014.

5:28 am Orion Marine beats by $0.03, beats on revs (ORN) : Reports Q1 (Mar) loss of $0.04 per share, $0.03 better than the Capital IQ Consensus Estimate of ($0.07); revenues rose 47.5% year/year to $75.1 mln vs the $73.26 mln consensus.

Backlog:
Backlog of work under contract as of March 31, 2013 was $150.4 mln, which compares with backlog under contract at March 31, 2012 of $215.4 mln. Additionally, the Company is currently the apparent low bidder on ~$117 mln of work.

Commentary on oder activity: ""During the first quarter we bid on approximately $340 mln worth of opportunities and were successful on approximately $41 mln...This represents an approximate 12% win rate or a book-to-bill ratio of 0.55 times for the quarter. We strategically pushed up bid margins on certain projects during the quarter, which was met with limited success. This contributed to a win rate that was below that of recent quarters; however, we are comfortable with our current backlog level, low bids outstanding, and bid market outlook. Currently, we have over $280 mln worth of bids outstanding, including approximately $117 mln on which we are apparent low bidder. We are confident in the way 2013 is shaping up across all our operating regions as we continue to see a healthy amount of bid opportunities..."

5:23 am Dolan beats by $0.05, reports revs in-line (DM) : Reports Q1 (Mar) earnings of $0.01 per share, $0.05 better than the Capital IQ Consensus Estimate of ($0.04); revenues fell 18.0% year/year to $54.7 mln vs the $54.36 mln consensus.

2013 Guidance
Due to the lack of near-term visibility into its NDeX default processing operation and the overall foreclosure-related environment, the company has provided only partial 2013 guidance. The company has provided revenue and adjusted EBITDA guidance only for its Business Information Division and litigation support segment, including corporate costs. The company's 2013 financial guidance for these segments is:

• Total revenues (excluding NDeX operations) $160-$170 million
• Adjusted EBITDA (excluding NDeX operations) $30-$35 million

4:34 am Royal Dutch Shell beats by $0.06; CEO to retire in 2014 (RDS.A) : Reports Q1 EPS of $1.19 vs $1.13 CIQ est. Cash flow from operating activities for the first quarter 2013 was $11.6 bln. Excluding working capital movements, cash flow from operating activities for the first quarter 2013 was $11.5 bln.

Key metrics:

• Capital investment for the first quarter 2013 was $8.8 bln. Net capital investment for the quarter was $8.2 bln.
• Gearing was 9.1% at the end of the first quarter 2013 versus 10.5% at the end of the first quarter 2012 (see Note 2).
• Oil and gas production for the first quarter 2013 was 3,559 thousand boe/d.
• Excluding the impact of divestments, PSC price effects and security impacts onshore Nigeria, first quarter 2013 production was 2% higher than in the same period last year.
• Equity LNG sales volumes of 5.15 million tonnes for the first quarter 2013 were broadly similar to the same quarter a year ago.
• Oil products sales volumes were 1% higher than for the first quarter 2012.
• Chemicals sales volumes for the first quarter 2013 decreased by 11% compared with the same quarter a year ago.

CEO update:
Additionally, co announces that Peter Voser, as Chief Executive Officer, has elected to retire from the Company in the first half of 2014. "The Nomination and Succession Committee of the Board will now lead a structured and comprehensive review of internal and external candidates to enable an orderly transition to a new CEO." 

4:25 am Zebra Tech misses by $0.13, misses on revs; guides Q2 EPS below consensus, revs in-line (ZBRA) : Reports Q1 (Mar) earnings of $0.50 per share, excluding non-recurring items, $0.13 worse than the Capital IQ Consensus Estimate of $0.63; revenues fell 2.9% year/year to $236.9 mln vs the $248.26 mln consensus.

• Net sales for the first quarter were affected by the ongoing challenged conditions in Europe and Asia, along with a slowdown in business during the first few weeks of the quarter in North America.
• Sales increases of 3.8% in Latin America and 0.9% in North America were offset by sales declines of 0.7% in Asia Pacific and 9.8% in the Europe, Middle East and Africa  region.
• On a constant-currency basis, sales in EMEA declined 2.8%.
• Sales of supplies -- thermal ribbons, labels, wristbands and receipts -- increased by 14.3%.
• Gross profit margin of 47.7%, versus 49.2% in 2012
• reflects lower sales across Europe, Middle East and Africa, and Asia Pacific regions in addition to unfavorable movements in product mix.

Stock Purchase Update
During the first quarter of 2013, Zebra returned $3.9 mln to shareholders through the repurchase of 87,254 shares of Zebra Technologies Corporation Class A Common Stock at an average price of $44.56 per share. At March 30, 2013, the company had 1,935,082 shares remaining in its stock buyback authorization, and 51,017,867 shares of common stock were outstanding.

Guidance
Co issues mixed guidance for Q2, sees EPS of $0.58-0.67 vs. $0.69 Capital IQ Consensus Estimate; sees Q2 revs of 246.0-258.0 mln vs. $254.31 mln Capital IQ Consensus Estimate.

3:59 am General Comm beats on top and bottom lines (GNCMA) : Reports Q1 EPS of $0.08 vs $0.06 CIQ est; revs increased YoY to 186.2 vs 180.43 CIQ est.

Wireless

• Wireless revenues of $33.8 mln, for the first quarter of 2013, increased $4.4 mln or 14.9% when compared to the prior year quarter and $1.2 mln or 3.5% on a --sequential basis.
• The increase is primarily due to increases in roaming revenue and retail non-Lifeline wireless subscribers. GCI served 141,600 wireless subscribers at the end of the first quarter 2013.
• GCI served 32,700 Lifeline customers at the end of the first quarter of 2013, a decrease of 8,700 when compared to the prior year quarter and an increase of 300 on a sequential basis.

3:45 am Aqua America beats by $0.02, reports revs in-line (WTR) : Reports Q1 (Mar) earnings of $0.29 per share, $0.02 better than the Capital IQ Consensus Estimate of $0.27; revenues rose 5.8% year/year to $180 mln vs the $179.35 mln consensus.

3:41 am Freightcar America misses by $0.24, misses on revs (RAIL) : Reports Q1 (Mar) loss of $0.18 per share, $0.24 worse than the Capital IQ Consensus Estimate of $0.06; revenues fell 60.0% year/year to $87.6 mln vs the $112.34 mln consensus.

• The Company delivered 1,073 railcars in the first quarter of 2013, which included 448 new railcars and 625 rebuilt railcars.
• This compares to 2,613 railcars delivered in the first quarter of 2012 and 1,308 railcars delivered in the fourth quarter of 2012.
• There were 274 units ordered in the first quarter of 2013. This compares to 1,244 units ordered in the first quarter of 2012 and 473 units ordered in the fourth quarter of 2012.
• Total manufacturing backlog was 2,082 units at March 31, 2013, compared to 6,934 units at March 31, 2012 and 2,881 units at December 31, 2012.
  

3:38 am Dynamics Research misses by $0.02, reports revs in-line; guides Q2 EPS below consensus, revs in-line (DRCO) : Reports Q1 (Mar) earnings of $0.12 per share, $0.02 worse than the Capital IQ Consensus Estimate of $0.14; revenues fell 14.3% year/year to $73.6 mln vs the $73.49 mln consensus.

Co issues mixed guidance for Q2, sees EPS of $0.10-0.12 vs. $0.14 Capital IQ Consensus Estimate; sees Q2 revs of $71-74 mln vs. $73.15 mln Capital IQ Consensus Estimate.

3:35 am BioMed Realty beats by $0.05, beats on revs; guides FY13 FFO above consensus (BMR) : Reports Q1 (Mar) funds from operations of $0.41 per share, $0.05 better than the Capital IQ Consensus Estimate of $0.36; revenues rose 33.7% year/year to $160.5 mln vs the $144.82 mln consensus. Co issues upside guidance for FY13, sees FFO of $1.44-1.52 vs. $1.42 Capital IQ Consensus Estimate.

3:32 am Triumph Group beats by $0.09, beats on revs; guides FY14 EPS below consensus, revs below consensus (TGI) : Reports Q4 (Mar) earnings of $1.68 per share, excluding non-recurring items, $0.09 better than the Capital IQ Consensus Estimate of $1.59; revenues rose 4.2% year/year to $986.3 mln vs the $942.92 mln consensus.

Segments Aerostructures
The Aerostructures segment reported net sales for the fourth quarter of fiscal year 2013 of $720.7 million compared to $714.2 million for the prior fiscal year period, an increase of one percent, all of which was organic.

Aerospace Systems
The Aerospace Systems segment reported net sales for the fourth quarter of fiscal year 2013 of $184.1 million compared to $151.7 million for the prior fiscal year period, an increase of twenty-one percent.

Aftermarket Services
The Aftermarket Services segment reported net sales for the fourth quarter of fiscal year 2013 of $83.9 million, compared to $83.1 million for the prior fiscal year period, an increase of one percent, all of which was organic.

Guidance:
Co issues downside guidance for FY14, sees EPS of $6.30-6.40 vs. $6.85 Capital IQ Consensus Estimate; sees FY14 revs of $3.8-4.0 bln vs. $4.07 bln Capital IQ Consensus Estimate.

From a segment perspective, the company expects the following:

• Aerostructures- revenue down slightly as a result of reductions in 767 and 747-8. Excluding Jefferson Street move related costs, operating income and operating margin will increase
• Aerospace Systems- revenue up significantly due to fiscal year 2013 acquisitions with modest increase organically. Operating income up with expected margin impact from fiscal year 2013 acquisitions
• Aftermarket Services- revenues essentially flat- organic growth offsetting the impact of the sale of the Instrument Companies with growth in operating income and margins
  
  

1:33 am Hess Comments on Glass Lewis Report (HES) : Co commented on the report issued by Glass Lewis & Co. Co states: "Glass Lewis's flawed recommendations do not reflect the overwhelmingly positive support Hess' transformation plan has received from its shareholders and independent Wall Street analysts. Glass Lewis also undermines the integrity of its own analysis by raising serious concerns about the highly problematic compensation scheme put in place for Elliott Management's director candidates, questioning the independence of the same dissident nominees it supports. Hess disagrees with Glass Lewis' recommendation and believes that shareholders who follow its recommendation at a time when Hess is executing on a market-endorsed transformation plan will put the value of their investment at risk. Hess continues to urge shareholders to vote on the WHITE proxy card FOR all of its new, highly qualified, independent director nominees at the Company's 2013 Annual Shareholders Meeting, which will be held on May 16, 2013."

1:31 am Hess: Glass Lewis endorses full slate of Elliott nominees (HES) : Elliott Management announces that Glass Lewis, a leading independent proxy voting advisory firm, has recommended that Hess shareholders vote on the GREEN proxy card to support all of Elliott's independent nominees: Rodney Chase, Harvey Golub, Karl Kurz, David McManus and Mark Smith. Glass Lewis recommended that Hess shareholders "DO NOT VOTE" on the Company's white proxy card.

1:30 am Idera Pharma prices public offering of common $5 mln stock and warrants (IDRA) : Co announces pricing of (i) for a combined public offering price of $0.50 per share of common stock and related warrant, 17,500,000 shares of common stock and related warrants to purchase up to 17,500,000 shares of common stock at an exercise price of $0.47 per share, and (ii) for a combined public offering price of $0.49 per pre-funded warrant and related warrant, pre-funded warrants to purchase up to 15,816,327 shares of common stock at an exercise price of $0.01 per share and related warrants to purchase up to 15,816,327 shares of common stock at an exercise price of $0.47 per share.

1:28 am ADTRAN authorizes the repurchase of an additional 5 mln shares of the common stock to commence upon completion of the repurchase plan announced Oct. 11, 2011. (ADTN) :  

1:25 am Chevron issues statement on Canadian Jurisdictional decision in Ecuador Enforcement Proceeding (CVX) :